P ROGR AM BOOK
YES, WE FOCUS ON HIV MEDICINES. WE ALSO FOCUS ON HELPING COMMUNITIES MEET THE NEEDS OF PEOPLE WHO ARE MOST AFFECTED BY HIV.
This ad is not intended to imply that the models pictured have HIV.
ViiV Healthcare is proud to be a part of the #2017USCA family focused on ending the epidemic.
SOLELY FOCUSED ON HIV Find out more at us.viivhealthcare.com and follow us
USCA CONFERENCE PLANNING TEAM The planning team of the 2017 USCA looks forward to making your participation in this year’s conference as comfortable and as rewarding an experience as possible. If you have any questions, do not hesitate to contact the conference planning team in the Conference Operations Office which is located in Marquis Salon 15, Meeting Level 2. Below are the main points of contact for you to reach out to for any questions or concerns you might have about various aspects of USCA.
02 Welcome 06 Hotel Maps 08 Sponsors 13 General Info 24 USCA Sponsor Information 29 Program Partners
PROGRAM FORMAT 13 22 24
Program Agenda Conference Format Exhibit Hall Map
Tara Barnes-Darby Director of Conferences
Tara is your contact for all USCA-related information. She is responsible for the overall function and logistics of the conference and can also help with any additional questions you might have about USCA’s programming. Alison J. McKeithen Conferences Manager
Alison is your contact for all conference related programmatic information. She is the go-to-person for any questions about sessions, faculty, and special events. Alison can address any needs you might have about workshops and poster & affinity sessions. Shanta’ Gray
Conferences and Registration Coordinator
Shanta is your contact for conference registration and scholarship concerns. Shanta will be stationed at the “On-Site Registration” booth at conference registration on the Mezzanine Level. Safisha Mance Thomas Exhibits Coordinator
Safisha is your contact for the conference exhibit hall. She can be reached through the Exhibitor Registration booth in the foyer of the Independence and Liberty Ballrooms on Meeting Level 4. Alexis Myers
Alexis is your contact for any issues related to volunteers. She can be reached in the Volunteer Office in Marquis Salon 17. Daniel Pino
Daniel is your contact for anything social media and USCA app related. He can be reached in the Press Office in Marquis Salon 16.
THURSDAY 34 37 41
Schedule At A Glance Session 1 Session 2
FRIDAY 50 54 58
Schedule At A Glance Session 3 Session 4
SATURDAY 68 72 76 80
Schedule At A Glance Session 6 Session 7 Session 8
SUNDAY 86 88
Schedule At A Glance Session 9
EN ESPAÑOL 94
Sessions 1 through 9 1
TO THE 21ST ANNUAL UNITED STATES CONFERENCE ON AIDS
he early days of the epidemic taught me that in times of great peril, I turned to my family to survive. They were not my family by blood, but they had my heart. This year the United States Conference on AIDS will celebrate the amazing diversity of families and what that means to our work. We will celebrate our birth families, our chosen families, our work families, and, most importantly, our nontraditional families. USCA is about building a movement. We bring people together to educate them on the latest cutting-edge information and science. Hopefully, we inspire the field to stay in the work and to build bridges across the many diverse communities impacted by HIV. This meeting could not happen without our sponsors, faculty, exhibitors, and you. The fact that we are still here 21 years later is kind of unbelievable to me. Thank you for trusting us with this responsibility. We have the biological science to build pathways to end the epidemic; however, we are still working out the implementation science. How many people need to be on PrEP to bend the curve of new infections? How many people living with HIV need to have an undetectable viral load in order for a community to develop “herd” immunity? NMAC believes in, supports, and advocates for U=U (HIV Undetectable=Untransmittable). Not only does it stop the stigmatization of people as vectors, but it also gives the power back to people living with HIV. They are not the problem; they are the solution. This meeting comes back to Washington at a time of great political unrest. The future is hard to predict, but I believe in us. I was a little worried that our ACT-UP days were too far behind us, that we had become complacent and part of the system.Yet, once again, we have risen to the challenge. Our community continues to amaze me. Thank you to all the leaders who are willing to stand up and speak truth to power. Charlottesville left me sad, angry, and lost. Once again, I turned to my family, the HIV family, for comfort, support, and understanding. It’s hard to believe that in 2017 we still need to say there is no place in America for neo-Nazis and white supremacists. Whatever the fight, I know that we are ready because we have each other. We truly are family. Yours in the Struggle,
Paul Kawata Executive Director NMAC A FAMILY REUNION
The future requires we use digital media effectively. Stop by and learn how to build or sharpen your skills. VISIT THE
SOCIAL MEDIA LAB LOCATED IN
MARQUIS 14 MEETING LEVEL 2
Thursday, September 7 10:15am-12:15pm, 2:45pm-4:45pm Friday, September 8 9:00am-11:00am, 2:00pm-5:00pm Saturday, September 9 9:00am-11:00am, 2:00pm-5:00pm Sunday, September 10 9:00am-11:00am
Government of the District of Columbia
Department of Health HIV/AIDS, Hepatitis, STD and TB Administration
August 22, 2017 Dear USCA Attendees: On behalf of Washington, DC Mayor Muriel Browser, welcome to the 21st Annual United States Conference on AIDS (USCA). Washington, DC had the honor to host USCA two years ago. Since 2015, the HIV community has seen tremendous advances and potential risks to our progress. It is very timely to convene in our nation’s capital to demonstrate the diversity, expertise and commitment of people living with and at risk of HIV. In the past two years, DC embraced the strategy to accelerate our goals for HIV with Mayor Bowser’s 90/90/90/50 Plan Ending the HIV Epidemic in the District of Columbia by 2020. The Plan goals are 90% of HIV-positive residents know their status, 90% of residents diagnosed on treatment, 90% of residents on treatment reach viral load suppression with a 50% reduction in new HIV infections. Complemented by our Integrated HIV Care and Prevention Plan, Washington, DC is setting ambitious goals to enhance routine and focused HIV testing, ensuring immediate access to medical care and rapid treatment initiation, support for adherence to viral load suppression, and expanding prevention options, primarily PrEP, PEP, syringe services and condom distribution. Community engagement, public-private partnerships, research and innovation are key principles that inform and drive our approaches and resources. Recently, we endorsed the research-based Undetectable equals Untransmittable or #UequalsU consensus statement as DC believes that persons living with HIV are the leaders and solution to achieve our goal of ending the epidemic. DC recognizes that reaching improved HIV health outcomes can only be accomplished by ensuring individual success and community equity and justice. We champion economic opportunity, housing stability, health insurance, gender identity, sex positivity, drug user health, stigma reduction and well-being regardless of age, race, ethnicity, sexual orientation, legal status and residence. We are a family and the conference’s theme “Our Family Reunion” speaks meaningfully to our lives and work more today than ever. We extend our appreciation to the host committee and the many volunteers who assisted with making sure that this conference is successful and that each conference attendee feels welcomed. Sincerely,
Michael Kharfen Senior Deputy Director 899 North Capitol Street, N.E. • 4th Floor • Washington, D.C. 20002 • Phone (202) 671-4900 • Fax (202) 671-4860
PARTNERING WITH PATIENTS, PROVIDERS, AND THE COMMUNITY.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Â©2017 Bristol-Myers Squibb Company, Princeton, NJ 08543, U.S.A. EVOTAZ is a registered trademark of Bristol-Myers Squibb Company.
7/27/17 12:41 PM
HOTEL MAPS SECOND FLOOR MEZZANINE
A Dahlia B C D E F G H
Boardroom Dahlia Foyer Business Center Geranium Holly Maple Honeysuckle Tulip
Silver Linden Scarlet Oak Dogwood Cherry Blossom Magnolia N Rose Garden Boardroom O Rose Garden Foyer I J K L M
G F E D C
A MEETING LEVEL 1
A B C D E F G
University of DC Catholic University Galludet University Howard University Georgetown University George Washington University American University
MEETING LEVEL 2
A B C D E F G H
G H I
Salon Salon Salon Salon Salon Salon Salon Salon
1 2 3 4 5 6 7 8
I J K L M N O P Q
Salon Salon Salon Salon Salon Salon Salon Salon Salon
9 10 11 12 13 14 15 16 17
O N A B
MEETING LEVEL 3
A Shaw B C
E F G
LeDroit Park Judiciary Square Mount Vernon Square Chinatown Union Station Penn Quarter Adams Morgan
R P MEETING LEVEL 4
A B C D E F G H I J K L
Salon Salon Salon Salon Salon Salon Salon Salon Salon Salon Salon Salon
A B C D E F G H I J K L
S M N O P Q R S T U V W X Y
Salon M Salon N Salon O Salon P Monument Supreme Court Senate Capitol Congress Mint Treasury Archives Pentagon
Dupont Circle Woodley Park L’Enfant Plaza Gallery Place Eastern Market Farragut North Capitol Hill Anacostia
I J K L M N O
SALONS A — H LIBERTY BALLROOM
SALONS I — P
SPONSORS PRESENTING SPONSOR
A special thank you to our sponsors who have made significant contributions to the United States Conference on AIDS.
Take comfort in knowing we have your back.
Letâ&#x20AC;&#x2122;s Grow Old Together From prevention to treatment, our HIV-specialized pharmacists provide confidential support every step of the way. To learn more, visit us at booth 207 or go to HIV.Walgreens.com. ÂŠ2017 Walgreen Co. All rights reserved.
“Learning is part of my journey. Asking questions helps me feel more confident.”
PREZCOBIX® (prez-koe-bix) (darunavir and cobicistat) tablets
What is PREZCOBIX® used for? PREZCOBIX® is a prescription HIV-1 (Human Immunodeficiency Virus 1) medicine used with other antiretroviral medicines to treat HIV-1 infection in adults. HIV is the virus that causes AIDS (Acquired Immune Deficiency Syndrome). PREZCOBIX® contains prescription medicines PREZISTA® (darunavir) and TYBOST® (cobicistat). PREZCOBIX® does not cure HIV-1 infection or AIDS. You must keep taking HIV-1 medicines to control HIV-1 infection and decrease HIV-related illnesses. What are the most serious warnings about PREZCOBIX®? • PREZCOBIX® may cause liver problems which may be life-threatening. Tell your healthcare provider right away if you have any symptoms such as: • Vomiting • Dark (tea-colored) urine • Pain or tenderness on your right side below your ribs • Yellowing of your skin or the whites of your eyes • Loss of appetite • Pale-colored stools (bowel movements) • Nausea • PREZCOBIX® may cause severe or life-threatening skin reactions or rashes. Stop taking PREZCOBIX® and call your healthcare provider right away if you develop any skin changes with symptoms below: • Blisters or skin lesions • Fever • Mouth sores or ulcers • Tiredness • Red or inflamed eyes, like “pink eye” (conjunctivitis) • Muscle or joint pain • PREZCOBIX,® when taken with some other medications, can cause new or worse kidney problems, including kidney failure. What do I need to tell my healthcare provider? Tell your healthcare provider if you: • Have liver problems, including hepatitis B or hepatitis C • Have kidney problems • Are allergic to sulfa (sulfonamide) • Have diabetes • Have hemophilia • Have any other medical condition
• Are pregnant or plan to become pregnant. (It is not known if PREZCOBIX® will harm your unborn baby. Tell your healthcare provider if you become pregnant while taking PREZCOBIX.®) • Are breastfeeding or plan to breastfeed. Do not breastfeed if you take PREZCOBIX® because it is unknown if PREZCOBIX® can pass into your breast milk. You should not breastfeed if you have HIV-1 because of the risk of passing HIV to your baby.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Some medications may prevent PREZCOBIX® from working or cause increased side effects. Do not start taking a new medicine without telling your healthcare provider. Who should not take PREZCOBIX®? • Do not take PREZCOBIX® with any of the following medicines: alfuzosin (Uroxatral®), carbamazepine (Carbatrol®, Epitol®, Equetro®, Tegretol®, Tegretol-XR®, Teril®), cisapride (Propulsid®), colchicine (Colcrys,® Mitigare,® if you have liver or kidney problems), dronedarone (Multaq®), elbasvir and grazoprevir (Zepatier®), dihydroergotamine (D.H.E.45,® Migranal®), ergotamine tartrate (Cafergot ,® Ergomar ,® Ergostat ,® Medihaler,® Migergot,® Wigraine,® Wigrettes®), methylergonovine (Methergine®), lovastatin or a product that contains lovastatin (Altoprev,® Advicor,® Mevacor ®), lurasidone (Latuda®), oral midazolam (Versed®), phenobarbital (Luminal®), phenytoin (Dilantin®, Dilantin-125®, Phenytek®), pimozide (Orap®), ranolazine (Ranexa®), rifampin (Rifadin,® Rifater,® Rifamate,® Rimactane®), sildenafil (Revatio®) when used for pulmonary arterial hypertension (PAH), simvastatin or a product that contains simvastatin (Simcor,® Vytorin,® Zocor ®), St. John’s Wort (Hypericum perforatum) or a product that contains St. John’s Wort, or triazolam (Halcion®). • Serious problems can happen if you take any of these medicines with PREZCOBIX.® What are the possible side effects of PREZCOBIX®? PREZCOBIX® may cause serious side effects including: • Diabetes and high blood sugar • Changes in body fat can happen in people taking HIV-1 medications • Immune system changes (Immune Reconstitution Syndrome) can happen in people who start HIV-1 medications • Increased bleeding can occur in people with hemophilia who are taking PREZCOBIX.® The most common side effects are: • Diarrhea • Headache • Nausea • Stomach area (abdominal) pain • Rash • Vomiting Tell your doctor if you have any side effect that bothers you or that does not go away. These are not all of the possible side effects of PREZCOBIX®. For more information, ask your healthcare provider. What should I know about this Brief Summary? This information is not complete. To get more information: • Talk to your healthcare provider or pharmacist • Visit www.PREZCOBIX.com to read over the FDA-approved product labeling and patient information • Call to report side effects either to the FDA at 1-800-FDA-1088 or to Janssen Products, LP at 1-800-JANSSEN (1-800-526-7736). © Janssen Therapeutics, Division of Janssen Products, LP 2017 05/17 054195-170522
“RESISTANCE IS A RISK I TAKE SERIOUSLY.” Everyone is at risk of developing drug resistance. So when deciding on an HIV treatment, think long-term. Once-Daily* PREZCOBIX® has a high genetic barrier to resistance, which may help. PREZCOBIX® is taken in combination with other HIV medications for the treatment of HIV-1 infection in adults. *
Wisdom inspired by real people
ASK YOUR DOCTOR ABOUT DRUG RESISTANCE AND ONCE-DAILY
WHAT IS PREZCOBIX®?
• It is not known if PREZCOBIX® is safe and effective in children under 18 years of age. • When used with other antiretroviral medicines to treat HIV-1 infection, PREZCOBIX® may help: ○ reduce the amount of HIV-1 in your blood. This is called “viral load.” ○ increase the number of CD4+ (T) cells in your blood that help fight off other infections. • PREZCOBIX is always taken in combination with other HIV medications for the treatment of HIV-1 infection in adults. PREZCOBIX® should be taken once daily with food. ®
• PREZCOBIX® does not cure HIV-1 infection or AIDS, and you may still experience illnesses associated with HIV-1 infection. You must keep taking HIV-1 medicines to control HIV-1 infection and decrease HIV-related illnesses. • Ask your healthcare provider if you have any questions on how to prevent passing HIV to other people. • Please read the Important Safety Information below and talk to your healthcare provider to learn if PREZCOBIX® is right for you.
IMPORTANT SAFETY INFORMATION What is the most important information I should know about PREZCOBIX®? • PREZCOBIX® may cause liver problems. Some people taking PREZCOBIX® may develop liver problems which may be life-threatening. Your healthcare provider should do blood tests before and during your treatment with PREZCOBIX.® ○ Chronic hepatitis B or C infection may increase your chance of developing liver problems. Your healthcare provider should check your blood tests more often. ○ Signs and symptoms of liver problems include dark (tea-colored) urine, yellowing of your skin or whites of your eyes, pale-colored stools (bowel movements), nausea, vomiting, pain or tenderness on your right side below your ribs, or loss of appetite. Tell your healthcare provider if you develop any of these symptoms. • PREZCOBIX® may cause severe or life-threatening skin reactions or rash. Sometimes these skin reactions and skin rashes can become severe and require treatment in a hospital. Call your healthcare provider right away if you develop a rash. ○ Stop taking PREZCOBIX® and call your healthcare provider right away if you develop any skin changes with symptoms such as fever, tiredness, muscle or joint pain, blisters or skin lesions, mouth sores or ulcers, red or inflamed eyes like “pink eye” (conjunctivitis). • PREZCOBIX,® when taken with certain other medicines, can cause new or worse kidney problems, including kidney failure. Your healthcare provider should check your kidneys before you start and while you are taking PREZCOBIX.® Who should not take PREZCOBIX®? • Do not take PREZCOBIX® with any of the following medicines: alfuzosin (Uroxatral®), carbamazepine (Carbatrol® Epitol®, Equetro®, Tegretol®, Tegretol-XR®, Teril®) cisapride (Propulsid®), colchicine (Colcrys®, Mitigare®, if you have liver or kidney problems), dronedarone (Multaq®), elbasvir and grazoprevir (Zepatier®), dihydroergotamine (D.H.E.45®, Migranal®), ergotamine tartrate (Cafergot®, Ergomar®,
Ergostat®, Medihaler®, Migergot®, Wigraine®, Wigrettes®), methylergonovine (Methergine®), lovastatin or a product that contains lovastatin (Altoprev®, Advicor®, Mevacor®), lurasidone (Latuda®), oral midazolam (Versed®), phenobarbital (Luminal®), phenytoin (Dilantin®, Dilantin-125®, Phenytek®), pimozide (Orap®), ranolazine (Ranexa®), rifampin (Rifadin®, Rifater®, Rifamate®, Rimactane®), sildenafil (Revatio®) when used for pulmonary arterial hypertension (PAH), simvastatin or a product that contains simvastatin (Simcor®, Vytorin®, Zocor®), St. John’s Wort (Hypericum perforatum) or a product that contains St. John’s Wort, or triazolam (Halcion®). • Serious problems can happen if you take any of these medicines with PREZCOBIX.® What should I tell my healthcare provider before taking PREZCOBIX®? • About all health problems. Tell your healthcare provider if you have liver problems, including hepatitis B or hepatitis C, have kidney problems, are allergic to sulfa (sulfonamide), have diabetes, have hemophilia, or have any other medical condition, are pregnant, breastfeeding, or plan to become pregnant or breastfeed. Tell your healthcare provider if you become pregnant while taking PREZCOBIX.® • About all medicines you take. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Some medicines interact with PREZCOBIX.® Keep a list of your medicines to show your healthcare provider and pharmacist. Do not start taking a new medicine without telling your healthcare provider. Your healthcare provider can tell you if it is safe to take PREZCOBIX® with other medicines. What are the possible side effects of PREZCOBIX®? • The most common side effects of darunavir, one of the medicines in PREZCOBIX,® include diarrhea, nausea, rash, headache, stomach area (abdominal) pain, and vomiting. • Other possible side effects include: ○ High blood sugar, diabetes or worsening diabetes, and increased bleeding in people with hemophilia have been reported in patients taking protease inhibitor medicines, including PREZCOBIX.® ○ Changes in body fat can happen in people who take HIV-1 medicines. The exact cause and long-term health effects of these changes are not known. ○ Changes in your immune system (Immune Reconstitution Syndrome) can happen when you start taking HIV medicines. Your immune system may get stronger and begin to fight infections that have been hidden in your body for a long time. These are not all of the possible side effects of PREZCOBIX.® For more information, ask your healthcare provider. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report side effects to Janssen Products, LP at 1-800-JANSSEN (1-800-526-7736). Please read accompanying Important Brief Summary for PREZCOBIX®. Janssen Therapeutics, Division of Janssen Products, LP © Janssen Therapeutics, Division of Janssen Products, LP 2017 07/17 068102-170627
• PREZCOBIX® is a prescription HIV-1 (Human Immunodeficiency Virus 1) medicine used with other antiretroviral medicines to treat HIV-1 infection in adults. HIV is the virus that causes AIDS (Acquired Immune Deficiency Syndrome). PREZCOBIX® contains the prescription medicines PREZISTA® (darunavir) and TYBOST® (cobicistat).
GENERAL INFO Affinity Sessions
Affinity sessions are impromptu meetings of conference attendees who want to discuss a particular subject. To schedule an affinity session and receive a room assignment, visit the Conference Operations Office, located in Marquis Salon 15 on Meeting Level 2 of the Marriott Marquis. Announcements for affinity sessions may be placed on the Affinity Session Board located near registration. The affinity session schedule is as follows: Thurs..........................5:00 pm – 6:00 pm Fri...............................6:30 pm – 7:30 pm Sat..............................6:30 pm – 7:30 pm Badges
Conference attendees must wear their official conference badge to all educational sessions, plenary sessions, special events and the exhibit hall. For your safety, do not wear your badge outside of the convention hotel. Security will not allow conference attendees to enter plenary sessions or the exhibit hall without a badge. A $10.00 fee will be assessed for replacement badges. Continuing Education Units
General continuing education units (CEUs) will be available for conference attendees. USCA is a provider of Category I continuing education contact hours for certified health education specialists and social workers. Please visit the Continuing Education Desk located at conference registration on the Mezzanine Level for additional information.
Your feedback provides important information to help us improve USCA in the future. Please take a few minutes to share your thoughts and input by completing the conference evaluation forms. Information about completing evaluation forms will be available in all of the sessions and in the conference app.
For the health and comfort of conference participants, smoking is not permitted in any of the conference areas. Thank you for your consideration and cooperation.
The exhibit hall is located in the Independence and Liberty Ballrooms on Meeting Level 4. USCA conference partners, government agencies, community-based organizations, pharmaceutical companies and many others will showcase their exhibits, providing valuable information and giveaways. Complimentary desserts will be offered in the exhibit hall on select days. The exhibit hall will be open during the following hours: Thursday..................10:30 am – 5:00 pm Friday–Saturday.......10:00 am – 5:00 pm (closed during plenary sessions)
Medical Service Information
For any medical emergency, please call extension 59667 (within the Marriott). Inform the hotel operator of the nature of the emergency and location. A specific response team of hotel managers will immediately respond. In non-emergency situations, the following is a list of nearby medical facilities: Howard University Hospital 2041 Georgia Ave NW Washington, DC 20060 (202) 865-6100 George Washington University Hospital 900 23rd St NW Washington, DC 20037 (202) 715-4000
PLWHIV Respite Lounge
The PLWHIV Respite Lounge will be staffed by volunteers from the Host Committee and on-call health providers. The lounge will be open during the following days and times (location will be announced on-site): Wed............................4:00 pm – 7:00 pm Thurs – Sat.................8:00 am – 5:00 pm Sun............................. 8:00 am – 12 noon Sign Language Interpreters
Sign language interpreters are available upon request. This service may be requested through the Conference Operations Office located in Marquis Salon 15 on Meeting Level 2 of the Marriott Marquis. Social Media Lab
This year’s Social Media Lab is brought to you by HIV.gov. Stop by Marquis Salon 14 on the 2nd floor to learn more about ways to connect digitally with fellow conference attendees and boost your advocacy skills on digital landscapes. Thurs......................10:15 am – 12:15 pm ..................................2:45 pm – 4:45 pm Fri.............................9:00 am – 11:00 am ..................................2:00 pm – 5:00 pm Sat.............................9:00 am – 11:00am ..................................2:00 pm – 5:00 pm Sun...........................9:00 am – 11:00 am Walgreens Locations
1155 F St NW, Washington, DC 20005 (202) 969-8814
Notes for conference attendees may be posted on the Message Board, located near Conference Registration.
801 7th St NW, Washington, DC 20001 (202) 789-5345
Conference Operations Office
9:00 am – 5:00 pm
Session 1 Workshops 10:15 am – 12:15 pm
The Conference Operations Office is located in Marquis Salon 15 on Meeting Level 2 of the Marriott Marquis. Feel free to stop by the office with conference-related questions and concerns during the following times: Wed..... 4:00 Thurs... 8:00 Fri........ 8:00 Sat....... 8:00 Sun...... 9:00
pm – 7:00 am – 6:00 am – 6:00 am – 6:00 am – 2:00
pm pm pm pm pm
8:00 am – 10:00 am
HIV/STD Action Day
Opening Plenary Breakfast
All attendees must register for the conference. The registration desk is located 2:00 pm on Second Floor Mezzanine Level and is open during the 3:00 pm following hours: Wed......4:00 pm – 7:00 pm Thurs.....7:30 am – 5:00 pm Fri.........8:30 am – 5:00 pm Sat........9:00 am – 3:00 pm
REGISTRATION OPENS 4:00 pm – 7:00 pm
EXHIBIT HALL / 10:30 am – 5:00 pm
REGISTRATION / 7:30 am – 5:00 pm
Plenary Lunch 12:30 pm – 2:30 pm
Session 2 Workshops 2:45 pm – 4:45 pm
Affinity Session 5:00 pm – 6:00pm
Welcome Reception 6:00 pm – 8:00 pm 7:00 pm
7:30 am 8:00 am
Session 3 Workshops
Session 6 Workshops
Session 9 Workshops
9:00 am – 11:00 am
9:00 am – 11:00 am
9:00 am – 11:00 am
11:30 am – 1:30 pm
Poster Presentations Session 4 Workshops 2:00 pm – 4:00 pm
EXHIBIT HALL / 10:00 am – 5:00 pm
REGISTRATION / 9:00 am – 5:00 pm
EXHIBIT HALL / 10:00 am – 5:00 pm
REGISTRATION / 8:30 am – 5:00 pm
Closing Plenary Lunch
11:30 am – 1:30 pm
11:30 am – 1:30 pm
Poster Presentations Session 7 Workshops 2:00 pm – 4:00 pm
Session 5 Workshops
Session 8 Workshops
4:15 pm – 6:15 pm
4:15 pm – 6:15 pm
6:30 pm – 7:30pm
6:30 pm – 7:30pm
TRIUMEQ is a once-a-day pill used to treat HIV-1. In some people, TRIUMEQ should not be used by itself. Take TRIUMEQ exactly as your healthcare provider tells you. APPROVED USES TRIUMEQ is a prescription HIV-1 (Human Immunodeficiency Virus-type 1) medicine used alone or with other antiretroviral medicines to treat HIV-1 infection in adults. HIV-1 is the virus that causes AIDS. TRIUMEQ is not for use by itself in people who have or have had resistance to abacavir, dolutegravir, or lamivudine. TRIUMEQ should not be used in children under the age of 18. TRIUMEQ does not cure HIV-1 or AIDS. You must keep taking HIV-1 medicines to control HIV-1 infection and decrease HIV-related illnesses.
IMPORTANT SAFETY INFORMATION What is the most important information I should know about TRIUMEQ? TRIUMEQ can cause serious side effects, including: • Serious allergic reactions (hypersensitivity reaction) that can cause death have happened with TRIUMEQ and other abacavir-containing products. Your risk of this allergic reaction to abacavir is much higher if you have a gene variation called HLA-B*5701. Your healthcare provider can determine with a blood test if you have this gene variation. If you get symptoms from 2 or more of the following groups while taking TRIUMEQ, call your healthcare provider right away: 1. fever; 2. rash; 3. nausea, vomiting, diarrhea, or stomach pain; 4. generally ill feeling, extreme tiredness, or achiness; 5. shortness of breath, cough, or sore throat. Your pharmacist will give you a Warning Card with a list of these symptoms. Carry this Warning Card with you at all times. If you stop taking TRIUMEQ because of an allergic reaction, never take TRIUMEQ or any other abacavir- or dolutegravir-containing medicines again. If you have an allergic reaction, dispose of any unused TRIUMEQ. Ask your pharmacist how to properly dispose of medicines. If you take TRIUMEQ or any other abacavir-containing medicine again after you have had an allergic reaction, within hours you may get life-threatening symptoms that may include very low blood pressure or death. If you stop TRIUMEQ for any other reason, even for a few days, and you are not allergic to TRIUMEQ, talk with your healthcare provider before taking it again. Taking TRIUMEQ again can cause a serious allergic or life-threatening reaction, even if you never had an allergic reaction to it before. If your healthcare provider tells you that you can take TRIUMEQ again, start taking it when you are around medical help or people who can call a healthcare provider if you need one. • A buildup of acid in your blood (lactic acidosis). Lactic acidosis can happen in some people who take TRIUMEQ. This serious medical emergency can cause death. Call your healthcare provider right away if you feel very weak or tired; have unusual muscle pain; have trouble breathing; have stomach pain with nausea and vomiting; feel cold, especially in your arms and legs; feel dizzy/light-headed; or have a fast/irregular heartbeat. • Serious liver problems can happen in people who take TRIUMEQ. In some cases, these serious liver problems can lead to death. You may be more likely to get lactic acidosis or serious liver problems if you are female, very overweight (obese), or have been taking nucleoside analogue medicines for a long time. Call your healthcare provider right away if you get any of the following signs or symptoms: • yellow skin, or the white part of the eyes turns yellow (jaundice); dark urine; light-colored stools; loss of appetite for several days or longer; nausea; pain, aching, or tenderness on the right side of your stomach area • Worsening of hepatitis B virus in people who have HIV-1 infection. If you have HIV-1 and hepatitis B virus (HBV), your HBV may get worse (flare-up) if you stop taking TRIUMEQ. A “flare-up” is when your HBV suddenly returns in a worse way than before. Worsening liver disease can be serious and may lead to death. Do not stop taking TRIUMEQ without first talking to your healthcare provider, so he or she can monitor your health. • Resistant hepatitis B virus. If you have HIV-1 and hepatitis B, the hepatitis B virus can change (mutate) during your treatment with TRIUMEQ and become harder to treat (resistant). ©2017 ViiV Healthcare group of companies. All rights reserved. Printed in USA. 821418R0 July 2017
• Use with interferon and ribavirin-based regimens. If you’re taking TRIUMEQ and interferon, with or without ribavirin, tell your healthcare provider about any new symptoms. Worsening of liver disease that has caused death has happened in people infected with both HIV-1 and hepatitis C who were taking antiretroviral medicines and interferon. Who should not take TRIUMEQ? • Do not take TRIUMEQ if you: • have the HLA-B*5701 gene variation • are allergic to abacavir, dolutegravir, or any of the ingredients in TRIUMEQ • take dofetilide (Tikosyn®) • have liver or kidney problems What are other possible side effects of TRIUMEQ? • People with a history of hepatitis B or C virus may have an increased risk of developing new or worsening changes in certain liver tests during treatment with TRIUMEQ. Your healthcare provider may do tests to check your liver function before and during treatment with TRIUMEQ. • When you start taking HIV-1 medicines, your immune system may get stronger and begin to fight infections that have been hidden in your body for a long time. Tell your healthcare provider right away if you start having new symptoms after you start taking TRIUMEQ. • Changes in body fat distribution can happen in people who take HIV-1 medicines. • Some HIV-1 medicines, including TRIUMEQ, may increase your risk of heart attack. The most common side effects of TRIUMEQ include: trouble sleeping, headache, tiredness These are not all the possible side effects of TRIUMEQ. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. What should I tell my healthcare provider before taking TRIUMEQ? • Before you take TRIUMEQ, tell your healthcare provider if you: • have been tested and know whether or not you have a gene variation called HLA-B*5701 • have or have had liver problems, including hepatitis B or C infection; have kidney problems; have heart problems, smoke, or have diseases that increase your risk of heart disease such as high blood pressure, high cholesterol, or diabetes; drink alcohol or take medicines that contain alcohol • are pregnant or plan to become pregnant. It is not known if TRIUMEQ will harm your unborn baby • are breastfeeding or plan to breastfeed. Do not breastfeed if you take TRIUMEQ • You should not take TRIUMEQ if you also take: • abacavir (EPZICOM®, TRIZIVIR®, or ZIAGEN®) • lamivudine (COMBIVIR®, DutrebisTM, EPIVIR®, EPIVIR-HBV®, EPZICOM, or TRIZIVIR) • emtricitabine (Emtriva®, Atripla®, Complera®, Stribild®, or Truvada®) Important Safety Information continued on next page
Peter Diagnosed with HIV in 2015
Garland Diagnosed with HIV in 2016
Leo Diagnosed with HIV in 2003
Jeannette Diagnosed with HIV in 2011
Jack Diagnosed with HIV in 2010
Real patients with HIV-1 taking TRIUMEQ as of 2014 or later. Individual results may vary. Individuals compensated for their time by ViiV Healthcare.
â&#x20AC;˘ Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines (for example, antacids or laxatives; vitamins such as iron or calcium supplements; anti-seizure medicines; other medicines to treat HIV-1, hepatitis, or tuberculosis; metformin; or methadone), vitamins, and herbal supplements (for example, St. Johnâ&#x20AC;&#x2122;s wort). Some medicines interact with TRIUMEQ. Keep a list of your medicines to show your healthcare provider and pharmacist. Do not start taking a new medicine without telling your healthcare provider. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Please see Important Facts about TRIUMEQ on the following pages.
Ask your doctor about
learn more at
This is only a brief summary of important information about TRIUMEQ and does not replace talking to your healthcare provider about your condition and your treatment. (TRI-u-meck) MOST IMPORTANT INFORMATION ABOUT TRIUMEQ
TRIUMEQ® may cause serious side effects, including: • Serious allergic reactions (hypersensitivity reaction) that can cause death have happened with TRIUMEQ and other abacavir-containing products. Your risk of this allergic reaction to abacavir is much higher if you have a gene variation called HLA-B*5701. Your healthcare provider can determine with a blood test if you have this gene variation. If you get symptoms from 2 or more of the following groups while taking TRIUMEQ, call your healthcare provider right away: 1. fever; 2. rash; 3. nausea, vomiting, diarrhea, or stomach pain; 4. generally ill feeling, extreme tiredness, or achiness; 5. shortness of breath, cough, or sore throat. A list of these symptoms is on the Warning Card your pharmacist gives you. Carry this Warning Card with you at all times. • If you stop taking TRIUMEQ because of an allergic reaction, never take TRIUMEQ or any other abacavir- or dolutegravir-containing medicines again. If you have an allergic reaction, dispose of any unused TRIUMEQ. Ask your pharmacist how to properly dispose of medicines. If you take TRIUMEQ or any other abacavir-containing medicine again after you have had an allergic reaction, within hours you may get life-threatening symptoms that may include very low blood pressure or death. If you stop TRIUMEQ for any other reason, even for a few days, and you are not allergic to TRIUMEQ, talk with your healthcare provider before taking it again. Taking TRIUMEQ again can cause a serious allergic or life-threatening reaction, even if you never had an allergic reaction to it before. If your healthcare provider tells you that you can take TRIUMEQ again, start taking it when you are around medical help or people who can call a healthcare provider if you need one. • Build-up of lactic acid in your blood (lactic acidosis), which is a serious medical emergency that can lead to death. Call your healthcare provider right away if you have any of these symptoms: feeling very weak or tired, unusual muscle pain, trouble breathing, stomach pain with nausea or vomiting, feeling cold (especially in your arms and legs), feeling dizzy or lightheaded, and/or a fast or irregular heartbeat. • Serious liver problems, which in some cases can lead to death. Call your healthcare provider right away if you have any of these symptoms: your skin or the white part of your eyes turns yellow (jaundice), dark “tea-colored” urine, light-colored stools (bowel movements), loss of appetite for several days or longer, nausea, and/or stomach pain on the right side.
You may be more likely to get lactic acidosis or severe liver problems if you are female, very overweight, or have been taking nucleoside analogues for a long time. • Worsening of Hepatitis B (HBV) infection. If you have both HIV-1 and HBV, your HBV may suddenly get worse if you stop taking TRIUMEQ. Do not stop taking TRIUMEQ without first talking to your healthcare provider, as they will need to check your health regularly for several months. • Resistant HBV. If you have HIV-1 and HBV, the HBV can change (mutate) while you’re on TRIUMEQ and become harder to treat (resistant). • Use with interferon and ribavirin-based regimens. Worsening of liver disease that has caused death has happened in people infected with both HIV-1 and hepatitis C virus who are taking antiretroviral medicines and are also being treated for hepatitis C with interferon with or without ribavirin. If you are taking TRIUMEQ and interferon with or without ribavirin, tell your HCP if you have any new symptoms. ABOUT TRIUMEQ
• TRIUMEQ is a prescription HIV-1 medicine used alone or with other antiretroviral medicines to treat HIV-1 infection in adults. TRIUMEQ is not for use by itself in people who have or have had resistance to abacavir, dolutegravir, or lamivudine. TRIUMEQ should not be used in children under the age of 18. • TRIUMEQ does not cure HIV-1 infection or AIDS. You must keep taking HIV-1 medicines to control HIV-1 infection and decrease HIV-related illnesses. DO NOT TAKE TRIUMEQ IF YOU
• have a certain type of gene variation called the HLA-B*5701 allele. Your HCP will test you for this before prescribing treatment with TRIUMEQ. • are allergic to abacavir, dolutegravir, or any of the ingredients in TRIUMEQ. See the full Medication Guide for a complete list of ingredients in TRIUMEQ. • take dofetilide (Tikosyn®). Taking TRIUMEQ and dofetilide (Tikosyn) can cause side effects that may be lifethreatening. • have liver or kidney problems. • If you also take: abacavir (EPZICOM, TRIZIVIR, or ZIAGEN); lamivudine (COMBIVIR®, DutrebisTM, EPIVIR®, EPIVIR-HBV®, EPZICOM, or TRIZIVIR); emtricitabine (Atripla®, Complera®, Emtriva®, Stribild®, or Truvada®).
IMPORTANT FACTS (cont’d) BEFORE TAKING TRIUMEQ
Tell your healthcare provider if you: • have been tested and know if you have a particular gene variation called HLA-B*5701. • have or had any kidney or liver problems, including hepatitis B or C virus infection. • have heart problems, smoke, or have diseases that increase your risk of heart disease such as high blood pressure, high cholesterol, or diabetes. • drink alcohol or take medicines that contain alcohol. • are pregnant or plan to become pregnant. It is not known if TRIUMEQ will harm your unborn baby. • are breastfeeding (nursing) or plan to breastfeed. Do not breastfeed if you have HIV-1 because of the risk of passing HIV-1 to your baby. Tell your healthcare provider about all the medicines you take: • Keep a list that includes all prescription and over-thecounter medicines, vitamins, and herbal supplements, and show it to your healthcare provider and pharmacist. • Ask your healthcare provider or pharmacist about medicines that should not be taken with TRIUMEQ. Do not start taking a new medicine without telling your healthcare provider. MEDICINES THAT MIGHT INTERACT WITH TRIUMEQ
• antacids, laxatives, or other medicines that contain aluminum, magnesium, sucralfate (Carafate®), or buffered medicines. TRIUMEQ should be taken at least 2 hours before or 6 hours after you take these medicines. • iron or calcium supplements taken by mouth may be taken at the same time with TRIUMEQ if taken with food. Otherwise, TRIUMEQ should be taken at least 2 hours before or 6 hours after you take these medicines. • anti-seizure medicines: oxcarbazepine (Trileptal ®), phenytoin (Dilantin ®, Dilantin ® -125, Phenytek ® ), phenobarbital, carbamazepine (Carbatrol®, Equetro ®, Tegretol®, Tegretol®-XR, Teril®, Epitol®). • any other medicine to treat HIV-1, medicines used to treat hepatitis virus infections (such as interferon or ribavirin), a medicine that contains metformin, methadone, rifampin (Rifater ®, Rifamate®, Rimactane®, Rifadin®), St. John’s wort (Hypericum perforatum). POSSIBLE SIDE EFFECTS OF TRIUMEQ
TRIUMEQ can cause serious side effects including: • See “What is the most important information about TRIUMEQ?” section • Changes in liver tests • Changes in your immune system (cont’d)
• Changes in body fat distribution • Some HIV-1 medicines including TRIUMEQ may increase your risk of heart attack. The most common side effects of TRIUMEQ are: trouble sleeping, headache, and tiredness. These are not all the possible side effects of TRIUMEQ. Tell your healthcare provider right away if you have any new symptoms while taking TRIUMEQ. Your healthcare provider will need to do tests to monitor your health before and during treatment with TRIUMEQ. You may report side effects to FDA at 1-800-FDA-1088. GET MORE INFORMATION
• Talk to your healthcare provider or pharmacist. • Go to TRIUMEQ.com or call 1-877-844-8872, where you can also get FDA-approved product labeling. COMBIVIR, EPIVIR, EPZICOM, TIVICAY, TRIUMEQ, TRIZIVIR, and ZIAGEN are registered trademarks of the ViiV Healthcare group of companies. EPIVIR-HBV is a registered trademark of the GSK group of companies. The other brands listed are trademarks of their respective owners and are not trademarks of the ViiV Healthcare group of companies. The makers of these brands are not affiliated with and do not endorse the ViiV Healthcare group of companies or its products. ©2017, ViiV Healthcare group of companies. All rights reserved. April 2017 TRM:5MG
Planned Parenthood Federation of America congratulates the
National Minority AIDS Council on its work in the ﬁght to achieve health equity for all, and is proud to sponsor the 2017 U.S. Conference on AIDS. Each year, our health centers provide more than 650,000 HIV tests and link patients living with HIV to treatment and care, an essential step in saving lives and reducing transmission rates. Additionally, more than one-third of Planned Parenthood health centers currently offer Pre-Exposure Prophylaxis (PrEP) as an integral component of their comprehensive HIV prevention programs and services alongside other critical prevention methods such as condoms. We are committed to working with pioneering organizations like the
National Minority AIDS Council to increase access to prevention, testing, linkage to care, and early treatment for the populations that need it most.
For more than 100 years, Planned Parenthood has been one of the nation’s leading providers of high-quality, affordable health care and the nation’s largest provider of sex education, serving 2.4 million every year.
CONFERENCE FORMAT Tracks
Biomedical HIV Prevention
Cis & Trans Women
Gay Men (focus on youth)
People Living with HIV (focus on stigma & aging)
Biomedical HIV prevention has expanded options to stop the spread of the virus. This new track will focus on PrEP (Pre-Exposure Prophylaxis), PEP (Post Exposure Prophylaxis), Treatment as Prevention (TasP) and START (Strategic Timing of AntiRetroviral Treatment). It will discuss the latest innovations, programs and targets in order to scale up biomedical HIV prevention programs at your agency, city or state.
What skills are needed to be an effective leader in the fight to end HIV? This skills building track focuses on leadership within CBOs, health centers, activist groups, and the government. Leaders are also getting old, when is it time to leave? How do you manage transition? How should our movement identify, nurture and grow the next generation? What can our movement do to support existing leaders?
What are the latest advances in services for women living with HIV or at risk for HIV? What are the opportunities, challenges and innovations in HIV prevention, treatment, housing, and healthcare? What are the effective trauma-informed care and HIV-related violence prevention programs? Is your agency open to cis and trans women directors, clients or board members?
This track will focus on what it means to live with HIV in America. PLWH are not a monolithic community and should not be treated like they are all the same. Stigma will be a major focus. This track will also cover aging, empowerment, self-determination, the criminal justice system, advocacy, and building a PLWH movement. The main focus will be for consumers; however, the conference also hopes to have a dialogue between providers and people living with the virus.
Gay men continue to have the highest rate of new infections and the largest number of people living with HIV in America. This track will focus on young gay men, particularly young gay men of color. Youth have the highest rates of new infections. What are the opportunity, challenges and innovations in HIV prevention, services, outreach, housing, treatment and healthcare? Is your agency open to gay men who could be directors, clients or board members?
This track will focus on city, county, state, and federal policies. It will examine policies that impact HIV prevention, healthcare, treatment, housing, research, and syringe exchange. It will look at federal programs like the Affordable Care Act, Medicaid expansion, HOPWA, and the Ryan White Care Act. What are the advocacy strategies to stop the criminalization of HIV transmission, increase state and federal appropriations, fund HIV research, prevention, healthcare, and end the epidemic?
Please join us for a plenary luncheon
Reset. Refuel. Retool. Friday, September 8, 2017 11:30am to 1:30pm ET Marquis Ballroom, Marriott Marquis
GILEAD and the GILEAD Logo are trademarks of Gilead Sciences, Inc. Â© 2017 Gilead Sciences, Inc. All rights reserved. UNBC4791 09/17
WASHINGTON, DC / SEPTEMBER 7 – 10
Dessert Area 118 317
EXHIBITOR LIST Booth No. 301 111 617 514 203,205 302 711 619 601 102 510
A&U — America’s AIDS Magazine 2017 USCA HOST Committee AIDS United AIDSVu Alere Inc American Exchange API Wellness Center APLA Health Avita Pharmacy BioLytical Laboratories Bristol Myers Squibb (BMS) Capacity Building Assistance Provider 712 Network (CPN) 709 Capacity for Health at APIAHF 511 Capital City AIDS Fund 717 CAPTC 116 CCN Pharmacy 105 CDC 206 Chembio Diagnostic Systems, Inc. 611 Cicatelli Associates Inc. T1, T2, T3 Common Threads 315 Curant Health 613 Denver Prevention Training Center 204 EMD Serono 716 ETR Associates 103 FDA Office of Women’s Health 208 Gilead HCV 312 Gilead HIV 501 Gilead HIV 607 Gilead HIV 317 Global Protection Corp.
Dessert Area 719 514 614
617 718 715
510 505 606
Greater Than AIDS — Kaiser Family Foundation 114 Housing Works 313 Human Rights Campaign 306 Janssen 718 JSI Research and Training Institute, Inc. 218 Let’s Kick ASS 612 MDHHS — Tobacco Control Section 503 Merck & Co. 110 Mr. Friendly 701 Napo Pharmaceuticals, Inc. 610 NASTAD 115,117 National Library of Medicine 304 NMAC NYC Department of Health & Mental 719 Hygiene Office of Minority Health Resource 107 Center 216 OraSure Technologies Primary Care Development 715 Corporation 504 PharmBlue LLC 118 Planned Parenthood 112 PLUS/Here Media Positively Trans — Transgender Law 104, 106 Center 101 POZ Smart +Strong 713 PROCEED, Inc. 305 Project Inform Puerto Rican Cultural Center-Vida/ 614 SIDA 113 R&S Northeast, LLC 502 Rare Patient Voice, LLC 704 Saddleback Church HIV&AIDS Initiative 606 Samaritan Ministry 100 A Southern AIDS Coalition 720 TARGET Center/UCSF 119 The AIDS Institute 512 The Black AIDS Institute 608 The Well Project 100 B The Women’s Collective 200,202 Theratechnologies 505 Total Access Group Inc. 703 TPAN 108 UCHAPS 705 UCSF CBA Partnership 615 University of Rochester 109 University of the District of Columbia 509 Until There’s A Cure Foundation 201 ViiV Healthcare 500 ViiV Healthcare 207 Walgreens 702 Walgreens 340B Services 303 What Works in Youth HIV 212,214
USCA SPONSOR Staff
Paul Akio Kawata, Executive Director Kim Ferrell, Director of Facilities Management
Tara Barnes-Darby, Director of Conferences Alison J. McKeithen, Conferences Manager Shanta’ Gray, Conferences & Registration Coordinator Alexis Myers, Program Associate Safisha Mance-Thomas, Exhibits Manager Daniel Pino, Communications Strategist
Robert York, Director
Linda Scruggs, Director Charles Shazor, Recruitment & Retention Specialist
Moisés Agosto-Rosario, Director Matthew Rose, Policy Manager Fernando De Hoyos, Program Coordinator Sable Nelson, Policy Analyst
Kim Johnson, Director Tamara J. Combs, Program Manager Robin Kelley, Evaluation Manager Munir Ahmed, Evaluation Specialist E. Taylor Doctor, Program Coordinator Dustin Baker, Program Coordinator Genoa Rucker, Program Coordinator
Board of Directors
Oscar De La O Bienestar Human Services Los Angeles, CA
Norm Nickens San Francisco Employees’ Retirement System San Francisco, CA
Evelyn Ullah Miami, FL
Brenda Hunt Borderbelt AIDS Resource Team (BART) Lumberton, NC
Mario Perez County of Los Angeles Department of Public Health Office of AIDS Programs & Policy Los Angeles, CA
John W. Hill, Jr., Washington, DC
Lance Toma, Asian & Pacific Islander Wellness Center, San Francisco, CA
Therese Rodriguez, Asian Pacific Islander Coalition on HIV/AIDS, New York, NY
Valerie Rochester, AIDS United, Washington, DC
Monica Johnson HEROES – Helping Everyone Receive Ongoing Effective Support Columbia, LA Kelsey Louie, MSW, MBA Gay Men’s Health Crisis (GMHC) New York, NY
Leonardo Ramon Ortega, MD, MPH Shalom Health Care Center, Inc. Indianapolis, IN Rev. Ed Sanders Metropolitan Interdenominational Church Nashville, TN
Rodolfo R. Vega JSI Research & Training Institute, Inc. Boston, MA Nancy Wilson Artist Altadena, CA
CONFERENCE FORmat Session Types
Plenary sessions are formal, motivational presentations on a specific topic held in the host ballroom and usually feature a guest speaker(s) and a plated breakfast or lunch. *Note: Meals will be available at the Thursday, Friday, and Sunday plenaries. Food will not be served at Saturday’s Federal Plenary session.
This year, USCA has 23 unique Pathways. NMAC is grateful to the lead agencies who have put together workshops for each individual pathway. Since these agencies are “experts” in the field, the conference is able to feature cutting edge sessions that will provide delegates with specialized programming needed to help all attendees in their work.
Coordinated by NMAC and ACRIA
Biomedical Interventions Capacity Building
Coordinated by NMAC
Centers for Disease Control and Prevention Ending the Epidemic
Workshops are in-depth, two hour presentations on topics directly relevant to one of more of the conference tracks or pathways.
Poster presentations are placard-type exhibits, which are often accompanied by handouts and/or other material relevant to one of the tracks. Posters are a great vehicle for abstracts that are data-driven and those that are displaying the results of a study. Posters will be displayed on Meeting Level 3.
Coordinated by CDC
Coordinated by Housing Works
Coordinated by The Balm in Gilead
Coordinated by NASTAD
Health Care Providers Hepatitis
Coordinated by ANAC and HIV Medicine Association
Coordinated by Project Inform
Coordinated by NMAC
Coordinated by Health and Human Services
HIV & The Trans Community HIV Health Care Access HIV Policy HRSA
Coordinated by Casa Ruby
Coordinated by Harvard University
Coordinated by The AIDS Institute
Coordinated by HRSA/ HAB
PLWHA Coordinated by Positive Women’s Network Race: African American and Black
Coordinated by The Black AIDS Institute and National
Black Leadership Commission on AIDS
Race: Asian & Pacific Islander Race: Latinx
Coordinated by API Wellness and APIAHF
Coordinated by Latino Commission on AIDS
Race: Native American & American Indian
Coordinated by the Office of Minority Health
Hosted by Duke University and AIDS Alabama
STD-related HIV prevention Structural Interventions Youth
Coordinated by National Coalition of STD Directors
Coordinated by FAPP Structural Interventions Workgroup
Coordinated by NMAC
PROGRAM PARTNERS AIDS UNITED 1424 K St, NW, Suite 200 | Washington, DC 20005
Tel: (202) 408-4848 Fax: (202) 408-1818
Created by a merger between the National AIDS Fund and AIDS Action in late 2010, AIDS United’s mission is to end the AIDS epidemic in the United States, through strategic grant-making, capacity building, formative research, and policy. AIDS United works to ensure access to life-saving HIV/AIDS care and prevention services and to advance sound HIV/AIDS-related policy for U.S. populations and communities most impacted by the epidemic. To date, our strategic grant-making initiatives have directly funded more than $85.8 million to local communities, and have leveraged more than $110 million in additional investments for programs that include, but are not limited to, HIV prevention, access to care, capacity building, harm reduction, and advocacy. AMERICAN ACADEMY OF HIV MEDICINE 1705 DeSales Street NW, Suite 700 | Washington, DC 20036
Tel: (202) 659-0699 Fax: (202) 659-0976
The American Academy of HIV Medicine is an independent organization of AAHIVM HIV Specialists™ and other HIV clinicians dedicated to advancing excellence in HIV/AIDS care. Through advocacy and education, AAHIVM is committed to supporting all HIV care providers and to ensuring better care of those living with HIV. AAHIVM is the only U.S. medical organization providing its entire membership of MDs, DOs, NPs, PAs and Pharmacists the opportunity to credential as HIV Specialists™, HIV Experts™ or HIV Pharmacists™. ASSOCIATION OF NURSES IN AIDS CARE HIV/AIDS Nursing Certification Board 3538 Ridgewood Road | Akron, Ohio 44333
Tel: (330) 670-0101 Fax: (330) 670-0109
The mission of the Association of Nurses in AIDS Care is to promote the individual and collective professional development of nurses involved in the delivery of health care to persons infected or affected by HIV and AIDS. ANAC advances expertise and excellence in nurses engaged in any dimension of HIV disease and its comorbidities, and ensures that nursing expertise is recognized as a key component of inter-professional care models, and is incorporated in decisions affecting the HIV community. ANAC is the leading professional HIV nursing association educating, connecting and advocating for nurses concerned about HIV and HIV-related care. ANAC promotes a comprehensive, holistic, and evidence-based approach to quality HIV care, and advocates for policies grounded in a human rights approach to health. THE BALM IN GILEAD, INC. 620 Moorefield Park Drive, Suite 150 | Midlothian, VA 23236
Tel: (804) 644-BALM (2256) Fax: (804) 644-2257
The Balm In Gilead, Inc.™ is a not-for-profit, non-governmental organization whose mission is to improve the health status of people of the African Diaspora by building the capacity of faith communities to address life-threatening diseases, especially HIV/AIDS. Since 1989, The Balm In Gilead’s pioneering achievements have enabled thousands of churches to become leaders in preventing the transmission of HIV by providing comprehensive educational programs and offering compassionate support to encourage those infected to seek and maintain treatment. The Balm In Gilead spearheads a dynamic response to the HIV/AIDS crisis in the faith community through its international programs The Black Church Week of Prayer for the Healing of AIDS and Our Church Lights The Way: The Black Church HIV Testing Campaign, The Black Church Training Institute for HIV and Other Health Disparities, and the Faith-based National Training and Technical Assistance Center. The Balm In Gilead is headquartered in Richmond, VA with offices in Washington, DC and Dar es Salaam, Tanzania. The Black AIDS Institute 1833 West 8th Street, #200 | Los Angeles, CA 90057-4920
Tel: (213) 353-3610 Fax: (213) 989-0181
Founded in May of 1999, the Black AIDS Institute (BAI) is the only national HIV/AIDS think tank in the United States focused exclusively on Black people. BAI’s mission is to end the AIDS pandemic in Black communities by engaging and mobilizing institutions, leaders, and individuals in efforts to confront HIV/AIDS. BAI disseminates information, conducts training, offers technical assistance and capacity building, interprets and influences public and private sector HIV/ AIDS policies, delivers prevention and linkage to care services, and provides advocacy mobilization from a uniquely and unapologetically Black point of view. Our motto is: “Our People, Our Problem, Our Solution.”
PROGRAM PARTNERS BROADWAY CARES / EQUITY FIGHTS AIDS 165 West 46th Street, Suite 1300 | New York, NY 10036
Tel: (212) 840-0770 Fax: (212) 840-0551
E-mail: email@example.com www.broadwaycares.org
Broadway Cares/Equity Fights AIDS is one of the nation’s leading industry-based, non-profit AIDS fundraising and grantmaking organizations. By drawing upon the talents, resources and generosity of the American theatre community, since 1988 BC/EFA has raised and distributed over $135 million for essential services for people with AIDS and other critical illnesses across the United States, awarding grants to over 400 AIDS and family service organizations nationwide.
HEALTHHIV 2000 S Street | Washington, DC 20009
Tel: (202) 232-6749 Fax: (202) 232-6750
HealthHIV is a leading national, 501(c)(3) non-profit working with organizations, communities, and professionals to advance effective prevention, care, and support for people living with or at risk for HIV through education and training, technical assistance and capacity building, advocacy, and health services research and evaluation. HealthHIV leads the AIDS Education and Training Center (AETC) National Center for HIV Care in Minority Communities (NCHCMC) and supports primary care providers treating HIV, as well as community and faith-based organizations involved in HIV prevention, care and treatment. INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE 1424 K Street, NW, Suite 200 | Washington, DC 20005
Tel: (202) 408-4848, ext. 252 Fax: (202) 315-3651
IAPAC represents more than 17,000 clinicians and other healthcare professionals in over 100 countries who deliver both prevention and treatment services in multiple disease areas, including HIV, hepatitis, malaria, and tuberculosis. Its educational, research, technical assistance, and advocacy activities are conducted by a professionally diverse staff, and are guided by an international Board of Trustees composed of highly esteemed medical, public health, and advocacy professionals from across five continents.
M·A·C AIDS FUND 130 Prince Street, 2nd Floor | New York, NY 10012
Tel: (212) 965-6300 Fax: (212) 372-6171
The M·A·C AIDS Fund’s (MAF) mission is to serve people of all ages, all races and all sexes affected by HIV and AIDS. To partner with the bold, the visionary and the brave who confront the epidemic in countries and communities where people are most neglected, off the radar and at highest risk. Responsible, agile and alert, MAF funds innovative programs that deal directly with the most marginalized, stigmatized and under-heard victims. MAF celebrates humanity, life, creativity and individuality. Making a difference one VIVA GLAM lipstick at a time.
THE NAMES PROJECT FOUNDATION Memorial Quilt 204 14th St NW | Atlanta, GA 30318-5304
Tel: (404) 688-5500 Fax: (404) 688-5552
Established in 1987, The NAMES Project Foundation, Inc. is the international non-governmental, 501(c)(3) organization that is the custodian of The AIDS Memorial Quilt and its associated document and media archive. The mission of The NAMES Project Foundation is to preserve, care for, and use the AIDS Memorial Quilt to foster healing, heighten awareness, and inspire action in the struggle against HIV and AIDS.
PROGRAM PARTNERS NATIONAL AIDS HOUSING COALITION 1000 Vermont Ave, NW Suite 500 | Washington, DC 20005
Tel: (202) 347-0333
The National AIDS Housing Coalition is a national nonprofit housing organization founded in 1994 in the belief that people with HIV/ AIDS have a fundamental right to decent, safe, affordable housing and supportive services, responsive and appropriate to their self-determined needs. NAHC works to end the HIV/AIDS epidemic by ensuring that persons with HIV/AIDS have quality, affordable and appropriate housing Financed by member dues, foundation grants and individual donations, NAHC is governed by a diverse board of directors representing communities in 12 states and the District of Columbia, with vast personal and professional experience as AIDS housing developers, providers, residents and AIDS housing advocates. NAHC’s contributions to AIDS housing include training, educating and sharing experiences through work in coalitions, AIDS housing institutes, research summits and workshops at conferences across the country as well as on-going advocacy with policymakers in Congress, the Department of Housing and Urban Development, the Office of Management and Budget and other relevant agencies to ensure that government policies are responsive to the housing and service needs of people with HIV/AIDS, including those who are homeless or unstably housed. NATIONAL ALLIANCE OF STATE AND TERRITORIAL AIDS DIRECTORS (NASTAD) 444 North Capitol Street, NW, Suite 339 | Washington, DC 20001
Tel: (202) 434-8090 Fax: (202) 434-8092
The National Alliance of State and Territorial AIDS Directors (NASTAD) represents the nation’s chief state health agency staff who have programmatic responsibility for administering HIV/AIDS and viral hepatitis healthcare, prevention, education, and supportive service programs funded by state and federal governments. NASTAD is dedicated to reducing the incidence of HIV/AIDS and viral hepatitis infections in the U.S. and its territories, providing comprehensive, compassionate, and high-quality care to all persons living with HIV/ AIDS and viral hepatitis, and ensuring responsible public policies. NASTAD provides national leadership to achieve these goals, and to educate about and advocate for the necessary federal funding to achieve them, as well as to promote communication between state and local health departments and HIV/AIDS and viral hepatitis care and treatment programs. NASTAD supports and encourages the use of applied scientific knowledge and input from affected communities to guide the development of effective policies and programs. THE AIDS INSTITUTE Program and Administrative Office 17 Davis Boulevard, Suite 403 | Tampa, FL 33606 Tel: (813) 258-5929 | Fax: (813) 258-5939 The AIDS Institute is a national nonprofit and nonpartisan public policy organization with offices in Washington, DC, Tampa and Tallahassee, FL. Its mission is to promote action for social change through public policy, advocacy, research, and education and began as a grass roots community mobilization effort in 1985. In 1992, this advocacy network became incorporated as a 501(c) 3 nonprofit organization. Over the years, The AIDS Institute has expanded its vision and scope to include an affiliation with the Division of Infectious Disease and International Medicine at the University of South Florida, College of Medicine. The AIDS Institute remains focused on HIV/AIDS while incorporating other disease focuses including hepatitis and systems issues such as access to care, treatment, services, poverty, and human rights.
National Policy Office 2000 S Street, NW | Washington, DC 20009 Tel: 202-835-8373 | Fax: 202-835-8368
The AIDS Institute achieves its mission and goals through collaborations, networks and programs that are targeted and focused, such as:
• AIDS Alliance for Women, Infants, Children,Youth & Families • I Am Essential Campaign • Patient Advocacy Leaders Summit • Capacity Building Assistance Network • Florida HIV/AIDS Advocacy Network • HepFlorida and HepInfoNow.org • National HIV/AIDS and Aging Awareness Day • Florida Consortium for HIV/AIDS Research
Please join us for an engaging and interactive workshop
Engagement in Care Friday, September 8, 2017 4:15pm to 6:15pm ET Marquis Ballroom, Marriott Marquis Refreshments will be served. Seating is limited. First come, first served.
GILEAD and the GILEAD Logo are trademarks of Gilead Sciences, Inc. ÂŠ 2017 Gilead Sciences, Inc. All rights reserved. UNBC4793 09/17
SCHEDULE AT A GLANCE
8:00 am – 10:00 am
OPENING PLENARY BREAKFAST: A CELEBRATION OF OUR FAMILIES Location: Marquis Ballroom, Meeting Level 2 Session 1 Workshops
10:15 am – 12:15 pm
Together: Innovative Partnerships to Support Treatment and PrEP Use Among MSMs of Color Location: Mount Vernon Square Square, Meeting Level 3
Nothing About Us Without Us: PLHIV’s Role in Ending HIV Criminalization Location: Shaw, Meeting Level 3
Latin Trans in HIV Care Location: Scarlet Oak, 2nd Floor
Where are we with an HIV CURE Strategy for Women? Location: Union Station, Meeting Level 3
HIV/AIDS Research among American Indian/ Alaska Natives Location: Gallaudet University, Meeting Level 1 Capacity Building: Older Adults and HIV — Working with Non-Medical Providers Location: Tulip, 2nd Floor
Providing PrEP/PEP to Minority Populations: An Agency-wide Effort Location: Mint, Meeting Level 4
The HIV Landscape Through a Faith-Based Lens: Successes, Challenges and Future Solutions Location: Dogwood, 2nd Floor
Overview of Viral Hepatitis: Hepatitis B, Hepatitis C and HIV Coinfections Location: George Washington, Meeting Level 1
Leadership Matters in HIV Prevention and Intervention Location: Judiciary Square, Meeting Level 3
HIV and HCV Co-infection: Discussing the Cure for HCV Location: Treasury, Meeting Level 4
Normalize Testing: Everyone Has an HIV Status Location: Chinatown, Meeting Level 3
Leaving No One Behind: Fulfilling the Promise to Sex Workers Location: Silver Linden, 2nd Floor
Southern Fried Votes: A Recipe for Effective Voter Mobilization Location: Marquis Salon 12, Meeting Level 2 Let’s Get Lubricated: Lube safety, access and advocacy Location: LeDroit Park, Meeting Level 3
10:30 am – 5:00 pm
CDC’s Update on Prevention Messages and Tools Location: Capitol, Meeting Level 4
A Global/Local Conversation on HIV: Updates from Canada, South Africa, Uganda, Zambia, Zimbabwe and the DMV Location: Archives, Meeting Level 4
EXHIBIT HALL OPEN*
Location: Liberty and Independence Ballroom, Meeting Level 4
*Exhibit Hall closed during plenary sessions.
SCHEDULE AT A GLANCE
07 Luncheon Session 1:Plenary Workshops
12:30 pm – HOW WE’RE ACTING NOW 2:30 pm
TO END AIDS IN THE U.S. Location: Marquis Ballroom, Meeting Level 2 Session 2 Workshops
2:45 pm – 4:45 pm
Nurturing Multi-Disciplinary Care Teams: Building Relationships and Dealing with Implicit Bias in Healthcare Location: Scarlet Oak, 2nd Floor Biggest Successes: Toughest Barriers Location: Magnolia, 2nd Floor Safer Sex for Trans Bodies Location: Dogwood, 2nd Floor The Struggle is Real: HIV Stigma in Minority Communities Location: Treasury, Meeting Level 4 HIV Housing: Policy and Practice Impact on Ending HIV Location: LeDroit Park, Meeting Level 3 Demystifying Sex Ed and its Role in HIV Prevention Location: Judiciary Square, Meeting Level 3 Novel Mechanisms for Delivery of PrEP Care Location: Silver Linden, 2nd Floor Black Male Leadership Development: Cultivating Future Kings Location: Mount Vernon Square, Meeting Level 3
HRSA Innovative Service Models and Best Practices Location: Chinatown, Meeting Level 3 Trauma-Informed Care for Women Living with HIV: Tools for Implementation Location: Capitol, Meeting Level 4 PrEP in American Indian/Alaska Native Communities Location: Gallaudet University, Meeting Level 1 Race, Class and Privilege in HIV Work Location: Mint, Meeting Level 4 Ensuring Funding for Domestic HIV Programs Location: Pentagon, Meeting Level 4 Developing Social Support and Treatment Knowledge for Fifty and Beyond Location: George Washington, Meeting Level 1 HIV & Aging: Understanding Social Isolation Location: Tulip, 2nd Floor Examining Narratives on Engagement in Care in Vulnerable Populations Location: Archives, Meeting Level 4
Protecting the Civil Rights of People Living with HIV Location: Marquis Salon 12, Meeting Level 2
5:00 pm – 6:00 pm
Location: Check Affinity Session board located near registration booths.
A heritage of helping See how weâ&#x20AC;&#x2122;re bringing science to life at emdserono.com.
EMD Serono is a business of Merck KGaA, Darmstadt, Germany
SESSION 1 WORKSHOPS
8:00 am – 10:00 am Opening Plenary Session
OPENING PLENARY BREAKFAST: A CELEBRATION OF OUR FAMILIES Location: M arquis Ballroom, Meeting Level 2
This year’s conference theme – A Family Reunion – will be the focus of the Opening Plenary Session as we both celebrate families and acknowledge the role that they play in healthy outcomes. The session will feature a diverse group of families that will share their stories of the special people in their lives. We will also hear from Dr. David Williams from Harvard University who will speak to us about his ground-breaking research on race and its impact on health. As a longtime friend to NMAC and 3-time attendee to USCA, we are excited to see what David will bring to his first USCA plenary speech. Joining David is Congresswoman Nancy Pelosi. Throughout her career, Leader Pelosi has been a staunch advocate in the fight against HIV. For her remarks, she will speak about her work to provide funding for HIV/AIDS organizations and the essential need to protect healthcare services for people living with or who are risk of HIV. She is a fearless ally for the HIV movement and we look forward to welcoming her at this year’s USCA. Finally, the Elizabeth Taylor AIDS Foundation will recognize Macy’s for their ongoing support of their work and founder by presenting the company with the first outstanding partner award. Presenting the award on behalf of ETAF is renowned immunologist Dr. Michael Gottlieb and award-winning actress and activist Judith Light. Presenters:
Dr. David Williams
Minority Leader Nancy Pelosi
Cecilia Chung and family
Kerry Lessard and family
Grissell Granados and family
Entertainment: Frenchie Davis, American Idol Alum and Broadway Veteran
10:15 am – 12:15 pm
Charles Shazor and family
Murray Penner and family
Session 1 Workshops
TOGETHER: INNOVATIVE PARTNERSHIPS TO SUPPORT TREATMENT AND PREP USE AMONG MSMS OF COLOR Presented by Walgreens
Location: Mount Vernon Square Square, Meeting Level 3 Track: Biomedical HIV Prevention Level: Intermediate
There is no way to “end AIDS” without addressing the disproportionate impact of HIV on gay/bisexual men of color. In this session, learn about successful models of integrated services and programs to promote PrEP usage and support adherence to HIV medications within this audience. Hear first-hand from our panel of HIV advocates, those living with HIV, and those who are currently taking PrEP.
SESSION 1 WORKSHOPS SEPTEMBER
LATIN TRANS IN HIV CARE
Presented by: Arianna Lint, Arianna’s Center, Fort Lauderdale, FL Location: Scarlet Oak, 2nd Floor Pathway: HIV & The Trans Community Level: Beginner
America is known as the land of freedom and opportunity. It is a place to live the “American Dream.” Sadly, not everyone has complete access to these opportunities advertise, especially Latina women, Latina Trans women. For many Latinas, it is a struggle to get here and a struggle to survive. These barriers come from many directions; however, the biggest barrier is financial stability. One of the few ways to ensure this stability is through education. Education can provide financial security, advancement and knowledge. HIV/AIDS RESEARCH AMONG AMERICAN INDIAN/ALASKA NATIVES
Presented by: Murlynn Crystal Lee, PhD, MPH, UCLA School of Medicine, Los Angeles, CA + Andrew Jolivette, PhD, San Fr ancisco State University, San Fr ancisco, CA Location: Gallaudet University, Meeting Level 1 Pathway: Race: Native American and American Indian Level: Intermediate
American Indian/Alaska Natives (AIAN) are disproportionately impacted by numerous social and behavioral factors associated with increased risk for HIV infection. However, AIAN experience a myriad of adverse conditions, such as high rates of substance abuse, sexually transmitted infections (STIs), and sexual violence that put them at-risk for HIV infection.The lack of research among AIAN is evident in the discipline of HIV/AIDS and biomedical prevention efforts.Therefore, this workshop will address the lack of research in the scopes of examining combination HIV prevention methods and the associated concerns and challenges from Native researchers. It will also highlight and discuss successful research such as “Urban Indian Two-Spirits/Transgender: Radical Love, HIV and InterGenerational Healing.” In addition, this workshop will cover how international mobility influences Indigenous health, especially as it relates to biomedical HIV prevention efforts. CAPACITY BUILDING: OLDER ADULTS AND HIV — WORKING WITH NON-MEDICAL PROVIDERS
Presented by: Lisa Frederick, ACRIA, New York, NY + Hanna Tessema, ACRIA, New York, NY + Mary McCarty-Arias, ACRIA, New York, NY + Michelle Scavnicky, The AIDS Institute, Washington, DC + Dr. Bambi W. Gaddist, South Carolina HIV/AIDS Council, Columbia, SC + Ron L. Swanda, District of Columbia Commission on Aging, Washington, DC + Orisha Bowers, Community Partner, Memphis, TN Location: Tulip, 2nd Floor Pathway: Aging Level: Advanced
This interactive session will serve as a training model for non-medical service providers, case managers, social workers, counselors, health navigators, and other front and mid-level staff. We will discuss the
need for providers to work across disciplines to address the many needs of older adult clients, including clinical issues associated with HIV, multi-morbidity, and aging. Providers will discuss the need to see their older adult clients as sexual beings to properly conduct risk assessments.We will examine tips, tools and techniques for engaging clients around issues of sexual health and well-being.This session will also discuss the importance of health literacy, adult learning theory, and the need for older adults to see themselves in campaigns that addresses their needs. This session will discuss the co-facilitation provider training model including discussion and interactive activities. THE HIV LANDSCAPE THROUGH A FAITH-BASED LENS: SUCCESSES, CHALLENGES, AND FUTURE SOLUTIONS
Moder ator: Dr. Pernessa Seele, The Balm in Gilead, Inc., Richmond, VA Presented by: Khadijah Abdullah, RAHMA, Washington, DC + Rev. Michael Schuenemeyer, United Church of Christ, Cleveland, OH + Debr a Dennison, Infectious Diseases and Microbiology, Pitt Public Health, University of Pittsburgh, Pittsburgh, PA Location: Dogwood, 2nd Floor Pathway: Faith Level: Intermediate
This session will explore the relationship between HIV and Faith and provide participants with real-life practical best practices from a panel of faith leaders sharing their experiences, challenges, lessons learned, and strategies for successes in addressing HIV and glean from their work in faith community. This session will allow attendees to learn from one another to leverage the successes of their local organizations and communities. LEADERSHIP MATTERS IN HIV PREVENTION AND INTERVENTION Presented by: Quinn M. Gentry, PhD, MBA, Messages of Empowerment Productions, Atlanta, GA Location: Judiciary Square, Meeting Level 3 Track: Leadership Level: Intermediate
This workshop focuses on bridging the gap between “organizational leadership” and “program management” in a way that maximizes the effective use of resources aimed at addressing health disparities in HIV/AIDS. Leadership and management are collaborative organizational functions that should operate seamlessly for optimum performance and empower agencies to be more responsive to the underlying social and structural determinants of HIV/AIDS. Practically, this workshop hones in on key organizational functions that must be integrated for enhanced capacity, including: general administration and operations; budgeting and accounting; human resources management; stakeholder engagement; program administration and management; information systems and technology; fundraising; marketing and brand management; crisis management; and strategic planning. The workshop also includes a self-development component where leaders and managers work through a model to set individual and organizational action plans towards institutionalizing the integration of leadership and management.
SESSION 1 WORKSHOPS
NORMALIZE TESTING: EVERYONE HAS AN HIV STATUS
Presented by: David Brinkman, Desert AIDS Project + Dr. Michael Gottlieb, Physician and Immunologist + Congresswoman Barbar a Lee (CA 13th District) + Congressman Raul Ruiz (CA 36th District) Moder ator: Joel Goldman, The Elizabeth Taylor AIDS Foundation, long term HIV survivor of 25 years Location: Chinatown, Meeting Level 3 Pathway: Health Care Providers Level: Intermediate
The Elizabeth Taylor AIDS Foundation (ETAF) will lead a panel discussing the opportunities and barriers around establishing HIV testing as a voluntary yet normalized and integral part of healthcare practices.This critical dialogue is co-inspired by ETAF grantee Desert AIDS Project who crafted ‘Get Tested Coachella Valley’, a program that assists Palm Springs and surrounding desert region medical facilities and health care providers to make HIV testing part of regular doctor visits for every client. In the last two years, results from the DAP program affirmed that 32 medical offices and 124 medical providers are now committed to making voluntary HIV testing a routine standard of care for all patients. Instituting routine testing contributes to a larger goal of helping the U.S. achieve the first two 90 treatment targets in UNAIDS 90-90-90 and in addition will be an effective method to decrease the elusive yet powerful force of stigma. SOUTHERN FRIED VOTES: A RECIPE FOR EFFECTIVE VOTER MOBILIZATION
LET’S GET LUBRICATED: LUBE SAFETY, ACCESS, AND ADVOCACY
Presented by: Pedro Carneiro, Callen-Lorde Health Center, New York, NY + Clare Collins, Microbicide Trials Network, Pittsburgh, PA + Charlene Dezzutti, Microbicide Trials Network, Pittsburgh, PA + Robert Newells, AIDS Project of the East Bay, Oakland, CA + Jim Pickett, AIDS Foundation of Chicago, Chicago, IL Location: LeDroit Park, Meeting Level 3 Track: Gay Men Level: Beginner
Personal lubricants are widely used by people around the world during sex for a variety of reasons – to reduce friction, improve comfort, and make sex more enjoyable – yet, very little is known and communicated about lube use, safety, and access. The need to make lubes safer, more effective, accessible, and affordable led to the November 2016 Global Consultation on Personal Lubricants in Bangkok, Thailand. To continue the discussion that took place at the Global Consultation, this session will address the need for clear public health messaging around the use and safety of lubes in the U.S., and provide an update on the development of lube-based HIV prevention products globally. Importantly, expert panelists will share their insights to providing safe and accessible lubes to all who need them. NOTHING ABOUT US WITHOUT US: PLWHIV’S ROLE IN ENDING HIV CRIMINALIZATION
Presented by: Esther Ross, ECU Infectious Disease Clinic, Greenville, NC + Matt Martin, NC AIDS Action Network, Raleigh, NC + Matthew Pagnotti, AIDS Alabama, Birmingham, AL
Presented by: Barb Cardell, US People Living with HIV Caucus/Positive Women’s Caucus/Color ado Mod Squad, Boulder, CO + Kamaria Laffrey, em POWER ed L egacies , W inter H aven , FL + T iommi L uckett , US P eople L iving with HIV C aucus /P ositive W omen ’ s N etwork /P ositively T r ans , P hiladelphia , PA + Robert Suttle, Sero Project, New York, NY
Location: Marquis Salon 12, Meeting Level 2 Track: Public Policy Level: Beginner
Location: Shaw, Meeting Level 3 Pathway: PLWHA Level: Intermediate
People living with or vulnerable to HIV are increasingly being denied political representation due to expanding voter suppression efforts. Southern organizations sit at the center of both the modern epidemic and systemic attacks on voting rights, yet are often unsure of how to include voter engagement within their work.This workshop will debunk myths around what actions nonprofits can take to remove barriers to the ballot box, and provide successful regional examples and best practices. Attendees will also be given tools to develop their own voter mobilization strategies back home.
Since the 1990s, over half of the US had criminal statutes specific to HIV disclosure, potential exposure, and sex. These laws have been used primarily to enhance sentencing options on sex workers, people already incarcerated, and people who use drugs. HIV criminalization creates a he-said/he-said (or whatever gender one prefers) situation, where the PLHIV bears the onus for proving disclosure. Without that proof, the PLHIV involved in the interaction is made a criminal, even if an equal (or unwilling) party. For decades, activists have worked to reform these laws. Some organizing has been about legislative change; other times the focus has been on case law. This workshop will address specifically why and how people living with HIV need to be at the center of organizing efforts. The panelists will include a focus on intersectional organizing across race, class, gender, sexuality, substance use history, and sex work history.
SESSION 2 WORKSHOPS SEPTEMBER
WHERE ARE WE WITH AN HIV CURE STRATEGY FOR WOMEN?
Presented by: Danielle M Campbell, AVAC, PxROAR, Los Angeles California, Los Angeles Women’s HIV/ AIDS Task Force + Julia Patterson, AVAC PxROAR, Cleveland, Ohio + David Evans, Project Inform, Los Angeles, California + Pedro Goicochea, Forum for Collaborative HIV Research, Washington, DC + Moisés Agosto, NMAC, Washington DC + Dawn Averitt, Women’s Research Initiative on HIV/ AIDS, Norwich, VT + Catalina Ramirez, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina + Karine Dubé, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Location: Union Station, Meeting Level 3 Track: Cis & Trans Women Level: Beginner
HIV/AIDS morbidity and mortality are a top health burden of cisgender and transgender women. Black and Latina women are most affected, representing 76% of all diagnoses among cisgender women in 2015, and transgender women have almost 50 times the odds of living with HIV compared to other reproductive age adults. Despite this, women are drastically underrepresented in HIV cure research studies. Not since Timothy Brown in 2007, have we seen any new reported cases of sterilizing cure – complete elimination of the HIV virus in the body.There are multiple HIV cure research methods being investigated, including latency-reversing agents, gene modification, stem cell transplantation, immune-based strategies, and some HIV reservoir assessments without any investigational agents. Current research has pointed to estrogen and sex-based differences affecting the establishment and distribution of the HIV reservoir.The need for a cure is critical, but will HIV cure strategies include women? CDC’S UPDATE ON PREVENTION MESSAGES AND TOOLS
Presented by: Jo Stryker, Cindy Lyles, Sar a Bresse, Vasavi Thomas, David Whittier, Jocelyn Patterson, Kathleen Green, Laur a Chiang, Laur a McElroy, Jeffrey Kemp Rinderle, Jocelyn Taylor, Euna M. August, and David Purcell, Centers for Disease Control and Prevention, Atlanta, GA Location: Capitol, Meeting Level 4 Pathway: Centers for Disease Control and Prevention Level: Intermediate
The expansion of behavioral and biomedical HIV prevention strategies has resulted in more HIV prevention options than ever before. Accordingly, prevention messages have become increasingly complex. As the science evolves, CDC continues to update its messages, materials and tools to ensure that resources meet the needs of distinct audiences. This process includes scientific reviews, translation of science into messages for distinct audiences, message testing, materials development and testing, and message dissemination. In this session, CDC will discuss the latest updates to its scientific review process, focusing on viral suppression, and how the science was translated into messaging. CDC will also present updated and new HIV prevention tools including the recently updated comprehensive HIV Risk Reduction Tool, various new PrEP training resources for healthcare providers and their patients, and a comprehensive HIV care resource kit for providers of gender-affirming health care and their transgender patients.
PROVIDING PREP/PEP TO MINORITY POPULATIONS: AN AGENCY-WIDE EFFORT
Presented by: Timothy Au, LMSW, Apicha Community Health Center, New York, NY + Melanie Dulfo, LMSW, Apicha Community Health Center, New York, NY + Phillip Miner, MLS, Apicha Community Health Center, New York, NY Location: Mint, Meeting Level 4 Pathway: Race: Asian & Pacific Islander Level: Intermediate
In this workshop, staff of Apicha Community Health Center describe how they successfully target and provide PrEP/PEP to people of color, especially Asian and Pacific Islanders. Topics include community health education through outreach and digital marketing, HIV/STI testing and linkage to primary care, and providing navigation to address the common barriers associated with obtaining a prescription and treatment adherence. OVERVIEW OF VIRAL HEPATITIS: HEPATITIS B, HEPATITIS C, AND HIV COINFECTIONS
Presented by: Robin Lord Smith, Hepatitis C Association and Help-4-Hep; + Chari Cohen, Hepatitis B Foundation, Doylestown, PA + Andrew Reynolds, Project Inform, San Fr ancisco, CA Location: George Washington, Meeting Level 1 Pathway: Hepatitis Level: Beginner
People living with or who are risk for HIV are also at increased risk for hepatitis B (HBV) and hepatitis C (HCV). This session will provide an overview HBV and HCV, including epidemiology, transmission, prevention, and treatment. The overview of HCV will include an emphasis on the prevention and treatment needs of people who inject drugs.The overview of HBV will include a review of vaccination and prevention of mother-to-child transmission. We will also focus on the risk for and prevention of sexual transmission of HCV in persons living with HIV.This overview is appropriate for people with all levels of knowledge of viral hepatitis. HIV AND HCV CO-INFECTION: DISCUSSING THE CURE FOR HCV
Presented by: Letha Healey, MD, HRSA/HAB, Rockville, MD + Sar a Woody, HRSA/HAB, Rockville, MD + Pamela Belton, HRSA/HAB, Rockville, MD Location: Treasury, Meeting Level 4 Pathway: HHS SMAIF Level: Beginner
People living with HIV (PLWH) are a priority population in the National Viral Hepatitis Action Plan. About 25% of PLWH are co-infected with HCV.This more than triples their risk for liver-related death.The opioid epidemic has led to an increase in injection drug use and HCV infections, putting over 220 U.S. counties at risk for HIV and HCV outbreaks. This session provides an overview of data on HIV and HCV co-infection, who is affected, the impact HCV co-infection has on treatment options, disease progression, and death among people living with HIV. We will
SESSION 2 WORKSHOPS
hear an account of what it means to be HIV positive and cured of HCV, and action taken by HRSA’s Ryan White Care Act Program and the Secretary’s Minority AIDS Initiative Fund (SMAIF). LEAVING NO ONE BEHIND: FULFILLING THE PROMISE TO SEX WORKERS
Presented by: Matthew Rose, NMAC, Washington, DC + Christa Darling, President of SWOP USA, Baltimore, MD Location: Silver Linden, 2nd Floor Track: Leadership Level: Intermediate
This workshop will be highly interactive, with group exercise and a case study analysis. We will close with a “how to” discussion about useful tips and common concerns that may come up when raising the topic with funding organization boards and/or with local sex worker rights organizations. A GLOBAL/LOCAL CONVERSATION ON HIV: UPDATES FROM CANADA, SOUTH AFRICA, UGANDA, ZAMBIA, ZIMBABWE AND THE DMV
Presented by: Kwaku Adomako, African Black Diaspora Global Network + Vivienne Naidoo, SisterLove/Women Now + Musah Lumumba El-Nasoor, Uganda Youth Coalition on Adolescent Sexual and Reproductive Health Rights and HIV + Martha Cameron, Women’s Collective + Pelagia Chabata, Zimbabwe Community Health Intervention Research Project + Cedric Pulliam, Alexandria Commission on HIV/AIDS/US Department of State. Moderator: Marsha Martin, DC Local Host Committee and Global Network of Black People working in HIV Location: Archives, Meeting Level 4 Track: People Living with HIV Level: Intermediate
Join colleagues from the DMV, Canada, and three of the most heavily burden countries as they share experiences working with communities and populations most at risk: immigrants/migrants, youth, women, men who have sex with men and other key populations. NURTURING MULTI-DISCIPLINARY CARE TEAMS: BUILDING RELATIONSHIPS AND DEALING WITH IMPLICIT BIAS IN HEALTHCARE
Presented by: Moder ator: Kumba Senna ar, HIV Medicine Association, Arlington, VA + Heather Alt, RN, ACRN, CPH Whitman-Walker Health, Association of Nurses in AIDS Care, Washington, DC + Lisa Fitzpatrick, MD, MPH, HIV Medicine Association, Washington, DC + Mitchell Wharton PhD, RN, FNP-BC, CNS, Johns Hopkins University, Association of Nurses in AIDS Care, Baltimore, MD Location: Scarlet Oak, 2nd Floor Pathway: Health Care Providers Level: Intermediate
Multi-disciplinary care teams are often more effective at delivering high quality, comprehensive HIV care. A care team’s success depends on strong, trusting working relationships between clients and team members, and the ability of each member to operate at the fullest extent of his or her training and expertise. Members of effective care teams also can identify implicit racial or other biases or stereotypes that may impede relationships within teams and with clients, and may affect a client’s perception of the clinic or social service setting. Learn tips and share your strategies for addressing these and other factors that improve or impede effective HIV care through case studies, activities, and an open discussion.
12:30 – 2:30 pm Plenary Luncheon
HOW WE’RE ACTING NOW TO END AIDS IN THE U.S. Location: M arquis Ballroom, Meeting Level 2
We are coming together, in all our diversities, because we believe an end to the AIDS epidemic in the United States is within our reach. In order to make this vision a reality for everyone, it’s crucial that we share our resources, experiences, challenges, and best practices with each other. This plenary will offer an overview of the growing movement of U.S. jurisdictions that have committed to and formulated plans for ending their respective AIDS epidemics, with an eye toward building on that momentum by inspiring other jurisdictions to follow with ending-the-epidemic plans of their own. Guest Speakers: Presented by the ACT NOW: END AIDS Coalition”
SESSION 2 WORKSHOPS SEPTEMBER
(CONTINUED FROM 41)
BIGGEST SUCCESSES: TOUGHEST BARRIERS Presented by: Jaron Benjamin, Housing Works, Brooklyn, NY Location: Magnolia, 2nd Floor Pathway: Ending the Epidemic Level: Intermediate
Representatives from San Francisco, Washington State, and Fulton County, GA will review the challenges and successes in launching their plans to end AIDS as an epidemic in a panel format. Fulton County participants will detail their journey, and discuss how the exercise of writing and implementing a plan resulted in a foundational shift in the organization of their department of health. Washington panelists will discuss how their exercise changed how their health department issued funds, how that changed who received funding, and how the efficacy of their funding was measured. San Francisco participants will discuss the challenges of enacting and crafting a plan during a housing crisis and a rapid shift in demographics. SAFER SEX FOR TRANS BODIES
Presented by: Jewel Addy, Whitman-Walker Health, Washington, DC + Josh Riley, Whitman-Walker Health, Washington, DC + Marvell Terry, Human Rights Campaign, Washington, DC + SaVanna Wanzer, Founder of Capital Tr ans Pride & Capital Pride Board Member, Washington, DC + Achim Howard, Founder of DC Tr ans Men Rising, Washington, DC Location: Dogwood, 2nd Floor Track: Biomedical HIV Prevention Level: Beginner
For too long, trans people have been left out of conversations about sex. No longer with “Safer Sex for Trans Bodies” a first-of-its-kind resource guide to help trans people talk about their sexual health needs with the people in their lives. This workshop will explore safer sex practices, HIV prevention, and other related topics through a panel discussion with the team of advocates, providers, and public health workers who helped put the guide together. Participants will leave this workshop with copies of the guide, actionable information, and key strategies for creating affirming materials to meet a range of unmet needs. “Safer Sex for Trans Bodies” was developed by Whitman-Walker Health and Human Rights Campaign Foundation.
THE STRUGGLE IS REAL: HIV STIGMA IN MINORITY COMMUNITIES
Presented by: Gabriel Maldonado, Presidential Advisory Council on HIV/ AIDS, Riverside, CA + Kim Williams, Centers for Disease Control and Prevention, Atlanta, GA + Aquarius Gilmer, Regional Resource Network Progr am, Philadelphia, PA + Guy Anthony, Positive Spin, Washington, DC + Christopher Barnett, Virginial Department of Health, Richmond, VA + Julie Fitch, Louisiana Department of Health, New Orleans, LA Location: Treasury, Meeting Level 4 Pathway: HHS SMAIF Level: Beginner
Stigma is a major barrier to getting tested for HIV among people who are unaware of their status. It also limits participation in prevention programs and is a barrier to linkage, retention, and adherence to HIV medical care and treatment. This session will discuss internalized stigma, stigma in the community, and stigma among medical providers We will highlight various recommendations and strategies including projects funded by the Secretary’s Minority AIDS Initiative Fund (SMAIF) that are working to transform HIV stigma in the community, lower stigma among medical providers, and reduce internalized stigma among racial and ethnic minority persons at risk for or living with HIV. The panelists will focus on successful stigma reducing strategies and those that appear to show promise. HIV HOUSING: POLICY AND PRACTICE IMPACT ON ENDING HIV
Presented by: Dr. Russell Bennett, Executive Director, National AIDS Housing Coalition, Birmingham, AL + Opal Jones, Executive Director, Doorways, St. Louis, MO + Sergio Farfan, Board Member, National AIDS Housing Coalition, Baton Rouge, LA + Dr. David Holtgr ave, Professor, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD + Christine Campbell, Progr am Consultant, National AIDS Housing Coalition, Washington, DC Location: LeDroit, Meeting Level 3 Pathway: Structural Interventions Level: Intermediate
This workshop will explore housings’ role as a structural intervention in ending the HIV epidemic in the United States and current policy changes. Panelists will focus on what the research tells us of housings’ causal relationship to improving health outcomes, how housing can be integrated into plans to end the HIV/AIDS epidemic, and how factors such as race and poverty play a role in how resources are allocated and therefore must be strategically addressed in any community strategy. This session will also explore the recently passed legislation modernizing the Housing Opportunities for Persons With AIDS (HOPWA) formula with increased funding to ensure that current program participants maintain housing, and the policy’s implications for housing providers to adjust their service delivery system to meet this new reality. Speakers will additionally share inclusive community planning strategies that takes into account racial and economic disparities to expand access to housing.
SESSION 2 WORKSHOPS
DEMYSTIFYING SEX ED AND ITS ROLE IN HIV PREVENTION
Presented by: Jesseca Boyer, Guttmacher Institute, Washington, DC + Kaitlyn Marchesano, Planned Parenthood Feder ation of America, New York, NY + Jennifer Drive, State Policy Director, Sexuality Information and Education Council of the U.S. (SIECUS), Washington, DC Location: Judiciary Square, Meeting Level 3 Track: Public Policy Level: Beginner
Sex education could be the most powerful HIV prevention tool available.Yet not only is it often overlooked in policy conversations, it’s confusing and misunderstood. Just what does “sex ed” mean? Come join representatives of national organizations leading efforts to advance the quality of sex education in the United States for a discussion of the current status of funding, policies, and practices across the country, opportunities and challenges in the current political climate, and what it all means for HIV prevention and overall sexual and reproductive health and rights for young people. NOVEL MECHANISMS FOR DELIVERY OF PREP CARE
Presented by: Brian Risley, MFA, Director, Men’s Health Foundation, Los Angeles, CA + Anthony Mills, MD, CEO/Medical Director, Men’s Health Foundation, Los Angeles, CA + Leandro Mena, MD, Medical Director, Crossroads Clinic, MSDH Location: Silver Linden, 2nd Floor Track: Biomedical HIV Prevention Level: Intermediate
Novel Mechanisms for Delivery of PrEP will look at several unique PrEP delivery models across the United States that are replicable.Accompanied by slide sets, a panel representing key staff from clinics in different states who provide PEP/PrEP services will discuss their models and what made them successful.The panel will talk about how integration of services is able to maintain clinic flow, as well as how utilizing other methods can be crucial to accessing hard to reach populations. BLACK MALE LEADERSHIP DEVELOPMENT: CULTIVATING FUTURE KINGS Presented by: Rob Newells, APEB, Oakland, CA
Location: Mount Vernon Square, Meeting Level 3 Track: Leadership Level: Beginner
PROTECTING THE CIVIL RIGHTS OF PEOPLE LIVING WITH HIV
Presented by: Christine Kim, United States Department of Justice, Civil Rights Division, Washington, DC + Megan Schuller, United States Department of Justice, Civil Rights Division, Washington, DC Location: Marquis Salon 12, Meeting Level 2 Pathway: Civil Rights Level: Intermediate
The Americans with Disabilities Act (ADA) gives federal civil rights protections to individuals with disabilities similar to those provided to individuals on the basis of race, color, sex, national origin, age, and religion. It guarantees equal opportunity for individuals with disabilities in public accommodations, employment, transportation, state and local government services,and telecommunications.People living with HIV, whether symptomatic or asymptomatic, qualify for legal protections under the ADA. Persons who are discriminated against because they are regarded as having HIV, or because they have a known association or relationship with an individual who has HIV are also protected. This presentation provides an overview of ADA legal protections in various contexts, including workplaces and healthcare settings; examples of recent actions by the federal government to enforce these rights; and information about how to file a complaint with the federal government if someone has been discriminated against because of HIV. HRSA INNOVATIVE SERVICE MODELS AND BEST PRACTICES
Presented by: Terr ance Moore, National Alliance of State and Territorial AIDS Directors, Washington, DC + Melinda Tinsley, Family Health Centers of S an D iego , S an D iego , CA + J essica X avier , U niversity of C alifornia San Fr ancisco, San Fr ancisco, CA + Kibibi Matthews-Brown, HRSA/HAB, Rockville, MD + Michelle Vatalaro and Daniel Driffin, John Snow, Inc. Location: Chinatown, Meeting Level 3 Pathway: HRSA Level: Intermediate
Community based organizations, service providers, and advocates utilize the USCA as an opportunity to take the information obtained at the conference back to their communities to implement change. This session will focus on engagement and assistance, highlighting RWHAP evidence-informed interventions and other HRSA/HAB-funded initiatives that support making positive changes at the local level.
Many leaders in the HIV/AIDS movement are not prepared to confront their own mortality, are reluctant to choose successors, or do not have many interests beyond their CBOs or activist groups. This workshop will explore strategies employed at AIDS Project of the East Bay (Oakland, CA) to develop a team of leaders by identifying the interests of emerging leaders and developing their knowledge, skills, and abilities so that they are prepared to assume leadership roles. Leadership development is more than succession planning. Existing leaders must be prepared to mentor the next generation so that their years of knowledge, experience, working relationships, and information are not lost.
SESSION 2 WORKSHOPS SEPTEMBER
(CONTINUED FROM 43)
TRAUMA-INFORMED CARE FOR WOMEN LIVING WITH HIV: TOOLS FOR IMPLEMENTATION
Presented by: Erin Nortrup, LCSW, AIDS United, Washington, DC + Erin Falvey, Ph, Christie’s Place, San Diego, CA + Sar a Durán, CHES, Christie’s Place, San Diego, CA Location: Capitol, Meeting Level 4 Track: Cis & Trans Women Level: Beginner
BAI has been creating space for conversations about class, race, and privilege, and the importance of addressing the resulting disparities, especially in HIV work. Furthermore, BAI has been striving to understand how these barriers impact individual decision-making and access to information. ENSURING FUNDING FOR DOMESTIC HIV PROGRAMS
This workshop will introduce a gender-responsive, traumainformed model of care to improve health outcomes for women living with HIV. Drawing on lessons from Christie’s Place and a toolkit created by Christie’s Place and AIDS United, presenters will discuss key strategies to integrate trauma-informed service provision into a strength-based, wrap-around services to improve health and service outcomes.
Presented by: Carl Schmid, The AIDS Institute, Washington, DC + Nick Armstrong, The AIDS Institute, Washington, DC + Carl Baloney, AIDS United, Washington, DC + M.A. Keifer, MPH, Office of Congresswoman Barbar a Lee (D-CA 13th), Washington, DC + Richard Wolitski, PhD, Office of HIV/AIDS and I nfection D isease P olicy , US. HHS, W ashington , DC + Emily McCloskey, NASTAD, Washington, DC + Kathie Hiers, AIDS Alabama, Birmingham, AL + Kevin Fisher, AVAC, New York, NY
PREP IN AMERICAN INDIAN/ALASKA NATIVE COMMUNITIES
Sufficient funding is necessary to reduce the number of new infections; provide care, treatment, and housing for people living with HIV; and conduct HIV research. This workshop will provide an update on the status of federal funding for domestic HIV programs in the first year of the Trump Administration and in a Republican controlled Congress. First, the presenters will describe the results of the fiscal year 2017 appropriations bill. Secondly, the Trump fiscal year 2018 budget will be discussed, and HIV programs will be highlighted. Next, the Congressional budget will be described, along with both the House and Senate consideration of the appropriations bills, with a focus on their priorities and activities to date. Finally, community activities will be described along with planned activities and actions attendees can take to ensure funding levels are adequate.
Presented by: Rick Haverk ate, MPH, Indian Health Service, Rockville, MD + Adrian Dominguez, MS, Urban Indian Health Institute, Seattle, WA Location: Gallaudet University, Meeting Level 1 Pathway: Race: Native American and American Indian Level: Intermediate
Uptake of PrEP in American Indian/Alaska Native (AIAN) communities is in early stages. The Indian Health Service (IHS) is seeking to increase clinical PrEP expertise and access. IHS has supported site level policy and practice with trainings and technical support, and is working with a collaborative of federal, tribal, and urban sites to establish best practices. Current efforts include a policy template for PrEP, web-based and regional in-person trainings, and clinical support for PrEP via telehealth and teleconsultation. Additionally, PrEP AIAN patient education materials are in development. Access to PrEP medication is available but currently entails an administrative burden. IHS is providing national support for sites, but provision of PrEP is a local decision. IHS will need to find ways to scale up access within its health network, as well as link with external PrEP services, especially for small rural communities and Urban Indian Health Programs with limited capacity. RACE, CLASS, AND PRIVILEGE IN HIV WORK Presented by: Marie-Fatima Hyacinthe, The Black AIDS Institute, Los Angeles, CA Location: Mint, Meeting Level 4 Pathway: Race: African American and Black Level: Beginner
BAI has long held that structural barriers such as racism, homophobia, and discriminatory policies exacerbate and perpetuate the HIV epidemic. In 2017, this is especially true due to the political climate and to the way HIV has become disproportionately a disease which affects those who are Black, those who are gay, those who are poor, and those who live in states where policies do not afford them care.
Location: Pentagon, Meeting Level 4 Pathway: HIV Policy Level: Intermediate
DEVELOPING SOCIAL SUPPORT AND TREATMENT KNOWLEDGE FOR FIFTY AND BEYOND
Presented by: Sar a Dur an, Christie’s Place, San Diego, CA + Erin Falvey, Christie’s Place, San Diego, CA Location: George Washington, Meeting Level 1 Track: People living with HIV Level: Beginner
During this workshop, presenters will discuss key strategies utilized to enhance social support for women living with HIV who are 50+. Presenters will also introduce findings from this innovative program, Coordinated HIV Assistance and Navigation for Growth and Empowerment (CHANGE) for Women Fifty and Beyond (FAB). Presenters will lead an interactive, skills building discussion on the Christie’s Place CHANGE for Women FAB program inclusive of planning and implementation strategies, trauma-informed practices and staff development.
HIV & AGING: UNDERSTANDING SOCIAL ISOLATION
EXAMINING NARRATIVES ON ENGAGEMENT IN CARE IN VULNERABLE POPULATIONS
Location: Tulip, 2nd Floor Track: People Living with HIV Level: Beginner
Location: Archives, Meeting Level 4 Track: People Living with HIV Level: Advanced
Social Isolation has been identified as the main issue for people living and aging with HIV. During this multimedia presentation, we will explore the effects of prolonged social isolation in the brain and body, as we discuss the possible causes and solutions, focusing on a holistic approach.
The Washington DC Regional Ryan White Planning Council conducted a Needs Assessment from February to May of 2017 aimed at assessing the level of unmet need and gaps in HIV care services within the District of Columbia’s Eligible Metropolitan Area (EMA). The EMA includes the District of Columbia, five counties in Maryland, 11 counties and six independent cities in Virginia, and two counties in West Virginia. The project examined current service utilization and potential barriers in being linked to, as well as remaining engaged in comprehensive HIV care. Data were collected using a Consumer Survey Tool, a Provider Survey Tool, Key Informant Interviews, and Focus Groups. This workshop will present data on the narratives obtained from the Key Informant Interviews and Focus Groups. There will be a particular focus on the way stigma impacts engagement in HIV services.
Presented by: Fernando De Hoyos, NMAC, Washington, DC
Presented by the USCA Host Committee
5:00 pm – 6:00 pm AFFINITY SESSIONS
Location: *Check Affinity Session board located near registration booths.
years of service and advocacy.
Since 1987, ANAC has supported nurses in HIV/AIDS care, research, prevention and policy and advocated for the rights and health of people living with HIV.
Learn more about our work and becoming a member at nursesinaidscare.org Proud national partner of USCA
SCHEDULE AT A GLANCE 7:00 am – 7:45 am
MORNING WORSHIP SERVICE
9:00 am – 11:00 am
SOCIAL MEDIA LAB
Location: Dogwood, 2nd Floor
Location: Marquis Salon 14, Meeting Level 2 Session 3 Workshops
9:00 am – 11:00 am
The Long View: Perspectives on Healthy Aging with HIV Location: Shaw, Meeting Level 3 Social Determinants of Health — Looking Closer at Racial, Ethnic, and Geographical Disparities in Health Care Outcomes. Location: Scarlet Oak, 2nd Floor Implicit Bias: HIV Prejudice and the Health of the Community Location: Dogwood, 2nd Floor Adaptation of Options: Alignment to the National HIV Strategy Location: Magnolia, 2nd Floor HIV PrEP Framework: National Blueprint for Scaling Up PrEP Location: Treasury, Meeting Level 4 Protecting Our Future: Leadership Skills-Building for Black Gay Men Location: Silver Linden, 2nd Floor Reforming Drug Pricing — An Advocate’s Toolbox Location: Judiciary Square, Meeting Level 3 The Missing Rx: Access to Employment Information, Services and Resources Location: LeDroit Park, Meeting Level 3 Succession Planning: Organizational Stability
10:00 am – 5:00 pm
and Leadership Development Location: Mount Vernon Square, Meeting Level 3 Clarifying Ryan White HIV/AIDS Program Clinical Quality Management Program Expectations Location: Chinatown, Meeting Level 3 The Secret Garden: Unlocking the Mysteries of the Vaginal Microbiome Location: Union Station, Meeting Level 3 Outbreak and Response Planning in the Rural South Location: Capitol, Meeting Level 4 Surviving the Epidemics and HIV/AIDS in Urban Indian Communities Location: Gallaudet University, Meeting Level 1 Breaking Racial Barriers to “ETE” in the Black Community Location: Mint, Meeting Level 4 Preventing HIV in the Trump Administration Location: Pentagon, Meeting Level 4 Embracing an Unanticipated Life Location: George Washington, Meeting Level 1 PrEPping For Sex: An Intimate Conversation — The Implication of Sex Positivity and The Uptake of PrEP Location: Archives, Meeting Level 4
EXHIBIT HALL OPEN*
Location: Liberty and Independence Ballrooms, Meeting Level 4 Plenary Luncheon
11:30 am – 1:30 pm REIMAGINE: RESET. REFUEL. RETOOL Presented by Gilead Sciences Location: Marquis Ballroom, Meeting Level 2
*Exhibit Hall closed during plenary sessions.
SCHEDULE AT A GLANCE
08 1:30 pm – 2:00 pm
2:00 pm – 4:00 pm
Session 4 Workshops
Location: Meeting Level 3
Risk, Relevance, Role — Conversations and Connections for Women with HIV Location: Chinatown, Meeting Level 3
Bijou: Using Online & Mobile Technology to Improve Health Outcomes Location: Scarlet Oak, 2nd Floor
Energy for Your Best Self: How to Help Maximize Your Internal Power Location: Marquis Salon 12, Meeting Level 2
Werk! Emotional Labor Among Trans WOC Peer Health Navigators Location: Union Station, Meeting Level 3
Psychosocial Issues among Older Adults with HIV: Challenges and Opportunities Location: Tulip, 2nd Floor
So, You’ve Got this Plan. What’s Next: Implementing ETE Plans Location: Capitol, Meeting Level 4
Collaboration: Bringing (and Keeping) the Right People to the Table Location: Magnolia, 2nd Floor
National Native HIV/AIDS Leadership Network Location: Gallaudet University, Meeting Level 1
Strolling into Truvada: PrEP Access Among Sex Workers Location: Dogwood, 2nd Floor
Chicas Charlando: Latinx Ladies Discuss Intersectionality Within a Sexual and Reproductive Justice Framework Location: Congress, Meeting Level 4
Ending HIV in the Trump Era: Risk or Opportunity? Location: Pentagon, Meeting Level 4
Stigma-ta: HIV, White Supremacy, Homophobia, and the Black Church Location: George Washington, Meeting Level 1
Developing a Network for Prevention Navigators When You Don’t Have One Location: Silver Linden, 2nd Floor
Getting on the Same Page: Viral Suppression and HIV Transmission Location: Treasury, Meeting Level 4
Community Mobilization: Facilitators & Barriers in 9 U.S. Cities Location: Judiciary Square, Meeting Level 3
Mask Off: Raising Hell and Raising Our Voices Location:Mount Vernon Square, Meeting Level 3
Food Is Medicine for People with HIV: Addressing Nutrition Needs Leads to Health and Savings Location: LeDroit Park, Meeting Level 3
2:00 pm – 5:00 pm 4:15 pm – 6:15 pm
Big Impact: PrEP Ed on Mobile Devices for MSM/Trans Location: Mint, Meeting Level 4
SOCIAL MEDIA LAB
Location: Marquis Salon 14, Meeting Level 2 Session 5 Workshops
REIMAGINE: Engagement in Care Location: Marquis Ballroom 1-3, Meeting Level 2 Engaging Community in Social Science PrEP Research Location: Archives, Meeting Level 4 Addressing the Social Drivers Location: Magnolia, 2nd Floor Aging Transgender — As the Sands Turn Location: Scarlet Oak, 2nd Floor How to Develop a PrEP Curriculum for CBOs Location: Dogwood, 2nd Floor
Navigating Health Systems Changes: Challenges and Priorities Location: Tulip, 2nd Floor Analyzing HIV, Poverty, and Race to Understand and Elevate our Work Location: Silver Linden, 2nd Floor Addressing the Overrepresentation of PLWHIV/HCV in the Criminal Legal System Location: LeDroit Park, Meeting Level 3 The Indirect Approach: Access for Gay Men Through Engagement and Empowerment Location: Judiciary Square, Meeting Level 3
There’s something everyone
TOGETHER WE CAN Gilead proudly supports the United States Conference on AIDS. LET’S GET STARTED.
can do to help stop HIV.
HELP STOP THE VIRUS. Â© 2017 Gilead Sciences, Inc. All rights reserved. UNBC4816 08/17
SCHEDULE AT A GLANCE Session 5 Workshops
4:15 pm – 6:15 pm
Staying in It: Building Frontline Staff Resilience & Preventing Burnout Location: Mount Vernon Square, Meeting Level 3 Health Care Rights Enforcement and Discrimination in the Trump Era Location: Shaw, Meeting Level 3 Addressing Needs of Women of Color Aging with HIV Location: Union Station, Meeting Level 3 New Developments in HIV Testing and Window Periods Location: Capitol, Meeting Level 4
Why the X? Understanding Latinx Location: Congress, Meeting Level 4 Coming of Age: Preparing the next generation of Asian & Pacific Islander HIV Leadership Location: Mint, Meeting Level 4 Ensuring Access to Care: Counting on the Ryan White Program Location: Pentagon, Meeting Level 4 NEG, UB2, FU! : Stigma in the MSM Community Location: George Washington, Meeting Level 1 Southern Stigma: New Research; Positive Action Location: Treasury, Meeting Level 4
6:30 pm – 7:30 pm
7:00 pm – 8:30 pm
MOVIE SCREENING: NOTHING WITHOUT US: THE WOMEN WHO WILL END AIDS
Location: Check Affinity Session board located near registration booths.
Location: Shaw, Meeting Level 3
EMPOWERING THE HIV COMMUNITY SINCE 1994 POZ.COM
SESSION 3 WORKSHOPS SEPTEMBER
7:00 am – 7:45 am MORNING WORSHIP SERVICE Location: Dogwood, 2nd Floor
9:00 am – 11:00 am Session 3 Workshops
THE LONG VIEW: PERSPECTIVES ON HEALTHY AGING WITH HIV Presented by Gilead Sciences
Location: Shaw, Meeting Level 3 Pathway: Aging Level: Beginner
The outlook for many people with HIV is shifting for the better.With early detection and proper treatment, HIV can now be a long-term, manageable chronic disease for many. But what does long-term healthy living look like for individuals living with or at risk for HIV? Please join us for a discussion about what healthy aging with HIV means now and in the future and hear perspectives from longterm survivors of the epidemic about achieving this goal and what challenges still exist. Host: HIV: The Long View Coalition SOCIAL DETERMINANTS OF HEALTH — LOOKING CLOSER AT RACIAL, ETHNIC, AND GEOGRAPHICAL DISPARITIES IN HEALTH CARE OUTCOMES
Moder ator: Carole Treston, Association of Nurses in AIDS Care, Philadelphia, PA Presented by: Erin Athey, DNP, FNP-BC, RN, George Washington University, Association of Nurses in AIDS Care, Washington, DC + David Hardy, MD, Whitman Walker Health, HIV Medicine Association, Washington, DC + Mitchell Wharton PhD, RN, FNP-BC, CNS, Johns Hopkins University, Association of Nurses in AIDS Care, Baltimore, MD Location: Scarlet Oak, 2nd Floor Pathway: Health Care Providers Level: Intermediate
Social determinants of health is a phrase commonly used in HIV research, planning, and advocacy. But what does it really mean? It can be a long list of factors that affect health and quality of life and measured by not only income, educational level and employment opportunities, but also affordable healthy food, safe and accessible housing and other quality of life indicators within neighborhoods. This session will utilize CDC data to map specific examples of important social determinants of health and compare that information to HIV and other health conditions and outcomes with a racial, ethnic, and geographical distribution nationally and locally. Come learn the data relevant to your state or county and through data, identify the factors that might have the largest effect on health outcomes where you live and work. IMPLICIT BIAS: HIV PREJUDICE AND THE HEALTH OF THE COMMUNITY Presented by: Dr. Marsha Martin
Location: Dogwood, 2nd Floor Pathway: Faith Level: Intermediate
Implicit Bias refers to the attitudes or stereotypes that unconsciously affect our understanding, actions, and decisions unintentionally. These biases negatively affect our society. In this session, attendees will explore the faith community’s unique opportunity to address implicit biases and strategic ways to dismantle this growing problem. Additionally, attendees will discuss HIV related stigma and its impact on our healthcare system, health outcomes, and issues of health disparities. ADAPTATION OF OPTIONS: ALIGNMENT TO THE NATIONAL HIV STRATEGY Presented by: Tiana Monteilh, APLA Health, Los Angeles, CA + Jeff Bailey MPH, APLA Health, Los Angeles, CA Location: Magnolia, 2nd Floor Track: Biomedical HIV Prevention Level: Intermediate
Authors will present on the adaptation of the evidence-based intervention, Options. Originally created for clinicians to deliver the Information-Motivation-Behavioral Skills (IMB) model for HIVpositive persons in clinical care, this workshop will focus on how APLA adapted the Options Intervention to align with the National HIV/AIDS Strategy and CDC’s high impact prevention initiative. Participants will also engage in an activity to learn how the intervention can be integrated into their services.The goal of the intervention is to ensure HIV-positive MSM are engaged in HIV care, promote adherence to prescribed HIV regimens, assist clients with navigating a complex HIV service delivery system, and encourage HIV-positive MSM to share biomedical risk reduction strategies with their sero-discordant partners. At the conclusion of the workshop, participants will also be able to describe the success of the intervention and how Options can be adapted to be responsive to the HIV continuum of care. HIV PREP FRAMEWORK: NATIONAL BLUEPRINT FOR SCALING UP PREP
Presented by: Nate Fecik, Public Health Advisor, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services, Washington, DC + Derick Wilson, Philadelphia thRIVE, Philadelphia, PA + Mary Elizabeth Marr, Chief Executive Officer, Thrive Alabama, Huntsville, AL Location: Treasury, Meeting Level 4 Pathway: HHS SMAIF Level: Intermediate
Scaling up pre-exposure prophylaxis (PrEP) is a crucial strategy to prevent HIV infection.Yet data show PrEP is being used less among communities of color. To help inform planning and monitoring
SESSION 3 WORKSHOPS
of PrEP programs and to increase PrEP use among communities of color, the National HIV/AIDS Strategy Federal Interagency Workgroup developed the HIV PrEP Framework. The Framework identifies essential components for a comprehensive response to scaling up PrEP use and serves as a tool to assess federal PrEP activities, identifies potential gaps, and describes future directions to improve the awareness, use, and monitoring of PrEP. PROTECTING OUR FUTURE: LEADERSHIP SKILLSBUILDING FOR BLACK GAY MEN
Presented by: Michael Everett, ETR & Associates, Los Angeles, CA + Christopher Wilson Smith, ETR & Associates, Los Angeles, CA + Aunsha Hall-Everett, The Black AIDS Institute, Los Angeles, CA + Adrian Jay Neil Jr., AIDS United, Washington, DC Location: Silver Linden, 2nd Floor Pathway: Capacity Building Level: Intermediate
Over the last 20 years Black gay men have been plagued with “risk” related stigma. HIV/AIDS has also played a large role in the socialization of Black gay men.The field of HIV prevention has offered a unique opportunity by creating pathways for these men to learn about a profession, experience the world through conferencing, and facilitate national and international networking. In an effort to combat the various risk factors experienced by Black gay men, supporting Black gay leadership development can serve as a protective factor against risk such as HIV, poverty and body image. When the HIV workforce is intentional about developing young gay Black men who embody this work, the trajectory of their lives can be changed instantly.This session will focus on the leadership development skills that exist for Black gay men that can also enhance protective factors and increase opportunity for an optimal life. REFORMING DRUG PRICING — AN ADVOCATE’S TOOLBOX
Presented by: Britten Pund, NASTAD, Washington, DC + Tim Horn, Treatment Action Group, New York, NY Location: Judiciary Square, Meeting Level 3 Track: Public Policy Level: Intermediate
In Washington, DC, drug pricing is the talk of the town. The details of drug pricing, however, often remain a mystery and removed from the debate.This session will prepare HIV providers and advocates with the tools to understand the drug pricing system and support reforms that will reduce prices for patients, providers, and public payers (Medicare and Medicaid). This session will provide an overview of the American drug pricing system and explore the impact of various policy proposals on the HIV sector, including the 340B Drug Discount Program. THE MISSING RX: ACCESS TO EMPLOYMENT INFORMATION, SERVICES, AND RESOURCES
Presented by: Brett Andrews, Positive Resource Center, San Fr ancisco, CA + Barb Cardell, Positive Women’s Network and Color ado Mod Squad, US People Living with HIV Caucus, Boulder, CO + Ashley Br azil, Chicago
House, Chicago, IL + Daniel Driffin, Thrive SS, Atlanta, GA + Kate Harrington-Rosen, Chicago House, Chicago, IL + Ken Hergenr ather, George Washington University, Washington, DC + Mark Misrok, National Working Positive Coalition, New York, NY + Kiar a St. James, New York Tr ansgender Advocacy Group, New York, NY + April Watkins, GMHC, New York, NY Location: LeDroit Park, Meeting Level 3 Pathway: Structural Interventions Level: Intermediate
What if communities most impacted by HIV received improved access to employment opportunities? Racial and other inequities associated with HIV health disparities are paralleled by those related to employment and economic opportunity. Initiatives implemented in a handful of states and communities are strengthening responses to employment needs of PLWHIV, and those placed at greater risk for HIV and other health conditions. Disparities targeted by these initiatives include those related to race, sexual orientation, gender identity, disabilities and chronic health conditions, criminal justice, age, national origin and poverty. In this session, community leaders, service providers, researchers, educators, policymakers and advocates will explore employment-related needs, barriers and effective service strategies to complement interventions across the HIV continuum of care and prevention. SUCCESSION PLANNING: ORGANIZATIONAL STABILITY AND LEADERSHIP DEVELOPMENT
Presented by: Rachael Gibson, Raffa P.C., Washington, DC + Larry Lehman, Positive Impact Health Centers, Atlanta, GA + Rob Newells, APEB, Oakland, CA + Debbie Warren, RAIN, Charlotte, NC Location: Mount Vernon Square, Meeting Level 3 Track: Leadership Level: Beginner
This session will focus on the importance of an organizational succession plan to ensure seamless transitions in senior leadership and uninterrupted client services. The session will incorporate the importance of fostering a culture of leadership development within an organization to identify and nurture the next generation of leadership within the field. The panel will consist of a succession planning expert and three leaders from HIV organizations around the country who have created succession plans within their organizations and gone through AIDS United’s Succession Planning Institute. CLARIFYING RYAN WHITE HIV/AIDS PROGRAM CLINICAL QUALITY MANAGEMENT PROGRAM EXPECTATIONS Presented by: Marlene Matosky, HRSA/HAB, Rockville, MD Location: Chinatown, Meeting Level 3 Pathway: HRSA Level: Intermediate
The goal of this session is for Ryan White HIV/AIDS Program (RWHAP) grant recipients to have a clear understanding of the key components of a clinical quality management program as identified in Health Resources and Services Administration Policy Clarification Notice 15-02.
SESSION 3 WORKSHOPS SEPTEMBER
THE SECRET GARDEN: UNLOCKING THE MYSTERIES OF THE VAGINAL MICROBIOME
Presented by: Gina Brown, Office of AIDS Research, NIH, Bethesda, MD + Clare Collins, Microbicide Trials Network, Pittsburgh, PA + Dazon Dixon Diallo, SisterLove, Inc., Atlanta, GA + Katy Godfrey, National Institute of A llergy and I nfectious D iseases , NIH, B ethesda , MD + S haron H illier , Microbicide Trials Network, Pittsburgh, PA Location: Union Station, Meeting Level 3 Track: Cis & Trans Women Level: Beginner
The vaginal microbiome, the microbial community of a woman’s vagina, may influence susceptibility to HIV infection and decrease the ability of certain drugs to prevent HIV. Indeed, understanding the microorganisms in the vagina is vitally important to identifying the factors that may make women more vulnerable to sexually transmitted infections like HIV. One such microorganism may be Lactobacillus that when in low levels in the vagina is linked to inflammation and bacterial vaginosis (BV).Women with BV, which is more prevalent in Latina and African American women than white women in the U.S., have a higher risk of sexually transmitted infections and pregnancy complications. This session is designed to reveal the secrets of the vaginal microbiome by providing the latest research related to vaginal microorganisms and susceptibility to HIV, and by addressing racial disparities and strategies to advocate for better testing and treatment of BV. OUTBREAK AND RESPONSE PLANNING IN THE RURAL SOUTH
Presented by: John Brooks and Dwayne Banks, Centers for Disease Control and P revention , A tlanta , GA + G ayle Y ocum , F r ankfort , KY Location: Capitol, Meeting Level 4 Pathway: Centers for Disease Control Level: Intermediate
A vulnerability assessment released by CDC in 2015, indicated that 54 (24%) of the 220 U.S. counties most vulnerable to rapid dissemination of HIV/HCV infections among people who inject drugs were in Kentucky. In response to these data, the state implemented comprehensive outbreak planning and response efforts.This session will highlight the strategies and best approaches used by Kentucky to coordinate their outbreak plan and response. SURVIVING THE EPIDEMICS AND HIV/AIDS IN URBAN INDIAN COMMUNITIES
Presented by: Sheldon Raymore, American Indian Community House, New York, NY + Kerry Hawk Lessard, Native American LifeLines, Inc., Baltimore, MD Location: Gallaudet University, Meeting Level 1 Pathway: Race: Native American and American Indian Level: Beginner
This session will share the depths of the “urban Indian” health crisis and challenges in accessing culturally competent healthcare services. Decades of neglect have placed urban Indians at greater risk of health disparities including new HIV/AIDS infections and late HIV diagnosis. From the east coast to west coast, American Indians/Alaska Natives (AIAN) from many tribal nations have scattered across the country
with 78% living away from reservations or villages. Within these urban Indian communities, AIAN continue to experience co-factors of risk including substance abuse, poverty, homelessness and highrisk behaviors. The urban AIANs have not been acknowledged or invisible in the efforts to address racial and ethnic disparities in health care. HIV/AIDS rates in urban Indian communities are seemingly high and/or are miscalculated/misclassified in epidemiology data. Continued recognition and awareness of the AIAN urban populations within the HIV/AIDS response is important to effective prevention programming, resource allocations and data/research initiatives. BREAKING RACIAL BARRIERS TO “ETE” IN THE BLACK COMMUNITY
Presented by: C. Virginia Fields, Eishelle Tillery, National Black Leadership Commission on AIDS, Inc., New York, NY Location: Mint, Meeting Level 4 Pathway: Race: African American and Black Level: Intermediate
Racial disparities in HIV/AIDS-related incidence, prevalence, and mortality are stark reminders of the barriers facing communities of color in America. This workshop seeks to enhance the effectiveness of health programming by making providers more aware of barriers that black Americans navigate daily. While many funding opportunities target minority communities, it is unreasonable to assume that programs will succeed in Black communities if Black men and women are not involved in program planning or service delivery activities. Engaging Black communities require sensitivity to issues such as poverty, educational attainment, and experiences with discrimination in its multiple complex forms, as well as awareness of policies that are burdensome to these communities. Ending the epidemic is reliant on engaging black communities through diverse staffing, holistic approaches to health, and improving access to potentially lifesaving local resources. PREVENTING HIV IN THE TRUMP ADMINISTRATION
Presented by: Carl Schmid, The AIDS Institute, Washington, DC + Kevin Jones, MEd, MPH, Urban Coalition for HIV/AIDS Prevention Services + Carolyn McAllaster, Southern HIV/AIDS Str ategy Initiative (SASI), Duke University School of Law, Durham, NC + Guillermo Chacón, Latino Commission on AIDS, New York, NY + Jesse Boyer, Guttmacher Institute, New York, NY + Monique Tula, Harm Reduction Coalition, Oakland, CA + Andrea Levario, Human Rights Campaign, Washington, DC Location: Pentagon, Meeting Level 4 Pathway: HIV Policy Level: Intermediate
The CDC has reported that the number of new HIV infections overall has declined in the U.S in recent years, but progress is uneven, and some communities and states, continue to experience higher rates. This includes gay and bisexual men, particularly those who are young, Black and Latino.This workshop will examine the current status of HIV prevention efforts in the U.S. and the key elements of CDC’s high impact prevention. This will include HIV testing, treatment as prevention, PrEP, sexual education, syringe service programs, and other priority prevention interventions. Changes in HIV prevention under theTrump Administration will be examined, including the Administration’s views
SESSION 3 WORKSHOPS
on the LGBT community, race, and immigrants. The budget for HIV prevention programs, along with policy changes will be discussed. Finally, ways in which attendees can help improve HIV prevention policies at the federal, state and local levels will be discussed. EMBRACING AN UNANTICIPATED LIFE
Presented by: David Fawcett PhD, LCSW, South Florida Center for Counseling, Wilton Manors, FL Location: George Washington, Meeting Level 1 Track: People living with HIV Level: Intermediate
People Living with HIV/AIDS (PLWHA) experience shame, stigma, discrimination, isolation, trauma, and higher rates of mental health, and addictive disorders.These are dramatically compounded when combined with the physical, psychological, and social impact of aging. Unless equipped with skills supporting ongoing emotional resilience, aging PLWHA can rapidly experience adverse physical and emotional health outcomes. Specific factors have been identified which boost the ability of aging PLWHA to better cope with these challenges. This workshop will begin with a review of the psychosocial concerns, compulsive behaviors, and co-occurring mental health problems that undermine successful coping among aging PLWHA. HIV-Associated Neurocognitive Disorders and their impact on resilience will be discussed followed by a detailed interactive discussion of specific skills and strategies to improve emotional resilience among this population, including mindfulness, fostering gratitude and increased social connectedness.
PREPPING FOR SEX: AN INTIMATE CONVERSATION — THE IMPLICATION OF SEX POSITIVITY AND THE UPTAKE OF PREP
Presented by: Ken Pettigrew, District of Columbia Department of Health, Washington, DC + Anthony Fox, District of Columbia Department of Health, Washington, DC Location: Archives, Meeting Level 4 Track: Biomedical HIV Prevention Level: Archives, Meeting level 4
TheWashington, DC, region has a complex urban epidemic, with high rates of HIV/AIDS, STDs, and viral and chronic hepatitis. As many as one in five gay and bisexual men are living with HIV in the District of Columbia.The overwhelming majority of new HIV infections are the result of sexual intercourse. As complex as the Washington DC area is, it’s challenges regarding health healthy sexual attitudes and the uptake of PrEP mirror those in both rural and urban settings across the county.The purpose of this panel discussion is to help participants take a fresh look at sexual health in a more positive light. Sexual activity has become stigmatized over the resent years with the increase of HIV/AIDS and other sexually transmitted diseases particularly among Black Gay and Bisexual men. This workshop will address positive sexual health from four perspectives: Physical, Emotional/ Mental, Affirmation/Spiritual, and Intergenerational. This discussion is relevant to our entire community regardless of HIV status.
10:00 am – 5:00 pm Exhibitions
EXHIBIT HALL OPEN*
Location: Liberty and Independence Ballroom, Level 4
*Exhibit Hall closed during plenary sessions.
SESSION 4 WORKSHOPS
08 11:30 am – 1:30 pm Plenary Luncheon
REIMAGINE: RESET. REFUEL. RETOOL. Presented by: Gilead Sciences
Location: M arquis Ballroom, Meeting Level 2 Reset The HIV community has been on a 35+ year journey of transformation and development. Regardless of the challenges, the
community has consistently demonstrated a collective capacity to engineer change from science to policy to practice. Refuel Sustaining the movement to end HIV requires staying focused in a fast-moving, often distracting, environment. As in the past, the HIV community will adapt, innovate and regenerate. Retool Please join us to reflect on the state of HIV, explore what’s needed and celebrate the experience, creativity and regenerative spirit of the HIV community. Presenters:
Jeffrey S. Crowley, Program Director O’Neill Institute for National & Global Health Law
Derrick Butler, MD Associate Medical Director, To Help Everyone Health and Wellness Centers
Laura van Dernoot Lipsky, Founder and Director, The Trauma Stewardship Institute
Darnell L. Moore, Editor-at-Large, CASSIUS / iOne Digital
1:30 pm – 2:00 pm Posters
POSTER PRESENTATIONS Location: Meeting Level 3 Session 4 Workshops
2:00 pm – 4:00 pm RISK, RELEVANCE, ROLE – CONVERSATIONS AND CONNECTIONS FOR WOMEN WITH HIV
Sponsored by: ViiV Healthcare Facilitator: Amelia Kor angy, ViiV Healthcare Panelists: Vignetta Charles, ETR, Scotts Valley, CA + Nathalie RubioTorio, Voces Latinas, New York, NY + Kiar a St. James, New York Tr ans Advocacy Group, New York, NY + Gina Brown, Southern AIDS Coalition, New Orleans, LA + Patrick Sullivan, Emory University, Atlanta, GA Location: Chinatown, Meeting Level 3 Track: Cis & Trans Women Level: Intermediate
Risk, Relevance, Role is a Positive Action for Women conversation series focused on solutions that break down isolation impacting women of color with HIV, and connect people and ideas that help women get the care and support they need right now.This workshop is designed to
focus on shifting muddled messages around women’s risk, using local data to better collaborate, and ways to bring in family and friends to break down stigma and make care real for women of color. Through an interactive dialogue between panelists and participants, we will tackle topics including: How does how we communicate “risk” impact HIV prevention, treatment, and care for women? How can we use the current epidemiologic data to better collaborate and improve care for women? How can organizations and providers support HIV discussion or disclosure among friends and family? Panelists include women of color living with HIV, advocates, service providers, and researchers. ENERGY FOR YOUR BEST SELF: HOW TO HELP MAXIMIZE YOUR INTERNAL POWER WORKSHOP
Sponsored by: Janssen Infectious Diseases Presented by: Rhonda Waters, Johnson & Johnson Human Performance Institute
SESSION 4 WORKSHOPS
THURSDAY FRIDAY Location: Marquis Salon 12, Meeting Level 2 Track: People Living with HIV Level: Intermediate
We all want to be our best when it matters most — in work and in life. Yet in today’s stress-filled, 24/7 world, it’s easy to feel overwhelmed or burned out at times. When you’re working hard to make a difference in the lives of people living with HIV, you’re often giving away energy without replenishing it. Energy is one of the most important resources you have as a human being. But without the right training, energy demands can exceed capacity, leaving you feeling anything but inspired. Fortunately, you can learn how to change energy-depleting behaviors, and Rhonda Waters, Performance Coach from the Johnson & Johnson Human Performance Institute (JJHPI), can help! Employing a sciencebased approach that incorporates performance psychology, exercise physiology and nutrition, Rhonda will share how to expand your energy capacity to help you perform at your best in all areas of life, and provide tips and tools you can use or share with colleagues and clients. PSYCHOSOCIAL ISSUES AMONG OLDER ADULTS WITH HIV: CHALLENGES AND OPPORTUNITIES
Presented by: Mark Brennan-Ing, PhD, ACRIA, New York, NY + Fernando De Hoyos, NMAC, Washington, DC + David Garcia, EdD, MPH, Latino Commission on AIDS, New York, NY + Michelle Lopez, ACRIA, New York, NY + Joseph Lunievicz, ACRIA, New York, NY + Luis Scaccabarrozzi, MPH, Latino Commission on AIDS, New York, NY Location: Tulip, 2nd Floor Pathway: Aging Level: Intermediate
Research consistently finds elevated levels of depressive symptoms among older people with HIV (PWH) compared to non-infected older adults, fueled by HIV stigma and concomitant social isolation, and a high burden of disease. Many older PWH, including long-term survivors, face these issues without adequate social supports. We will begin with an introduction to aging and HIV, and then turn to a panel discussion of recent research on psychosocial issues affecting older PWH. Next, a demonstration will be provided of easy-touse screening tools to identify depression and social isolation in older PWH clients. This will be followed by a presentation of a recent policy initiatives, and panel discussion of the community responses to the psychosocial challenges of aging with HIV. An audience discussion with the panelists will conclude the workshop. Addressing psychosocial concerns among older PWH is paramount to efforts to end AIDS and support healthy aging in this population.
an example of a community driven initiative that operates at the state level of government. A panelist from Houston will discuss challenges and victories in their campaign, which saw a city-wide focus expand to the overlapping county. Our Washington, DC partner will share their unique story, along with challenges and lessons learned. STROLLING INTO TRUVADA: PREP ACCESS AMONG SEX WORKERS Presented by: Marcel Byrd, NASTAD, Washington, DC Location: Dogwood, 2nd Floor Track: Biomedical HIV Prevention Level: Intermediate
This session will discuss PrEP access and the gaps in PrEP utilization among sex workers. This session will discuss why there are gaps in PrEP use among sex workers and how criminalization of sex work and medical stigma contribute to worse outcomes for this population. Participants will be encouraged to brainstorm and share ways to remove barriers to PrEP access for sex workers and to design preliminary outreach programs for this population. We will discuss the frequent exclusion of both women and sex workers in PrEP advertisements and how to augment representation within PrEP promotional materials. ENDING HIV IN THE TRUMP ERA: RISK OR OPPORTUNITY?
Presented by: Ronald Johnson, AIDS United, Washington, DC + William McColl, AIDS United, Washington, DC + Carl Schmid, The AIDS Institute, Washington, DC Location: Pentagon, Meeting Level 4 Pathway: HIV Policy Level: Beginner
A comprehensive set of federal HIV policies and implementation plans are crucial to keeping the country on course for ending the domestic HIV epidemic. Clear polices and progress on action plans are indicators of how the administration prioritizes the federal response to HIV. This workshop will examine the Trump administration’s approach to the domestic HIV epidemic and the impact that the administration is having on federal HIV policy. Presenters will address the status of the National HIV/AIDS Strategy and federal efforts to end the HIV epidemic, provide an overview of HIV action plans of key federal agencies, and discuss how issues related to HIV, such as LGBT rights, social justice, race and ethnicity, women’s health, the opioid epidemic, and immigration are being affected by the administration.The workshop will provide an opportunity to engage participants in a discussion of ways to increase the visibility and prioritization of HIV in the administration.
COLLABORATION: BRINGING (AND KEEPING) THE RIGHT PEOPLE TO THE TABLE Presented by: Jaron Benjamin, Housing Works, Brooklyn, NY Location: Magnolia, 2nd Floor Pathway: Ending the Epidemic Level: Intermediate
This workshop will feature a panel of discussants from diverse jurisdictions that are working in government/community partnerships to end AIDS as an epidemic. A panelist from New York will provide
SESSION 4 WORKSHOPS SEPTEMBER
DEVELOPING A NETWORK FOR PREVENTION NAVIGATORS WHEN YOU DON’T HAVE ONE
Presented by: Miguel Chion, MD, AIDS Project Los Angeles, Los Angeles, CA + Oscar Márquez, AIDS Project Los Angeles, Los Angeles, CA + Kim Johnson, MD, NMAC, Washington, DC + Tamar a Combs, NMAC, Washington, DC + Jagadisa-devasri Dacus, LMSW, MPhil, Organizational Development/Management Consultant NY, NY Location: Silver Linden, 2nd Floor Pathway: Capacity Building Level: Intermediate
With the advent and introduction of biomedical interventions (pre-exposure prophylaxis [PrEP] and post-exposure prophylaxis [PEP]) for helping HIV-negative persons to remain seronegative, Prevention Navigators have become important persons in HIV prevention, treatment, and care services. Prevention Navigators assist and guide clients as they travel through the prevention and social services system to keep them in engaged in services, as well as HIV-negative. Prevention Navigators provide a lot of client support, they also greatly benefit from being supported; however, this may not always be the case. So, how do Prevention Navigators develop supportive networks when they do not have any? BIG IMPACT: PREP ED ON MOBILE DEVICES FOR MSM/TRANS
Presented by: Robbyn Kistler, Brooklyn, NY + Chris Barnett, Richmond, VA + Peter a Reine, New Orleans, LA Location: Mint, Meeting Level 4 Track: Biomedical HIV Prevention Level: Beginner
Through presentations and interactive discussions, health department representatives from Virginia and Louisiana will share PrEP marketing strategies to use on digital platforms, including Facebook,YouTube, and MSM-focused dating apps like Grindr and Jack’d, to reach MSM of color and transgender individuals with minimal investments. Topics addressed during the interactive presentation include: -Using paid Facebook ads to reach MSM of color and transgender individuals in the community - Assessing cost and developing strategies to get the most out of your budget - Difference between a boosted post versus a paid Facebook ad - Accessing free videos and images to use in ads - Frequently asked questions about PrEP online - Monitoring comments on Facebook ads to gauge information gaps and perceptions about PrEP - Feedback from community partners and focus groups about PrEP messaging on digital platforms
COMMUNITY MOBILIZATION: FACILITATORS & BARRIERS IN 9 U.S. CITIES
Presented by: Kenyon Farrow, Treatment Action Group, New York, NY + Tim Horn, Treatment Action Group, New York, NY Location: Judiciary Square, Meeting Level 3 Track: Public Policy Level: Intermediate
What’s the role of the community in ending the epidemic in the US? Since the beginning of the HIV epidemic, communities have mobilized to force health care institutions and public health authorities to respond to the needs of people living with, and vulnerable to, HIV. Mobilized networks of activists also created CBOs to provide prevention and care services, and organized to change policies and laws at every level of government. Though this work is established in oral and written histories of the response to the epidemic, its methodologies and outcomes have been poorly described in scientific literature. This workshop will report the findings of a report by Treatment Action Group (TAG) entitled “Community Mobilization: An Assessment of Mechanisms and Barriers at Community-Based and AIDS Service Organizations in Nine U.S. Metropolitan Areas” and engage the participants in solutions to make community mobilization a stronger priority in the US HIV response. FOOD IS MEDICINE FOR PEOPLE WITH HIV: ADDRESSING NUTRITION NEEDS LEADS TO HEALTH AND SAVINGS
Presented by: Karen Pearl, God’s Love We Deliver, New York, NY + Mark Ryle, Project Open Hand, San Fr ancisco, CA + Matt Pieper, Open Hand Atlanta, Atlanta, GA + Daniel Driffin, THRIVE SS Location: LeDroit Park, Meeting Level 3 Pathway: Structural Interventions Level: Intermediate
This workshop will discuss research on the efficacy of food and nutrition services (FNS) for PWH, practice issues with a specific focus on the impact of Race, and opportunities in policy to encourage provision of this life-saving service. Research on FNS for PWH will begin the workshop, including a recently published study from San Francisco and other studies in progress. Using experiential case studies of leading FNS agencies, the panel will focus on the impact of Race as it intertwines with other trends in the epidemic and how practice has evolved in the current environment. An analysis of the Ryan White FNS Program, the most robust FNS program in the country for people living with severe illness, will then be used to model how this relatively inexpensive benefit could be incorporated into our nationwide healthcare delivery system to capitalize on the results evident in the outcomes of the research presented.
SESSION 4 WORKSHOPS
BIJOU: USING ONLINE & MOBILE TECHNOLOGY TO IMPROVE HEALTH OUTCOMES
Presented by: Sar ah Cook-Raymond, Impact Marketing + Communications, Washington, DC + Dr. Lisa Hightow-Weidman, University of North Carolina Department of Infectious Diseases, Chapel Hill, NC Location: Scarlet Oak, 2nd Floor Track: Gay Men Level: Beginner
Whether it’s a ride service, picking a restaurant, or learning new health information, young people are using online platforms to fulfill their needs and answer their questions. Technology-based platforms have the unique opportunity of engaging youth in familiar and comfortable mediums. “Bijou” was designed as an innovative intervention to engage HIV-positive young patients in their long-term health and HIV management leading to sustained viral suppression. Bijou was designed as a collaboration between researchers at UNC and Impact Marketing + Communications, a leader in the field of creating and disseminating HIV-related health communications materials Although there have been successful in-person and online self-management programs implemented, Bijou is the first designed for and with HIV-positive YMSM. WERK! EMOTIONAL LABOR AMONG TRANS WOC PEER HEALTH NAVIGATORS Presented by: Luis Gutierrez-Mock, UCSF Center of Excellence for Tr ansgender Health, San Fr ancisco, CA Location: Union Station, Meeting Level 3 Track: Cis & Trans Women Level: Beginner
As part of a US-based multi-site initiative to improve engagement in HIV treatment among transgender women living with HIV, we conducted 19 qualitative individual interviews with transgender women of color peer health navigators. Grounded theory methodology was used to analyze the transcribed audio recordings of 19 adult trans women of color intervention staff. Emotional labor, the management of feelings according to workplace rules (Hoschild, 1983) emerged as a central theme. This workshop will explore the following research questions: What is the impact of delivering peer-based HIV treatment interventions on the personal lives, (trans) community relationships and life goals of trans women of color intervention staff? How is emotional labor supported (or not supported) within the interventions and organizations? Recommendations for recognizing, validating and supporting the emotional labor of trans women of color peer health navigators will be proposed.
SO, YOU’VE GOT THIS PLAN. WHAT’S NEXT: IMPLEMENTING ETE PLANS
Presented by: Demetre Dask alakis, New York City Department of Health and Mental Hygiene, New York, NY + Michael Karen, DC Department of Health, Washington, DC + Carmen Batista, Arizona Department of Public Health + Katie Burk, San Fr ancisco Department of Health, San Fr ancisco, CA + Jennifer Flannagan and Alyssa Kitlas, NASTAD, Washington, DC Location: Capitol, Meeting Level 4 Pathway: Health Departments Level: Beginner
The National HIV/AIDS Strategy and UNAIDS Fast Track Cities Initiative were the first US and global plans to reduce the number of people living with HIV. Since ending the HIV epidemic in the United States will look different in every jurisdiction, health departments have been working with community partners to develop plans that fit their local needs. Currently, 13 jurisdictions have developed plans and 9 others are in the process of doing so. Some jurisdictions are leveraging their ETE plans to develop plans to end their Hepatitis C epidemics. This session will provide examples of what health departments are doing to implement their ETE plans including how they are engaging key communities in these initiatives, how they are measuring outcomes of their work, and how they are using these frameworks to create city and state plans to end the Hepatitis C epidemic. NATIONAL NATIVE HIV/AIDS LEADERSHIP NETWORK
Presented by: Ayn Whyte, Albuquerque Area Indian Health Board, Albuquerque, NM + Savannah Gene, Albuquerque Area Indian Health Board, Albuquerque, NM + Hannabah Blue, John Snow Inc., Denver, CO Location: Gallaudet University, Meeting Level 1 Pathway: Race: Native American and American Indian Level: Beginner
This session will build upon the discussions and action planning that have taken place at the United States Conference on AIDS and the Circle of Harmony HIV/AIDS Wellness Conferences, to discuss and plan for a “National Native HIV/AIDS Leadership Network”. This Network will address the current gap and need for Native and tribal HIV/AIDS organizations throughout the country to establish a collaborative space to identify and promote needs, provide support to each other, and have a unified voice in pursuit of healthy Indigenous people and communities. Available resources will also be reviewed, including the availability of capacity building assistance from CDC CBA Providers. This session will be highly interactive, and will include a review of previous discussions, as well as planning for action steps moving forward.
SESSION 5 WORKSHOPS SEPTEMBER
CHICAS CHARLANDO: LATINX LADIES DISCUSS INTERSECTIONALITY WITHIN A SEXUAL AND REPRODUCTIVE JUSTICE FRAMEWORK
Presented by: Elizabeth Marie Rivera, Oasis Wellness Center, Latino Commission on AIDS, New York, NY + Devan Diaz, Latino Commission on AIDS, New York, NY + Gabriela S. Betancourt, Latino Commission on AIDS, New York, NY Location: Congress, Meeting Level 4 Pathway: Race: Latinx Level: Intermediate
This workshop explores the inter-sectional identities of gender, sexuality, class, race and ethnicity within a sexual and reproductive justice framework. The workshop highlights barriers to and facilitators for effective prevention and optimal sexual and reproductive health outcomes in an inclusive manner that respects and dignifies Latinas of both trans and non-trans experiences, of varied race, ethnicity, and immigration status. Participants will unpack the term “trans-exclusionary radical feminism” (TERF) and be presented with the comparable and contrasting realities and experiences of being “othered” by the larger societal structure, as well as within Latinx communities and families; the role of trauma, intimate partner violence, misotrans, misogyny, and coercion. STIGMA-TA: HIV, WHITE SUPREMACY, HOMOPHOBIA, AND THE BLACK CHURCH Presented by: Delma Jackson III, Wellness Services Inc., Flint, MI Location: George Washington, Meeting Level 1 Track: People living with HIV Level: Intermediate
There are profound parallels between the creation of “whiteness”; and the creation of “heterosexuality”; within both the religious and scientific communities. Likewise, both institutions created and perpetuated consequential stigmas for millions of same-sex couples (particularly) of color. We will explore this history in the context of people of color living with HIV (POCLWH), and the specific role the “Black Church” has played in maintaining many of these stigmas arguably leaving Black communities less safe, irrespective of sexuality or HIV status. This interactive, multi-media workshop explores that trajectory and provides participants with a matrix for exploring partnerships with faith-based communities which might circumvent theological differences and focus the discourse on connectivity, safety, wholeness, and community. GETTING ON THE SAME PAGE: VIRAL SUPPRESSION AND HIV TRANSMISSION
Presented by: Richard Wolitski, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services, Washington, DC + Bruce Richman, Prevention Access Campaign, “Undetectable = Untr ansmittable (U=U)”, New York, NY + Jessica Lacy, Centers for Disease Control and Prevention,Atlanta, GA Location: Treasury, Meeting Level 4 Pathway: HHS SMAIF Level: Intermediate
Compelling new evidence demonstrates that HIV treatment greatly reduces sexual transmission of HIV.The research also found no cases of HIV that were transmitted by individuals with a suppressed viral load. These results added to previous findings that assessed HIV treatment, viral load, and transmission. These results, however, have been inconsistent across the Federal government, health departments, and community organizations. To address this issue, DHHS agencies and offices partnered to engage policy makers, researchers, and communicators to develop accurate, clear, and consistent messages. Input from national and community organizations, state and local health departments, advocates, people living with HIV and people at-risk for HIV helped inform the final messages. GETTING ON THE SAME PAGE: VIRAL SUPPRESSION AND HIV TRANSMISSION
Presented by: Richard Wolitski, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services, Washington, DC + Bruce Richman, Prevention Access Campaign, “Undetectable = Untr ansmittable (U=U)”, New York, NY + Jessica Lacy, Centers for Disease Control and Prevention,Atlanta, GA Location: Treasury, Meeting Level 4 Pathway: HHS SMAIF Level: Intermediate
Compelling new evidence demonstrates that HIV treatment greatly reduces sexual transmission of HIV.The research also found no cases of HIV that were transmitted by individuals with a suppressed viral load. These results added to previous findings that assessed HIV treatment, viral load, and transmission. These results, however, have been inconsistent across the Federal government, health departments, and community organizations. To address this issue, DHHS agencies and offices partnered to engage policy makers, researchers, and communicators to develop accurate, clear, and consistent messages. Input from national and community organizations, state and local health departments, advocates, people living with HIV and people at-risk for HIV helped inform the final messages. MASK OFF: RAISING HELL AND RAISING OUR VOICES
Presented by: Cydney O. Brown, Advocates for Youth, Washington, DC + Luis A. Ortiz-Fonseca, Advocates for Youth, Washington, DC Location: Mount Vernon Square, Meeting Level 3 Pathway: Youth Level: Beginner
Why is storytelling important in social justice movements? How can being the narrators of lives help eliminate HIV stigma? One answer is that we exist in a society hell-bent on silencing our voices and experiences. This interactive workshop highlights the power of storytelling as a tool for social justice and addressing HIV stigma. Through the lens of #MyStoryOUTLoud, a digital storytelling campaign that focuses on uplifting the narratives of LGBTQ youth of color, Participants will be given tools on how to develop and share their stories through various methods and on across different social media platforms. By the end of the workshop, participants should be able to identify their own stories as powerful mechanisms that can effect change and will leave with knowledge on how to share their stories, including example storytelling curations such as #MyStoryOUTLoud.
SESSION 5 WORKSHOPS
This workshop will feature government and community-based social science researchers to inform and lead a discussion on psycho social factors that influence PrEP awareness, acceptance, and delivery among the groups within communities of color at highest risk of HIV transmission (e.g. cisgender and transgender MSM and transgender and cisgender women. The importance of stakeholder engagement throughout the research process, and how the use of the Good Participatory Practice (GPP) guidelines can frame this work, will also be introduced and discussed. Presenters will discuss challenges to ensuring adequate representation of racial and ethnic groups in social science about PrEP, and emerging solutions. This workshop will be dedicated to answering questions that participants have about HIV prevention social science research, particularly related to PrEP. ADDRESSING THE SOCIAL DRIVERS
Presented by: Jaron Benjamin, Housing Works, Brooklyn, NY Location: Magnolia, 2nd Floor Pathway: Ending the Epidemic Level: Intermediate
This panel discussion will focus on addressing the social drivers of the AIDS epidemic, and will feature participants from New York City, Oregon, and Mississippi. Panelists will discuss their efforts to mitigate housing instability and food security while implementing their city or state’s “Ending the Epidemic” initiative. AGING TRANSGENDER — AS THE SANDS TURN Presented by: Dee Curry, Casa Ruby, Washington, DC Location: Scarlet Oak, 2nd Floor Pathway: HIV & The Trans Community Level: Intermediate
A detailed workshop on the different generations of transgender people and how the medication, successes, trauma, and life experiences, civil rights and HIV epidemic shape their paths. HOW TO DEVELOP A PREP CURRICULUM FOR CBOS
Presented by: Brittney Gr aham, MS, Tennessee Department of Health, Nashville, TN Location: Dogwood, 2nd Floor Track: Biomedical HIV Prevention Level: Beginner
This workshop aims to provide direction, instruction, and tools on developing training for CBOs on how to identify and refer patients to PrEP for HIV prevention.TheTennessee Department of Health’s, HIV Prevention team has developed PrEP training materials and has trained 157 people to date including Disease Investigation Specialists, public health educators, and public health nurses. The training serves as an orientation to PrEP for those seeking to know more about PrEP and/ or conducting PrEP referrals.This workshop will detail Tennessee’s PrEP curriculum and provide guidance as to how participants can modify the materials for their own agency.
NAVIGATING HEALTH SYSTEMS CHANGES: CHALLENGES AND PRIORITIES
Presented by: Amy Killelea, NASTAD, Washington, DC + Ann Lefert, NASTAD, Washington, DC Location: Tulip, 2nd Floor Track: Public Policy Level: Intermediate
We are facing unprecedented threats to the health care programs that serve low-income individuals living with and at risk for HIV. Under the Affordable Care Act (ACA), millions of Americans gained access to private insurance and Medicaid, including tens of thousands of people living with HIV. We are now at risk for losing these coverage gains and non-discrimination protections. These changes to the ACA and Medicaid will disproportionately impact low-income people living with HIV and other chronic conditions. This workshop will explore how people living with HIV, HIV providers, and AIDS Drug Assistance Programs will be affected by proposed and enacted health reforms, with a particular focus on state and federal strategies to preserve the gains in coverage and access made since the ACA went into effect and to ensure continued access to care and treatment. ANALYZING HIV, POVERTY, AND RACE TO UNDERSTAND AND ELEVATE OUR WORK
Presented by: Berwick Mahdi Davenport, The People’s Institute for Survival and B eyond , N ew O rleans , LA + D iana D unn , T he P eople ’ s I nstitute for Survival and Beyond, New Orleans, LA + Milta Vega-Cardona, The People’s Institute for Survival and Beyond, New Orleans, LA Location: Silver Linden, 2nd Floor Pathway: Capacity Building Level: Intermediate
As a society, we often believe individuals and their communities are solely responsible for their conditions. However, there are factors that lead to racial disparities, chronic illness, morbidity, mortality and poverty; conditions such as poor housing, poor educational and health systems to name a few. Through an analysis of institutional power, we will identify and unpack the systems external to the community that create the internal realities people experience daily. Stereotypes of poverty, HIV and race will be explored through dialogue and exercises. An excerpt of the Peoples Institute’s Undoing Racism training, this workshop will address questions such as: What are the relationships between wealth, class, race and poverty and how do these relationships impact health outcomes for PLWH? What are our own biases around poverty, class and race? What are the historical and present relationships of institutions, systems and social determinants of health, and their impact on the communities we serve?
SESSION 5 WORKSHOPS SEPTEMBER
ADDRESSING THE OVERREPRESENTATION OF PLWHIV/HCV IN THE CRIMINAL LEGAL SYSTEM
Presented by: Elizabeth Paukstis, National Vir al Hepatitis Roundtable, Washington, DC + Meghan Maury, National LGBTQ Taskforce, Washington, DC + Kate Boulton, Center for HIV Law and Policy, New York, NY + Scott Schoettes, Lambda Legal, Chicago, IL Location: LeDroit Park, Meeting Level 3 Pathway: Structural Interventions Level: Beginner
Addressing the overrepresentation of PWLHIV and HCV in the criminal legal system requires elimination of HIV- and HCV-specific criminal laws and other reforms to address systemic barriers to housing, healthcare, and employment. Many states criminalize HIV/ HCV exposure, non-disclosure, or transmission, as well as sex work and possession of sterile syringes. These laws perpetuate stigma, undercut public health, and disproportionately affect women, sex workers, people of color, and immigrants. At the same time, LGBTQ people and PLWHIV and HCV, particularly people of color, experience discrimination in housing, employment, health care, and education, resulting in poverty, homelessness, and reliance on sex work to survive. Once incarcerated, PLWHIV and HCV face violence, discrimination, inadequate health services, and frequent segregation or solitary confinement. Reentry also presents significant challenges related to housing, employment, and healthcare. This workshop will discuss past, current, and planned policy and advocacy efforts to address these intersecting forms of oppression. THE INDIRECT APPROACH: ACCESS FOR GAY MEN THROUGH ENGAGEMENT AND EMPOWERMENT
Presented by: Yashica Ellis, Wellness Services Inc., Flint, MI + Teresa Springer, Wellness Services Inc., Flint, MI Location: Judiciary Square, Meeting Level 3 Track: Gay Men Level: Intermediate
HIV testing and linkage services with gay men have always been focused on HIV education and then testing. It has been a burden of Gay men to have HIV prevention or care as a major focus in their social lives. This workshop will focus on creating safe access points in the community that do not focus directly on HIV education and testing but instead on engagement and empowerment with an undertone of recruitment into testing and care services. Wellness Services recruitment process includes a drop-in center for LGBTQ+ youth, skills building workshops, a cyber center, game and movie nights, linkage to community resources, food pantry, community closet and hosting Flintâ&#x20AC;&#x2122;s Gay Pride festival. We focus on building rapport and trust first while engaging readiness for testing and treatment.This has led to an increase in testing and care services for MSM of color between the ages of 13-29.
STAYING IN IT: BUILDING FRONTLINE STAFF RESILIENCE & PREVENTING BURNOUT
Presented by: Julie Barnes, LMHC, Same Boat Consulting, Boston, MA + Br andon A. Harrison, Primary Care Development Corpor ation, New York, NY Location: Mount Vernon Square, Meeting Level 3 Track: Leadership Level: Intermediate
Staff from Primary Care Development Corp, Same Boat Consulting, & a NewYork-based LGBT Community Health Center will present their 2016-17 partnership, addressing vital challenges that the clinic faced in retaining and supporting a diverse staff.The workshop will present a tailored mental health curriculum to prevent burnout and support staff working in a healthy, sustainable way. This training includes grief, transference & countertransference, vicarious trauma, & microaggressions to build a foundation for staff to better understand their experience working with complex HIV+ LGBTQIA clients and on their team together. This workshop, will present key learnings from this partnership, share a sample of the staff training content and approach, and discuss staff-centered approaches to support high quality work and a happy, healthy team. HEALTH CARE RIGHTS ENFORCEMENT AND DISCRIMINATION IN THE TRUMP ERA
Presented by: Wayne Turner, NHeLP, Washington, DC + Scott Schoettes, Lambda Legal, Chicago, IL + Megan McLemore, Human Rights Watch, New York, NY + Kevin Costello, Center for Health Law and Policy Innovation, Harvard Law School, Cambridge, MA Location: Shaw, Meeting Level 3 Pathway: HIV Health Care Access Level: Intermediate
Reforms introduced by theAffordable CareAct (ACA) have increased access to affordable and high-quality private health insurance and Medicaid for individuals living with HIV. But this promise depends upon insurers providing transparent, meaningful coverage of the treatments and services that matter most, with affordable costsharing responsibilities.To ensure that the ACAâ&#x20AC;&#x2122;s promises are met, litigation in various forms is an important advocacy strategy for enforcing consumer rights. This workshop will identify bad actor insurance and provider practices in both Medicaid and private health insurance, and discuss successful litigation efforts and other strategies to address the ongoing challenges we face in the Trump era. Join us and learn how to hold the public and private insurance industries accountable to people living with HIV! ADDRESSING NEEDS OF WOMEN OF COLOR AGING WITH HIV
Presented by: Vanessa Jacuinde, APLA Health, Los Angeles, CA + Jenny Liu, APLA Health, Los Angeles, CA Location: Union Station, Meeting Level 3 Track: Cis & Trans Women Level: Beginner
This workshop will present key findings from a study on aging specific to HIV positive women ages 50 and older in the Los Angeles
SESSION 5 WORKSHOPS
area and how they parallel to national findings about women in this age group as well as women in the Southern United States. It will also demonstrate how social determinants of health promote health disparities for women across the country, specifically for Black/ African American cis-women, and how to use that information to address HIV for aging women in the southern United States who are disproportionally affected by the epidemic. Participants will utilize a “tool” to examine individual organizational gaps in service for this population and develop solutions to address these. Furthermore, the facilitators will review the Theory of Gender & Power to illustrate how imbalances in those two further propagate women’s risk for HIV, substantiating the need to increase women’s participation in decision-making roles in the HIV/AIDS response. NEW DEVELOPMENTS IN HIV TESTING AND WINDOW PERIODS
Presented by: Kevin Delaney, Centers for Disease Control and Prevention, Atlanta, GA + Elizabeth DiNenno, Centers for Disease Control and Prevention, Atlanta, GA Location: Capitol, Meeting Level 4 Pathway: Centers for Disease Control Level: Advanced
This workshop will provide an overview of the linkage to care programs being implemented by the South Dakota Department of Health and Bienestar (Los Angeles, CA). The South Dakota Department of Health’s linkage to care and retention program has experienced a significantly high success rate in re-locating known HIV positive individuals determined lost to care. Since 2009, the department of health identified 324 HIV positive individuals whose status was unknown. This session will highlight the strategies and approaches used to implement comprehensive linkage to care program in South Dakota. Bienestar has developed and implemented a training toolkit for linkage to care coordinators/navigators. This workshop will highlight the four training sessions and how the sessions are designed to provide tools to support linkage to care services for PLWH who are newly and/or previously diagnosed. WHY THE X? UNDERSTANDING LATINX
Presented by: Devan Diaz, Latino Commission on AIDS, New York, NY + David Garcia, Latino Commission on AIDS, New York, NY Location: Congress, Meeting Level 4 Pathway: Race: Latinx Level: Beginner
The term Latinx was developed through online activism, yet there is great resistance to the term among various Latino community members. This interactive workshop addresses the intersection of ethnicity, race, gender, age, immigration history, and social justice by examining the Latinx identity for non-binary, genderfluid Latinos. We will engage in conversations of how language evolves over time to accommodate identity. Understanding the roles identity and language play in prevention efforts is crucial for developing culturally-responsive programming.Within the context of this workshop, both pros and cons of using the term Latinx will
be given space and unpacked. Participants will be given an unbiased perspective to or not to adopt the Latinx term in identifying their community. COMING OF AGE: PREPARING THE NEXT GENERATION OF ASIAN & PACIFIC ISLANDER HIV LEADERSHIP Presented by: Benjamin Ignalino, API Wellness, San Fr ancisco, CA Location: Mint, Meeting Level 4 Pathway: Race: Asian & Pacific Islander Level: Beginner
The HIV movement was grown by the HIV community’s infected and affected members. Their activism and strategic response to the governments inadequate research and treatment resources, lack of supportive policy, and funding to address HIV were essential in cultivating our programs and work today. But, who taught these activists to be activists? How were they prepared to take on a cause and create a revolution that so many have benefitted from and died for? Our goal is to prepare participants to ensure that they include leadership development in their current HIV prevention and care work with clients and volunteers. This workshop will include discussion activities centered on effective coaching and leadership development techniques. A case study will be presented on how to create safe and supportive spaces for young API leaders. This presentation will include the necessary steps we can take now in preparing young API youth to become great leaders in the fight against HIV. ENSURING ACCESS TO CARE: COUNTING ON THE RYAN WHITE PROGRAM
Presented by: Jesse Milan, AIDS United, Washington, DC + Ronald Johnson, AIDS United, Washington, DC + William McColl, AIDS United, Washington, DC + Carl Schmid, The AIDS Institute, Washington, DC Location: Pentagon, Meeting Level 4 Pathway: HIV Policy Level: Intermediate
The Trump Administration has identified the Ryan White Program as a highly effective program, yet almost every federal program serving people living with HIV is under pressure from budget cuts or the potential of being realigned or eliminated. How can a program that fills in gaps between private and public insurance including Medicare and Medicaid; that provides connections to other programs like HIV Prevention and Housing Opportunities for People With AIDS (HOPWA) and community health centers; and which provides essential services such as transportation, food and nutrition, emergency housing, case management and more maintain its progress into the future? Hear from Ryan White Program Policy Experts, Administration Officials, and Congressional staff on the future of the Program, the potential for change, and provide discussion input on how best to enhance our health care system to end HIV in the U.S.
MOVIE SCREENING SEPTEMBER
NEG, UB2, FU!: STIGMA IN THE MSM COMMUNITY
Presented by: Robert Pompa, MSW, LCSW LVHN AIDS Activities Office Allentown PA Location: George Washington, Meeting Level 1 Track: People living with HIV Level: Beginner
I’m clean! UB2! DDF DIRTY, these and other messages are commonplace in the social landscape in which many MSM do their best to meet-n-greet (or to just get laid). These disparaging code words communicate to PLWHIV men; “we don’t mingle with you”. Since HIV is now “chronic and manageable”, compassion has turned to hate as PLWHIV are “biological terrorists”, creating a sero-status divide that is stigmatizing, re-traumatizing, and hateful. This “raw and real” workshop is meant to define stigma, give witness to experiences of stigma enacted, raise awareness with providers of stigmatizing behaviors / policies. In the era of TasP and PrEP, it is a call to challenge members of the MSM community to find ways to come together to eliminate “the shade” and release PLWHIV from the “social death” experience as a result of HIV stigma.
6:30 pm – 7:30 pm
SOUTHERN STIGMA: NEW RESEARCH; POSITIVE ACTION
Presented by: Susan Reif, MSW, PhD, Duke University Center for Health Policy, Durham, NC + Meta Smith-Davis, HAART, Inc., Baton Rouge, LA + Venita Ray, JD, Legacy Community Health, Houston, TX + Larry L. Walker, THRIVE SS, Inc., Atlanta, GA Moder ator: Gina Brown, Community Organizer, Southern AIDS Coalition, New Orleans, LA Location: Treasury, Meeting Level 4 Pathway: South Level: Intermediate
The disproportionate burden of new HIV cases in the South is further exacerbated by the need to respond within stigmatized surroundings. Pervasive internal and external stigma in the US South creates additional barriers toward achieving optimal health. Participants will hear about the latest stigma research coming out of the Deep South, including the results of the Southern HIV/AIDS Strategy Initiative’s Stigma Study and the results of the PLWHIV Stigma Index Project in Louisiana. These studies describe HIVrelated stigma in the Deep South and report some of the negative effects of stigma on health outcomes. Presenters will describe onthe-ground initiatives that empower PLWHIV and fight stigma, including the Undetectables Model from Atlanta, GA, and the Positive Organizing Project from Houston, TX. This workshop will engage the audience in a discussion of HIV-related stigma and initiatives that have been successful in combatting stigma.
Location: *Check Affinity Session board located near registration booths.
7:00 pm – 8:00 pm Movie Screening
NOTHING WITHOUT US: THE WOMEN WHO WILL END AIDS Location: Shaw, Meeting Level 3
Nothing Without Us: The Women Who Will End AIDS is a 70 minute long film and is the first documentary to tell the story of how HIV+ women on two continents turned a devastating diagnosis into a fight for survival – and a movement to end a global epidemic.The film takes viewers into the twin hearts of the current HIV/AIDS pandemic— sub-Saharan Africa and Black America – to meet five women who transformed public health policy with their refusal to accept a racist, sexist status quo. Featuring an all-female cast and an exciting mix of new and rare archival footage from Burundi, Nigeria, New York, and Louisiana, this inspiring documentary traces the journey from private
grief and political oppression to community leadership and collective action. Nothing Without Us reveals the unsung work that HIV+ women do not only for themselves but for children and men – from inside prisons, out in the streets, in the fields of healthcare, and in the highest halls of government. The film reveals that no plan to end the HIV epidemic will be complete until it addresses the complex realities of all women’s lives. Currently, women represent more than half the more than 37 million people who are living with HIV worldwide. In fact, women account for two-thirds of new infections globally.
SCHEDULE AT A GLANCE 7:00 am – 7:45 am
MORNING WORSHIP SERVICE
9:00 am – 11:00 am
SOCIAL MEDIA LAB
9:00 am – 11:00 am
Location: Dogwood, 2nd Floor
Location: Marquis Salon 14, Meeting Level 2 Session 6 Workshops
Survival Sex Work: Walking the Green Mile Location: Scarlet Oak, 2nd Floor The Geriatricians Are In — Are Older Adults Aging Differently? Location: Tulip, 2nd Floor Race and Health Outcomes in the United States Location: Dupont Circle, Meeting Level 3 How to Engage Faith Communities in HIV Programs Location: Dogwood, 2nd Floor Recognizing and Leveraging Your Current Resources: You Can Provide PrEP Location: Archives, 2nd Floor Building the Capacity of HIV and PrEP Navigation Programs Location: Silver Linden, 2nd Floor Data Quality and Data Dashboard User Engagement Location: Chinatown, Meeting Level 3 Building Support for HIV Criminalization Reform & Advocacy Location: Judiciary Square, Meeting Level 3 The Men’s Health Foundation Model: Novel Engagement Strategies for YMSMOC Location: LeDroit Park, Meeting Level 3
“A Seat at the Table” — Public Health Leaders Managing Transition! Location: Marquis Salon 12, Meeting Level 2 BRING IT! Young Women, Trans Women, Trans Females and Femmes Working Together Location: Mount Vernon Square, Meeting Level 3 Black Women and PrEP Location: Union Station, Meeting Level 3 Developing a Plan to End Your State’s HIV Epidemic Location: Capitol, Meeting Level 4 We Need to Talk: Latinx Community “Isms” and Trauma Location: Congress, Meeting Level 4 Structural Competency and Access to HIV Services among LGBT AANHPIs Location: Mint, Meeting Level 4 HIV Health Care Access: Impact of ACA Repeal Efforts Location: Shaw, Meeting Level 3 Community Reentry Project: Reducing Stigma for People Living with AIDS Location: George Washington, Meeting Level 1 Using the Law to Discriminate, a Southern Perspective Location: Treasury, Meeting Level 4 Faith, Social Justice, and HIV: A Blueprint for the Black Church Location: Magnolia, 2nd Floor
10:00 am – 5:00 pm 68
EXHIBIT HALL OPEN*
Location: Liberty and Independence Ballrooms, Meeting Level 4 *Exhibit Hall closed during plenary sessions.
SCHEDULE AT A GLANCE
09 Plenary Session
11:30 am – 1:30 pm FEDERAL PERSPECTIVES ON RESEARCH,
PREVENTION AND TREATMENT Note: No food will be served. Location: Marquis Ballroom, Meeting Level 2
1:30 pm – 2:00 pm
POSTER PRESENTATIONS Location: Meeting Level 3 Session 7 Workshops
2:00 pm – 4:00 pm
HIV PrEP Implementation Models: Expanding Access to Priority Populations Location: Archives, Meeting Level 4
Pelo a Pelo, Sin Miedo: Changing Language in HIV Prevention Location: LeDroit Park, Meeting Level 3
PrEP Location, Location, Location: Identifying and Addressing Access Disparities Location: Treasury, Meeting Level 4
When They Go Low We Go High: Courageous Leadership Location: Mount Vernon Square, Meeting Level 3
Inside the Mind: Youth Homelessness in DC Location: Scarlet Oak, 2nd Floor
Fierce: A New Approach to Engage Transwomen in PrEP Care Location: Union Station, Meeting Level 3
Using STDs as PrEP Candidacy Location: Silver Linden, 2nd Floor Saving Future Generations: HIV, Faith & Youth Location: Dogwood, 2nd Floor Ending the Epidemic for Everyone Location: Magnolia, 2nd Floor JUSTICE FOR ALL!! Protecting Civil Rights through HIV Advocacy for Black Communities Location: Marquis Salon 12, Meeting Level 2
Novel Approaches in an Era of Resource Scarcity for Asian Americans, Native Hawaiians, and Pacific Islanders Location: Mint, Meeting Level 4 Access to Care and Communities of Color Location: Shaw, Meeting Level 3
Undoing Structural Racism: A Local and National Perspective Location: Capitol, Meeting Level 4
Addressing Stigma and Risk among Incarcerated Women Living with HIV/AIDS Location: Congress, Meeting Level 4
The AIDS Education and Training Center (AETC) Program National HIV Curriculum Location: Chinatown, Meeting Level 3
HIV, Aging and Co-morbidities Location: Tulip, 2nd Floor
The Healthcare Landscape is Changing; is Your Organization Looking at Service Delivery Model Changes? Location: Judiciary Square, Meeting Level 3
2:00 pm – 5:00 pm
Safer Drug Consumption Spaces for People Who Use Drugs Location: George Washington, Meeting Level 1
Legend-ins & Young-ins — An Intergenerational Dialogue of Leaders Location: Dupont Circle, Meeting Level 3
SOCIAL MEDIA LAB
Location: Marquis Salon 14, Meeting Level 2
SCHEDULE AT A GLANCE 4:15 pm – 6:15 pm
Session 8 Workshops
Here and Now: The State of PrEP Access and Uptake in Distinct Populations Location: Archives, Meeting Level 4
Creating a Welcoming and Comfortable Environment for Trans Clients Location: Union Station, Meeting Level 3
Caring for the Aging HIV Positive Patient: It Can be Complicated and It’s the Future Location: Scarlet Oak, 2nd Floor
STD Prevention is HIV Prevention Location: Silver Linden, 2nd Floor
Live Undetectable: Scaling Up Viral Suppression Support for Vulnerable Populations Location: Magnolia, 2nd Floor Linkage to Care Programs and Supportive Services Location: Capitol, Meeting Level 4 How to Write Grant Applications that Win Funding Location: Judiciary Square, Meeting Level 3 We Are Family: Mothers & Sons Navigating HIV Together Location: LeDroit Park, Meeting Level 3 Youth Leadership Matters! Location: Mount Vernon Square, Meeting Level 3 Community-Based Strategies to Address HIV Stigma Location: Pentagon, Meeting Level 4
Expanding Sanctuary: Reimagining Resistance and Safety in Our Cities Location: Congress, Meeting Level 4 Where is the Love? Ending the Epidemic Location: Mint, Meeting Level 4 The Future of Medicaid, the Marketplaces, and Ryan White Location: Shaw, Meeting Level 3 Race and Health Disparities in Hepatitis: A Call to Action Location: George Washington, Meeting Level 1 The Intersection of Racial Justice, Mass Incarceration, and HIV in the South Location: Treasury, Meeting Level 4 Strong Communities: Race & Social Drivers of HIV Location: Tulip, 2nd Floor
6:30 pm – 7:30 pm
8:00 pm midnight
A MAGICAL NIGHT OF THE DANCING GOWNS
Location: Check Affinity Session board located near registration booths.
Location: Marquis Ballroom, Meeting Level 2
SESSION 6 WORKSHOPS SEPTEMBER
7:00 am – 7:45 am MORNING WORSHIP SERVICE Location: Dogwood, 2nd Floor
9:00 am – 11:00 am Session 6 Workshops
SURVIVAL SEX WORK: WALKING THE GREEN MILE Presented by: Diamond Brown, Casa Ruby, Washington, DC Location: Scarlet Oak, 2nd Floor Pathway: HIV & The Trans Community Level: Beginner
Is it truly survival or is it recreational? During this workshop, we will have a detailed interactive and in-depth discussion about what has lead individuals to sell their bodies to survive in today’s society whether it be lack of a formal education, lack of ascertaining an employment opportunity, or lack of stable housing. THE GERIATRICIANS ARE IN — ARE OLDER ADULTS AGING DIFFERENTLY?
Presented by: Stephen Karpiak, PhD, ACRIA, NYU College of Nursing, New York, NY + Meredith Greene, MD, Department of Medicine, Division Geriatrics at UCSF, San Fr ancisco, CA + Jonathan Appelbaum, MD, Florida State Medical, Tallahassee, FL Location: Tulip, 2nd Floor Pathway: Aging Level: Intermediate
Join us to explore the HIV epidemic among African Americans using AIDSVu, an interactive online mapping tool that visualizes the impact of the HIV epidemic at the state-, county- and ZIPcode level. We will also share new tools to inspire action among Black faith leaders, created by The Black Church & HIV: The Social Justice Imperative and the NAACP. RACE AND HEALTH OUTCOMES IN THE UNITED STATES
Presented by: Berwick Mahdi Davenport, The People’s Institute for Survival and B eyond , N ew O rleans , LA D iana D unn , T he P eople ’ s I nstitute for Survival and Beyond, New Orleans, LA + Milta Vega-Cardona, The People’s Institute for Survival and Beyond, New Orleans, LA Location: Dupont Circle, Meeting Level 3 Pathway: Capacity Building Level: Beginner
Race remains an important indicator of success in US society. When other factors that are cited as the probable reasons for health or social problems are controlled for in statistical analyses, race remains an important independent predictor of health, social, education, criminal justice and other outcomes.
This workshop will present health status data on older adults with HIV, illustrating ethnic and USA location differences. Data shows that multiple risks of HIV affect the health status of older adults as they age. These risk factors increase the inflammatory response which underlies increased rates of multi-morbidity seen in the older adults with HIV. Clinical management can no longer focus only on CD4 and viral load. Integrated care that involves the patient is needed. An awareness of the challenges of managing multiple disorders reflects a need to shift how care is delivered. Geriatric care principles best address these needs and should be embraced. Optimal health outcomes are not a function of the number of medications taken, but also the psychosocial supports that are needed to achieve healthy aging.
Why do we have race? What is it? What is the history of it? How does it factor in to the outcomes of health in the United States? This workshop will explore these questions and begin to look at the history of advantage in the United States which has led to racial disparities in the outcomes of the structures and institutions in our country.
FAITH, SOCIAL JUSTICE, AND HIV: A BLUEPRINT FOR THE BLACK CHURCH
With almost three decades of developing and providing capacity building services designed and tailored exclusively to faith based organizations to effectively address health disparities, The Balm In Gilead has been at the forefront of the fight against HIV/AIDS in minority communities, bringing national attention to the HIV/ AIDS epidemic in the United States and the extraordinary role faith communities can and are playing in HIV/AIDS prevention, education, service and advocacy. The Balm In Gilead has a longstanding commitment to domestic and international faithbased health education and disease prevention. This informative
Presented by Gilead Sciences
Location: Union Station, Meeting Level 3 Pathway: Faith Level: Intermediate
When Black faith leaders, religious institutions and community members come together we can empower systems, communities and individuals to fight HIV as a social injustice.
HOW TO ENGAGE FAITH COMMUNITIES IN HIV PROGRAMS Presented by: Cary Goodman, The Balm
Gilead, Inc., Richmond, VA
Location: Dogwood, 2nd Floor Pathway: Faith Level: Intermediate
SESSION 6 WORKSHOPS
workshop is designed to provide participants with practical, strategic approaches to collaborating with faith leaders to address the unique issues of HIV/AIDS in African American communities. RECOGNIZING AND LEVERAGING YOUR CURRENT RESOURCES: YOU CAN PROVIDE PREP
Presented by: Glen Pietr andoni, R.Ph., AAHIVP, Walgreens Co., Deerfield, IL + Jeffrey Kwong, DNP, MPH, ANP-BC, FAANP, Columbia University School of Nursing, New York, NY Location: Archives, Meeting Level 4 Pathway: Biomedical Interventions Level: Intermediate
With PrEP taking center stage, community based organizations (CBOs) and healthcare providers are trying to figure out their place. There are numerous uncertainties in this new landscape. CBOs not linked to clinics are left wondering what their role should be and healthcare providers are contemplating how to support and deliver PrEP services in their current settings. I offer this piece of advice: Don’t overthink it! If you successfully deliver education and/or medical care, you are almost there.Though having a PrEP navigator is ideal; you don’t have to be a PrEP navigator to navigate. BUILDING THE CAPACITY OF HIV AND PREP NAVIGATION PROGRAMS
Presented by: Peter Gamache, PhD, MBA, MPH, Turnaround Life, Inc., Tampa, FL + Robin Kelley, PhD, NMAC, Washington, DC + Kim Johnson, MD, NMAC, Washington, DC Location: Silver Linden, 2nd Floor Pathway: Capacity Building Level: Intermediate
Navigation is not a new concept; it has been in existence for decades, particularly in cancer care. As more and more navigators are used in the HIV field, what are their roles and responsibilities? Are their tasks interchangeable with those of other staff? This interactive workshop provides details on various types of capacity building services for navigation practices. It will focus not only on biomedical HIV prevention navigation, but also use with different populations. From defining what is red carpet service for those who are HIV positive, to understanding how CBOs can be involved with PrEP, this workshop explores the benefits of navigation technical assistance. Technical assistance will be explained so that participants leave with a clear understanding of what resources and services can be accessed to build their capacity around establishing, monitoring, supervising, strengthening and evaluating navigators and navigation programs. Capacity building assistance provider resources will also be available.
This panel session will discuss the importance of data for improving the treatment and care of people living with HIV (PLWH) and present best practices for using data to inform retention in care and treatment. HRSA/HAB staff will present on how the RWHAP uses data from grant recipients to inform program decision making and priorities. In addition, HRSA/HAB staff will reiterate how HAB continues to strive toward advancing data utilization to improve health outcomes for RWHAP clients. BUILDING SUPPORT FOR HIV CRIMINALIZATION REFORM & ADVOCACY
Presented by: Erin Athey, DNP,FNP-BC, RN, ANAC + Barb Cardell, Positive Women’s Network and Color ado Mod Squad, US People Living with HIV Caucus, Boulder, CO + Sean Strub, Sero Project + Carole Treston, ANAC Location: Judiciary Square, Meeting Level 3 Track: Public Policy Level: Intermediate
Come hear an update on the current state of HIV criminalization in the US. Strategies for building partnerships between advocates and providers will be discussed.The impact of HIV criminalization laws on HIV stigma will be featured. This interactive session will utilize the HIV Criminalization Clinicians Guidelines as a mechanism for opening the dialogue to engage others in efforts to modernize HIV Criminalization laws. THE MEN’S HEALTH FOUNDATION MODEL: NOVEL ENGAGEMENT STRATEGIES FOR YMSMOC Presented by: Anthony Mills, Men’s Health Foundation, Los Angeles, CA Location: LeDroit Park, Meeting Level 3 Track: Gay Men Level: Intermediate
Engaging priority populations, especially healthy young MSM of color (YMSMOC), into care is often challenging.The Men’s Health Foundation utilizes a model that connects with young men on issues of men’s health that are of personal interest to them.Through active community engagement with YMSMOC, we received feedback that engaging in and improving athletic performance, achieving personal goals, and enhancing sexual confidence are often active concerns of YMSMOC. Utilizing integrated programs of physical fitness, nutrition, and wellness, the Foundation connects to clients in a fitness-positive, life-positive, sex-positive manner. We listen to the voices and the needs of young gay men and often they in return trust our message of the importance of integrated medical care and of HIV and STD prevention. We hope to share our experience to help other organizations working with this population improve patient engagement and linkage to care.
DATA QUALITY & DATA DASHBOARD USER ENGAGEMENT Presented by: Stacy Cohen, HRSA/HAB, Rockville, MD Location: Chinatown, Meeting Level 3 Pathway: HRSA Level: Intermediate
SESSION 6 WORKSHOPS SEPTEMBER
“A SEAT AT THE TABLE” — PUBLIC HEALTH LEADERS MANAGING TRANSITION!
Presented by: Legendary Father George Mizr ahi, APEB, Oakland, CA Location: Marquis Salon 12, Meeting Level 2 Track: Leadership Level: Beginner
Biomedical HIV/AIDS prevention has advanced substantially in recent years.Unfortunately,the leadership and ideas haven’t.With the recent advancements in biomedical HIV/AIDS prevention, is there truly a need for a new generation of leadership? If so, what can be done to ensure that the next generation of HIV/AIDS prevention leaders are ready for “A Seat At The Table?” How can executive directors shift organizational culture? How can next generation leaders be identified?What can be done to enhance the next generation of HIV/ AIDS workforce? How do you prepare for leadership transference? This workshop promises to explore the answers to these questions and many more. BRING IT! YOUNG WOMEN, TRANS WOMEN, TRANS FEMALES & FEMMES WORKING TOGETHER
Presented by: Lisa Carver, Washington, DC + Jenna Rapues, UCSF Center of Excellence for Tr ansgender Health, San Fr ancisco, CA Location: Mount Vernon Square, Meeting Level 3 Pathway: Youth Level: Intermediate
Young women, transgender females, and femmes can have loud, beautiful voices in social justice, HIV advocacy and public health activism! How can you make sure you’re heard? The challenge is not only building confidence and knowing who you are, but building bridges with other young women, trans females and femmes so everyone can stand in solidarity and have collective impact. We must build alliances and respect between women of diverse races, genders, sexual orientations, bodies and experiences. This isn’t always easy! Our workshop will use interactive exercises, art and creative expression to help you identify your strengths as a young woman, trans female or femme who works in or wants to work for social justice. We will look at our own identities, find common ground, learn to hold space for each other in our work, and define how advocacy and activism can be inclusive of all women. BLACK WOMEN AND PREP
Presented by: Marie Fatima Hyacinthe, The Black AIDS Institute, Los Angeles, CA Location: Union Station, Meeting Level 3 Track: Cis & Trans Women Level: Intermediate
Although Black women make up only a small proportion of new incidences of HIV, they are overrepresented in their risk for contracting HIV. According to the CDC, 1 in 48 Black women will contract HIV if rates persist. At the same time, Black women are underutilizing biomedical prevention methods such as PrEP. So far, only 21% of those who have signed up for PrEP are women, and of
those, Black women are four times less likely than white women to have begun PrEP. In order to impact the HIV epidemic, providers and advocates must focus on the structural issues that form barriers to PrEP access. These issues include a lack of access to PrEP education, a lack of bodily autonomy, and stigma associated with sex and HIV. DEVELOPING A PLAN TO END YOUR STATE’S HIV EPIDEMIC
Presented by: Mel Mattson, Color ado Department of Public Health and Environment, Denver, CO + Barb Cardell, Positive Women’s Network and Color ado Mod Squad, US People Living with HIV Caucus, Boulder, CO + Beth Crutsinger-Perry, Washington State Department of Health, Olympia, WA + Richard Aleshire, Washington State Department of Health, Olympia, WA Location: Capitol, Meeting Level 4 Pathway: Health Departments Level: Intermediate
The session will highlight two states activities to mobilize resources, policies, and political will to eliminate new HIV infections in their states. Presenters will offer varying perspectives on the state, city, community, and other partnership participation necessary to develop and implement these plans. Discussion will include lessons learned regarding: setting targeted priorities and goals; addressing populations disproportionately impacted by HIV; engaging Medicaid and insurance in new partnerships; and collaborating with a range of state, city, and community stakeholders. WE NEED TO TALK: LATINX COMMUNITY “ISMS” AND TRAUMA Presented by: Edward Videla, Latino Commission on AIDS, New York, NY + Bolivar Nieto, Latino Commission on AIDS, New York, NY Location: Congress, Meeting Level 4 Pathway: Race: Latinx Level: Intermediate
Latinx individuals and communities are often labeled with “undesirable” characteristics that contribute to the formation of stereotypes.This can lead to violent acts of discrimination (or “stigma in action”) resulting in collective trauma, as experienced with the tragedy at Pulse. But, is this trauma solely the result of external oppression? As Latinx, have you engaged in difficult conversations with other Latinx about the different -isms that are pervasive in our community and that perpetuate stereotypes, prejudice, stigma, and violence amongst us, and compounding individual trauma? Join us in this workshop and share your experiences on how -isms are exemplified in our community; and the impacts on us as individuals and as part of diverse groups within the Latinx community (women, LGBT, youth, elders). Let’s channel this conversation into strategies and concrete action steps to address these challenges using the strengths we inherently have as a community. STRUCTURAL COMPETENCY AND ACCESS TO HIV SERVICES AMONG LGBT AANHPIS
Presented by: Ben Cabangun, Asian & Pacific Islander American Health Forum, Oakland, CA + Cathy Kapua, Life Foundation, Honolulu, HI + Kunane Dreire, Life Foundation, Honolulu, HI
SESSION 6 WORKSHOPS
Location: Mint, Meeting Level 4 Pathway: Race: Asian & Pacific Islander Level: Intermediate
HIV Service Providers are often trained to assess race and ethnicity in the context of individual clinical interactions—specifically, how a client’s demographic and cultural factors influence their health behaviors (Metzl et. al., 2014). To develop this skill, service providers turn to “cultural competency“ training aimed to strengthen interaction with clients that are different from them. This workshop will challenge traditional notions of cultural competency or sensitivity. The presenters will discuss an educational movement referred to as Structural Competency—locating approaches away from bodies, backgrounds, and attitudes of clients and providers, and centering focus on understanding biological, socioeconomic, and racial impacts of structural factors. The workshop will begin with discussing the 5 core competencies of Structural Competency, with Asian American, Native Hawaiian, and Pacific Islander (AANHPI) service providers discussing each competency in practice. Finally, workshop participants will participate in small group discussions to explore each core competency in depth and identify opportunities for application in their own organizations when serving LGBT AANHPIs. HIV HEALTH CARE ACCESS: IMPACT OF ACA REPEAL EFFORTS
Presented by: Robert Greenwald, Center for Health Law and Policy Innovation, Harvard Law School, Cambridge, MA + Ramon Gardenhire, AIDS Foundation Chicago, Chicago, IL + Kenyon Farrow, Treatment Action Group, New York, NY + Andrea Weddle, HIV Medicine Association, Washington, DC Location: Shaw, Meeting Level 3 Pathway: HIV Health Care Access Level: Intermediate
This workshop will provide an overview of recent Trump Administration and Congressional efforts related to the repeal and replacement of the Affordable Care Act (ACA) and changes to Medicaid. It will provide attendees with information on the potential impact of these efforts on meaningful access to health care for people living with HIV and other low-income and vulnerable populations. The panelists will discuss community-based strategies for responding to initiatives that have the potential to undermine a strong health care landscape in the United States. They will also provide recommendations for alternative health reforms that could improve upon current HIV health care systems. Join us and learn how to participate in efforts to stop this Administration and Congress from threatening the health of people living with HIV! FAITH, SOCIAL JUSTICE, AND HIV: A BLUEPRINT FOR THE BLACK CHURCH Presented by Gilead Sciences
Location: Union Station, Meeting Level 3 Pathway: Faith Level: Intermediate
When Black faith leaders, religious institutions and community members come together we can empower systems, communities and individuals to fight HIV as a social injustice. Join us to explore the HIV epidemic among African Americans using AIDSVu, an interactive online mapping tool that visualizes the impact of the HIV epidemic at the state-, county- and ZIPcode level. We will also share new tools to inspire action among Black faith leaders, created by The Black Church & HIV: The Social Justice Imperative and the NAACP. COMMUNITY REENTRY PROJECT: REDUCING STIGMA FOR PEOPLE LIVING WITH AIDS
Presented by: Rashonda L. Williams, Public Health Institute of Metropolitan Chicago, Chicago, IL + Jennifer Epstein, Public Health Institute of Metropolitan Chicago, Chicago, IL Location: George Washington, Meeting Level 1 Track: People living with HIV Level: Beginner
This workshop highlights the Community Reentry Project (CRP), a statewide a program designed to address the complex needs of incarcerated individuals living with and highest risk for HIV as they reintegrate in their communities. Individuals released from jails and prisons face multiple stigmatizing characteristics, as well must learn to navigate resources in society. People living with HIV (PLWH) who have also been formerly incarcerated can often suffer from not only disclosing their criminal background but also their status. Failure to disclose when necessary could cause individuals to miss out on resources such as housing, legal identification, healthcare and employment. Through correctional case management and other supportive services, CRP seeks address the unique needs of these individuals post-release. USING THE LAW TO DISCRIMINATE, A SOUTHERN PERSPECTIVE
Presented by: Kathie M. Hiers, AIDS Alabama, Birmingham, AL + Venita Ray, JD, Legacy Community Health, Houston, TX + Nic Carlisle, JD, Southern AIDS Coalition, Birmingham, AL Moder ator: Carolyn McAllaster, JD, Duke Law School, Durham, NC Location: Treasury, Meeting Level 4 Pathway: South Level: Intermediate
Stigma has always been a challenge for both persons living with HIV and for service providers in our country. Misguided efforts by policy makers to criminalize HIV or to legislate religious values are far too common, and the South is experiencing a growing number of these unfair laws based in ideology, not science. Learn specifics about these proposed and passed statutes, as well as successes in defeating them in our southern states. Advocates must remain vigilant and proactive in recognizing this trend and in stopping these discriminatory laws before they negatively impact lives.
SESSION 7 WORKSHOPS
09 10:00 am – 5:00 pm Exhibitions
Location: Liberty and Independence Ballrooms, Meeting Level 4
11:30 am – 1:30 pm Plenary Luncheon
FEDERAL PERSPECTIVES ON RESEARCH, PREVENTION AND TREATMENT Location: M arquis Ballroom, Meeting Level 2
Join us as we hear from our federal family leaders that have worked tirelessly to address HIV. Dr. Fauci will update us on the current work to end the epidemic and help us understand the latest scientific advances and what that means to leaders working on the frontlines. Dr. Mermin, another long-term friend of the community and a leader in the battle to end HIV, will speak to us about the Future of HIV Prevention as well as the strategies meant to end the epidemic. Dr. Cheever will speak about the future and importance of the Ryan White Care Act. Presenters:
Laura Cheever, M.D., Sc.M., Associate Administrator for HIV/AIDS Bureau, Health Resources & Services Administration
Anthony S. Fauci, M.D., Director of the National Institute of Allergy and Infectious Diseases
Jonathan Mermin, M.D., M.P.H., Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention
Maureen Goodenow, PhD, Moderator, Director, Office of AIDS Research
1:30 pm – 2:00 pm Posters
POSTER PRESENTATIONS Location: Meeting Level 3
*Exhibit Hall closed during plenary sessions.
Billy Gilman, Singer and Contestant on The Voice
SESSION 7 WORKSHOPS
2:00 pm – 4:00 pm Session 7 Workshops
HIV PREP IMPLEMENTATION MODELS: EXPANDING ACCESS TO PRIORITY POPULATIONS
Presented by: Jonathan Fuchs, MD, MPH, San Fr ancisco Department of Public Health/UCSF, San Fr ancisco, CA Location: Archives, Meeting Level 4 Pathway: Biomedical Interventions Level: Intermediate
PrEP is a highly effective bio-behavioral intervention that, if brought to scale, may reduce HIV incidence among at-risk populations. A PrEP package of services extends beyond medication prescribing and clinical monitoring to include STI screening, benefits navigation, risk reduction and adherence counseling, condom provision, partner services, and other wrap-around support. PrEP can be delivered “under one roof ” or involve collaborations between health departments (HDs), community-based and health care organizations (CBOs/HCOs). This workshop will feature four PrEP delivery models that seek to reach MSM of color, cis- and transgender women, and adolescents: a federally qualified health center closely linked to a large city HD; a municipal STI clinic; and a community-based AIDS Service Organization. A moderated panel and interactive breakout session will encourage participants to draw cross-cutting lessons from these programs’ successes and ongoing challenges.
In a survey conducted in 2015 the Department of Human Services in DC learned that there were approximately 500+ young people under the age of 25 living on the streets of DC. 43% of those youth identified as LGBTQ, and about 20% had a history of abuse, neglect, incarceration, sexual assault, or survival sex work. The city’s response to this crisis included a strategic plan to end youth homelessness in DC by the year 2022 with services that include emergency shelter, transitional living, mental health and crisis interventions, and follow-up care. USING STDS AS PREP CANDIDACY
Presented by: Thomas Deem, Color ado Department of Public Health and Environment, Denver, CO + Dan Wohlfeiler, Building Healthy Online Communities, Berkeley, CA + Phil Chan, Miriam Hospital, Providence, RI Location: Silver Linden, 2nd Floor Pathway: STD Related HIV Prevention Level: Intermediate
STD clinics are epicenters for sexual health expertise and can be utilized in HIV prevention. Pre-exposure prophylaxis (PrEP) is a highly effective HIV prevention tool. In assessing potential PrEP candidates, recent rectal STD infections can serve as a marker for possible HIV prevention use. The speakers will share strategies, successes, and opportunities where already established institutions can support HIV prevention efforts.
PREP LOCATION, LOCATION, LOCATION: IDENTIFYING AND ADDRESSING ACCESS DISPARITIES
SAVING FUTURE GENERATIONS: HIV, FAITH & YOUTH
Presented by: Aaron Siegler, PhD, Emory University, Atlanta, GA
Presented by: Cary Goodman, The Balm In Gilead, Inc., Richmond, VA
Location: Treasury, Meeting Level 4 Track: Biomedical Interventions Level: Intermediate
Location: Dogwood, 2nd Floor Pathway: Faith Level: Intermediate
This workshop will leverage data from preplocator.org, a national database of PrEP-providing clinics, to initiate a discussion about PrEP access. We will have an interactive activity to familiarize participants with how to use the PrEP Locator as a public health tool for community organizations, advocates, and PrEP clinicians. In particular, we will explore how the locator can be used as a tool to help those with financial or other barriers to PrEP access. Next, we will share preliminary data regarding analyses of the Locator data, including comparing the density of PrEP-providing clinics relative to need in different areas of the United States. An interactive discussion will explore new methods for facilitating access to PrEP, and engage the group regarding successes and limitations in facilitating PrEP access in the face of geographic and other access barriers.
Today in the United States HIV continues to remain a major problem. The disparities seen within African-American and minority communities is a full-blown epidemic. Unfortunately, this crisis is now threatening the future of our youth and young adults. Advances in technology, changes in culture, family structures, and social norms are all contributing factors and influencers in the lives of today’s youth that can influence their sexual behaviors and risks for infection. This interactive session will present current statistical trends in HIV among youth as well as discuss other social determinants influencing youth sexual behaviors, and provide participants with strategies to address these challenges through the establishment of faith/community based youth wellness programs and initiatives.
INSIDE THE MIND: YOUTH HOMELESSNESS IN DC Presented by: Larry Villegas, Casa Ruby, Washington, DC Location: Scarlet Oak, 2nd Floor Pathway: Trans Level: Beginner
SESSION 7 WORKSHOPS SEPTEMBER
ENDING THE EPIDEMIC FOR EVERYONE Presented by: Jaron Benjamin, Housing Works, Brooklyn, NY Location: Magnolia, 2nd Floor Pathway: Ending the Epidemic Level: Intermediate
Discussants from the states of Arizona, Massachusetts, and Louisiana will discuss the challenges of ending AIDS as an epidemic across heterogeneous populations. Arizona panelists will include conversation of integration withTribal governments and communities, Massachusetts representatives will discuss their unique geographic challenges, and Louisiana panelists will detail the struggle of crafting a plan without the experience of expanding state Medicaid. JUSTICE FOR ALL! PROTECTING CIVIL RIGHTS THROUGH HIV ADVOCACY FOR BLACK COMMUNITIES
Presented by: Venton C. Hill-Jones, National Black Justice Coalition, Washington, DC + Cornelius Baker, National Black Gay Men’s Advocacy Coalition + Dr. Ivy Turnbull, National Black Women’s HIV/AIDS Network, Washington, DC + Valerie Rochester, AIDS United, Washington, DC Location: Marquis Salon 12, Meeting Level 2 Pathway: Civil Rights Level: Intermediate
The objective of this workshop will be to explore the intersection of Civil Rights and HIV Advocacy affecting Black communities. Session participant will participate in a panel discussion that will provide an analysis of the critical issues that Black people need to advocate for before our leaders in Congress and other legislative bodies. The discussion will provide additional information and context that can be used to support advocacy for congressional offices visits, state and local stakeholder meetings, and future national advocacy efforts. UNDOING STRUCTURAL RACISM: A LOCAL AND NATIONAL PERSPECTIVE
Presented by: Blake Rowley, NASTAD, Washington, DC + Michael Weir, NASTAD, Washington, DC Location: Capitol, Meeting Level 4 Pathway: Health Departments Level: Intermediate
In this workshop, participants will gain insight on how health departments and national organizations have worked to undo racist practices and ideologies by first understanding how racism shows up in their organizations and themselves. Participants will be engaged in experiential learning via two activities and a robust dialogue around how racist practices are engrained and nurtured within people, systems, and institutions. Facilitators will walk through their experiences with the People’s Institute and how their work has evolved and informs their service delivery and/or shapes their policies and priorities for populations.
THE AIDS EDUCATION AND TRAINING CENTER (AETC) PROGRAM NATIONAL HIV CURRICULUM
Presented by: David Spach, MD, Mountain West AIDS Education Center, Seattle, WA
Location: Chinatown, Meeting Level 3 Pathway: HRSA Level: Intermediate
The HRSA AETC Program National HIV Curriculum has been designed to keep you updated on state-of-the-science in HIV infection prevention and management. Comprised of six modules, each representing a different core competency identified as essential by HIV care experts, the curriculum was designed to provide novice-to-expert clinicians (primarily physicians, physician assistants (PAs), advanced practice nurses (APNs), and pharmacists) with updated information and national guideline recommendations for quality HIV infection prevention and treatment. THE HEALTHCARE LANDSCAPE IS CHANGING; IS YOUR ORGANIZATION LOOKING AT SERVICE DELIVERY MODEL CHANGES? Presented by: Laur a Ger ard, John Snow Research & Tr aining, Inc. Location: Judiciary Square, Meeting Level 3 Track: Public Policy Level: Beginner
The HIV prevention landscape has changed dramatically in recent years and likely will continue to see dramatic changes in the coming years. With limited funding and mandates that require supporting the entire HIV continuum of care, traditional CBOs have had to reassess their service delivery models and determine how they will remain viable in an evolving environment. Applying to become an FQHC is an option of consideration for many CBOs. In addition to learning about the 19 specific federal policy requirements for FQHCs, participants will learn about the benefits of becoming an FQHC including grant money to offset the costs of uncompensated care, drug pricing discounts for pharmaceutical products under the 340B program, federal loan guarantees for capital improvements and access to National Health Service Corps (NHSC) medical, dental and mental health providers. A case study of an ASO that successfully transformed to become an FQHC will be presented throughout. PELO A PELO, SIN MIEDO: CHANGING LANGUAGE IN HIV PREVENTION Presented by: Bolivar Nieto, Latino Commission Michael Diaz, New York, NY
AIDS, New York, NY +
Location: LeDroit Park, Meeting Level 3 Track: Gay Men Level: Intermediate
As HIV service providers, part of our role is to disseminate HIV prevention messages. We discuss sexual health through scientifically supported and carefully crafted discourses regarding viral suppression, negligible risk, being undetectable; and in the advent of pre-exposure prophylaxis (PrEP), protected condomless
SESSION 8 WORKSHOPS
sex. But, how is this information being translated and interpreted by gay and bisexual Latinx who continue to see increases in HIV rates despite national declines in other priority populations? Searle’s (1969) speech-acts theory focuses on the ways in which words can be used not only to present information, but to carry out actions.We will explore and assess how well (or not) science-based messages are being translated (coded) and interpreted (decoded) by the communities most impacted. We will also examine how “noise” (factors distorting messages) between the message sender (HIV service providers) and message receiver (intended audience) is being addressed in messaging created for Latinx. WHEN THEY GO LOW WE GO HIGH: COURAGEOUS LEADERSHIP
Presented by: J. Phoenix Smith, MSW, Alameda County HIV Care Services, Oakland, CA + Rama Fr anklin, M.Ed., Alameda County HIV Care Services, Oakland, CA Location: Mount Vernon Square, Meeting Level 3 Track: Leadership Level: Beginner
The primary goals of this workshop is to present a holistic framework on intergenerational leadership, that is not based on hierarchy driven by ego and separation but collective consciousness awareness and collaboration encouraging all team members to learn and display leadership abilities. Leadership tenants will be presented to increase knowledge and skills while changing outdated attitudes and concepts of who is a leader that debunks business as usual. FIERCE: A NEW APPROACH TO ENGAGE TRANSWOMEN IN PREP CARE
Presented by: Hilda Sandoval, PhD., LMFT, AltaMed Health Services, Los Angeles, CA + Natalie Sanchez, MPH, AltaMed Health Services, Los Angeles, CA + Jenna Rapues, MPH, Center of Excellence for Tr ansgender Health, San Fr ancisco, CA + Luis Gutierrez-Mock, MPH, MA, Center of Excellence for Tr ansgender Health, San Fr ancisco, CA Location: Union Station, Meeting Level 3 Track: Cis & Trans Women Level: Advanced
Transwomen are disproportionately impacted by HIV and are approximately 49 times more likely to be living with HIV than the general population. Traditional prevention methods have fallen short to reach this highly impacted community. Transgender populations face a number of HIV prevention challenges, including socio-cultural, economic and health-related factors. Transgender women of color, especially African-Americans and Latinas, experience disproportionately high rates of HIV infection. While these challenges continue to threaten the health and quality of life for Transwomen, a new digital campaign aims to engage, educate and connect transwomen to PrEP services in their respective community to reduce new rates of HIV infection. The 5-part bilingual series highlights scenarios that reflect real life issues and experiences while incorporating prevention messages to help reduce the risk of HIV infection through the use of PrEP.
SAFER DRUG CONSUMPTION SPACES FOR PEOPLE WHO USE
Presented by: Andrew Reynolds, Project Inform, San Fr ancisco, CA + Laur a Thomas, Drug Policy Alliance, San Fr ancisco, CA + Robert Suarez, United States Alliance of Drug Users, New York, NY + Rajani Gudlavalleti, Johns Hopkins, Baltimore, MD Location: George Washington, Meeting Level 1 Pathway: Hepatitis Level: Beginner
The opioid crisis, along with renewed recognition of the harms the war on drugs has inflicted on people of color, has led to significant movement towards alternative approaches to substance use and health issues related to injection drug use. One approach is establishing safer drug consumption spaces (SCS), also known as safe injection facilities (SIFs). SCS are “protected places for the hygienic consumption of pre-obtained drugs in a non-judgmental environment and under the supervision of trained staff. SIFs represent a public health intervention operating as part of a wider network of services for people who use drugs, woven into local networks of coordinated strategies to address the individual risks and community impact of drug use” (IDCP 2012). This session will review SCS, discuss their health and social benefits, including HIV, HCV and drug overdose prevention, as well provide an update on the current state of SCS organizing in the U.S. NOVEL APPROACHES IN AN ERA OF RESOURCE SCARCITY FOR ASIAN AMERICANS, NATIVE HAWAIIANS, AND PACIFIC ISLANDERS Presented by: Jacob Smith Yang, Asian & Pacific Islander American Health Forum, Oakland, CA Location: Mint, Meeting Level 4 Pathway: Race: Asian & Pacific Islander Level: Intermediate
Programs and organizations for Asian Americans, Native Hawaiians, and Pacific Islanders (AANHPIs) have continued to provide targeted HIV services despite a funding environment that does not prioritize targeted resources for these populations. This workshop invites strategists who work across health departments, community based organizations, and community health centers to discuss current service strategies and opportunities for innovation to maximize limited resources targeting AANHPIs. Part one of this workshop will comprise of a discussion among representatives from HIV/AIDS programs targeting AANHPIs in three metropolitan regions. Panelists will discuss how these organizations utilize research and surveillance, service integration strategies, and multi-ethnic community mobilization to maximize impact across the HIV continuum in AANHPI communities despite decreasing resources. In part two, all workshop attendees will provide insights, drawing from tools and techniques within innovation frameworks, to prototype new service designs to make greater progress towards achieving zero new HIV infections, zero AIDS related deaths, and zero HIV stigma in AANHPI communities in an era of funding scarcity.
SESSION 8 WORKSHOPS SEPTEMBER
ACCESS TO CARE & COMMUNITIES OF COLOR Presented by: Jamille Fields, Planned Parenthood Feder ation of America, Washington, DC + Venita Ray, Legacy Community Health, Houston, TX + Sur aj Madoori, Treatment Action Group, New York, NY Location: Shaw, Meeting Level 3 Pathway: HIV Health Care Access Level: Beginner
Overall, people of color, including those living with HIV, experience worse access to care and worse health outcomes than their white counterparts. While the Affordable Care Act (ACA) has narrowed some of these health disparities, the health care reform efforts of the Trump Administration and Congress threaten to undo even these gains. During this workshop, advocates will discuss the threats to access to care for communities of color in the current political climate. They will also describe opportunities for advocates to use to protect and strengthen access to care in historically underserved communities. Come learn how to protect access to care for your communities! ADDRESSING STIGMA AND RISK AMONG INCARCERATED WOMEN LIVING WITH HIV/AIDS
Presented by: Melissa Thomas Proctor, MS, Centers for Disease Control and P revention , A tlanta , GA + E ric G rossman , LCSW, W omen ’ s P rison Association, New York, NY + Rose Harris, Counseling and Services Coordinator, Women’s Prison Association, New York, NY Location: Congress, Meeting Level 4 Track: People living with HIV Level: Intermediate
NewYork State currently has the largest number of HIV+ incarcerated people in the country, and HIV infection rates among incarcerated women are more than double the rate for incarcerated men. Additionally, rates of HIV are disproportionately high among incarcerated women of color. Women’s Prison Association (WPA) provides comprehensive services to women at all stages of criminal justice involvement, and will present its scope of services provided to women living with HIV in prison and jails.
HIV AGING AND CO-MORBIDITIES
Presented by: Anthony Mills, MD, Men’s Health Foundation, Los Angeles, CA Location: Tulip, 2nd Floor Track: People Living with HIV Level: Beginner
This will be both, a didactic and interactive workshop, that will address topics related to aging with HIV infection, inflammation and non-HIV related co-morbidities. Participants will learn about these topics and have the opportunity to engage in discussions with presenters and other participants. LEGEND-INS & YOUNG-INS — AN INTERGENERATIONAL DIALOGUE OF LEADERS
Presented by: Gina Brown, New Orleans, LA Southern AIDS Coalition + Vanessa Johnson, Washington, DC Ribbon Consulting Group, LLC + Far ah Jeune, Boston, MA Host of Farenheight TV + Peter McLody, Chicago, IL Ruth M. Rothstein CORE Center + Venton C. Jones Jr Washington, DC National Black Justice Coalition (NBJC) + Kahlib J Barton, Alexandria, VA Young Black Gay Leadership Initiative + Kamaria Laffrey, Tampa, FL em POWER ed L egacy Location: Dupont Circle, Meeting Level 3 Pathway: Leadership Level: Beginner
NMAC’s Youth Initiative invites you to join us in an in-depth dialogue on leadership. This session is designed to create a shared opportunity to discuss the importance of working in collaboration across the generational space in HIV leadership. The dialogue will look at how the community has shaped programs, policy and advocacy to meet the needs of persons living with HIV of all ages. We have invited both our season advocates and youth advocates to present key concerns and challenges in creating a shared vision to identify meaningful solutions.
4:15 pm – 6:15 pm Session 8 Workshops
HERE AND NOW: THE STATE OF PREP ACCESS AND UPTAKE IN DISTINCT POPULATIONS
Presented by: Jenna Rapues, MPH, UCSF Center of Excellence for Transgender Health, San Francisco, CA + Kurt Begaye, Begaye Consulting, San Francisco, CA + Ben Cabangun, Asian and Pacific Islander Health Forum, San Francisco, CA + Dominika Seidman, MD, UCSF, San Francisco, CA Location: Archives, Meeting Level 4 Pathway: Biomedical Interventions Level: Intermediate
This workshop panel and moderated discussion will focus on distinct populations, not typically covered in the PrEP conversation or mentioned in PrEP guidelines. Join our panel discussion for a richer story that is emerging from distinct populations around HIV prevention, including PrEP: API transwomen, Native Americans,
people who access abortions or family planning, people who desire conception/safer conception, people who are substance involved, API MSM, and people who exchange sex for survival. From a strengths-based perspective, invited panel participants will present background information (5-6 minutes each) on facilitators and barriers for reaching distinct populations, i.e. those currently left out of the mainstream PrEP dialogue, who may benefit from an expanded HIV prevention toolkit. The use of storytelling as a method for overcoming stigma and including people from distinct backgrounds will be described. The moderated panel discussion will include the lived experience of audience members as participants, providing a highly interactive and engaging format. Resources will be shared. The panel discussion will be summarized with best practices for moving forward with an inclusive PrEP implementation agenda.
SESSION 8 WORKSHOPS
CARING FOR THE AGING HIV POSITIVE PATIENT: IT CAN BE COMPLICATED AND IT’S THE FUTURE
Presented by: Heather Alt, RN, ACRN, CPH Whitman-Walker Health, Association of Nurses in AIDS Care, Washington, DC + David Hardy, MD, Whitman Walker Health, HIV Medicine Association, Washington, DC + Jeffrey Kwong, DNP, MPH, ANP-BC, ACRN, Columbia University, Association of Nurses in AIDS Care, New York, NY Moder ator: Carole Treston, Association of Nurses in AIDS Care Location: Scarlet Oak, 2nd Floor Pathway: Health Care Providers Level: Intermediate
As more people age with HIV, health issues associated with aging emerge as a knowledge gap for caregivers and providers. What do we need to be aware of? This session will address co-morbidities such as renal and cardiac disease and bone health associated with frailty including conditions more common within racial and ethnic populations. We will also look at poly-pharmacy associated with the many prescribed medications and look at the impact of HIV drug resistance in the older population as well as strategies on recognizing neurocognitive and other issues that compound isolation and mental health risks.This session will be useful for case managers, community health workers, and others who may provide in-home services. We will use case studies and attendees are encouraged to bring their own questions and challenges for discussion. LIVE UNDETECTABLE: SCALING UP VIRAL SUPPRESSION SUPPORT FOR VULNERABLE POPULATIONS
Presented by: Anna Thomas-Ferraioli, New York City Department of Health and Mental Hygiene, New York, NY + Ginny Shubert, Housing Works, Brooklyn, NY + Cheyanda Onuoha, Housing Works, Brooklyn, NY + Gina Gambone, New York City Department of Health and Mental Hygiene, New York, NY Location: Magnolia, 2nd Floor Track: Biomedical HIV Prevention Level: Intermediate
The Undetectables is an antiretroviral therapy (ART) support model combining a superhero-themed social marketing campaign with a “tool kit” of evidence-based adherence supports, to enhance care for persons with HIV (PWH) who face barriers to medication adherence.The intervention was pioneered by NewYork City (NYC) agency HousingWorks and has been scaled-up by NYC Department of Health and Mental Hygiene (DOHMH), which contracted with seven agencies to implement the Undetectables program citywide. The program is expected to serve 1,500 PWH in year one. DOHMH and Housing Works have worked together (in collaboration with other partners) to develop and replicate the Undetectables program model via trainings, materials and social marketing tools that are adaptable to different geographic settings, service configurations and target populations.
LINKAGE TO CARE PROGRAMS AND SUPPORTIVE SERVICES Presented by: Ron Buchanan and Kischa Hampton, Centers for Disease Control and Prevention, Atlanta, GA + Brendan O’Connell, Bienestar, Los Angeles, CA + Laur a Castillo, Bienestar, Los Angeles, CA + Susan Gannon, South Dakota Department of Health, Pierre, SD Location: Capitol, Meeting Level 4 Pathway: Centers for Disease Control Level: Advanced
This workshop will provide an overview of the linkage to care programs being implemented by the South Dakota Department of Health and Bienestar (Los Angeles, CA). The South Dakota Department of Health’s linkage to care and retention program has experienced a significantly high success rate in re-locating known HIV positive individuals determined lost to care. Since 2009, the department of health identified 324 HIV positive individuals whose status was unknown. This session will highlight the strategies and approaches used to implement comprehensive linkage to care program in South Dakota. Bienestar has developed and implemented a training toolkit for linkage to care coordinators/navigators. This workshop will highlight the four training sessions and how the sessions are designed to provide tools to support linkage to care services for PLWH who are newly and/or previously diagnosed. HOW TO WRITE GRANT APPLICATIONS THAT WIN FUNDING
Presented by: Stephen Fallon, PhD, Skills4, Ft Lauderdale, FL + Theo Noel, II, Theo, The Guiding Right, Midwest City, OK + Ok an Gunay, Esq., Latinos Salud, Wilton Manors, FL Location: Judiciary Square, Meeting Level 3 Track: Leadership Level: Intermediate
Funding for HIV prevention and services is changing. Agencies must adapt if they want to make their best case when completing evermore complex applications. This highly interactive workshop will guide participants to assess their service priorities, align them with each funder’s stated goals, and then make every word count in their grant applications to win scarce funding. The facilitators will crack the grant writing code, and reveal tricks of the trade that make some grant applications more likely to win funding. Participants will examine actual grant narrative samples, and learn to identify the strengths in each, as well as any missed opportunities. The facilitators will also show participants how to break into pieces the overwhelming task of writing a state or federal grant application, so that the whole proposal comes together in time to meet due dates.
The workshop will employ a “learning lab” approach to discuss the pilot intervention and its citywide scale-up.
SESSION 8 WORKSHOPS SEPTEMBER
WE ARE FAMILY: MOTHERS & SONS NAVIGATING HIV TOGETHER
Presented by: Trina Scott, Kaiser Family Foundation, Greater Than AIDS, Washington, DC Location: LeDroit Park, Meeting Level 3 Track: Gay Men Level: Beginner
Mothers and their gay sons show what is possible with love, support, and ongoing care for people living with and affected by HIV. Audiences will hear from Greater Than AIDS ambassadors about the importance of family support in getting educated about HIV, starting conversations, and initiating treatment for PrEP or antiretroviral therapy. YOUTH LEADERSHIP MATTERS!
Presented by: Marvell Terry II, Human Rights Campaign Location: Mount Vernon Square, Meeting Level 3 Pathway: Youth Level: Intermediate
Join the Human Rights Campaign (HRC) for an honest and thoughtprovoking conversation about the impact of HIV on young people in the United States and the need to develop the next generation of movement leaders. This highly-interactive workshop will include lessons learned from the inaugural cohort of HRC’s HIV 360 Fellowship Program. Made possible with the support of the Elton John AIDS Foundation, HIV 360 is a capacity-building fellowship program for young, nonprofit leaders looking to take HIV-inclusive organizations and initiatives to the next level. COMMUNITY-BASED STRATEGIES TO ADDRESS HIV STIGMA
Presented by: Andrew Spieldenner, Ph.D., Cal State San Marcos and US People Living with HIV Caucus, San Diego, CA + Barb Cardell, Positive Women’s Network and Color ado Mod Squad, US People Living with HIV Caucus, Boulder, CO + Vanessa Johnson, Positive Women’s Network and US People Living with HIV Caucus, Washington, DC + Dwight Peavey, Rutgers University, Newark, NJ + Gina Brown, Southern AIDS Coalition, New Orleans, LA + Teresa Sullivan, Positive Women’s Network, Philadelphia, PA Location: Pentagon Meeting Level 4 Pathway: People Living with HIV Level: Intermediate
The National HIV/AIDS Strategy acknowledges HIV-related stigma destabilizes prevention and treatment efforts. HIV-related stigma can be persistent and subtle in the way PLHIV are treated in health care, employment, social and familial situations. While stigma is widely recognized as a problem, there are few sustained efforts to reduce HIV-related stigma. In this workshop, three community-based efforts to address HIV-stigma will be addressed — all led by people living with HIV. These include: the HIV Stigma Index (done in Detroit, Louisiana and New Jersey), the Colorado Stigma survey, and the Stand Up to HIV Stigma Campaign in Philadelphia. The presenters will address why people living with HIV have to lead anti-stigma work, as well as models to do so. Each initiative is intersectional in scope, with an emphasis on the experiences of people of color.
CREATING A WELCOMING AND COMFORTABLE ENVIRONMENT FOR TRANS CLIENTS
Presented by: Dustin Wagner, Denver Prevention Tr aining Center, Denver, CO + Mazdak Mazarei, Primary Care Development Corpor ation, Westlake Village, CA + Paige Jackson, Denver Health, Denver, CO Location: Union Station, Meeting Level 3 Track: Cis & Trans Women Level: Beginner
Transgender individuals continue to face a range of challenges that deprive them of opportunities and respect; this continues to impact all aspects of health. Action is needed across multiple levels and in multiple organizations to enhance the provision and uptake of comprehensive HIV prevention services. This workshop will address the benefits of trans-focused navigation service, provide tips for how to create an inclusive environment, and ensure transgender individuals are more visible in data collection to increase health equity for transgender communities. STD PREVENTION IS HIV PREVENTION
Presented by: Dr. Bryce Furness, Centers for Disease Control and Prevention, Washington, DC + Dr. Khalil Ghanem, Johns Hopkins University School of Medicine, Baltimore, MD Location: Silven Linden, 2nd Floor Pathway: STD Related HIV Prevention Level: Intermediate
Reducing the burden of STDs is important for HIV prevention and treatment. Like STDs, HIV is most commonly transmitted through sex, making individuals at risk for STDs also at risk for HIV. STD testing is a key opportunity for HIV testing, prevention messaging, and identifying people living with HIV and linking them to treatment and care. Organizations that test for HIV have a role to play in reducing STD infections as well which in turn, is likely to reduce the HIV burden in communities. Join us to discuss the relationship between HIV and other STD infections and the need for STD testing and prevention within HIV prevention, treatment, and care settings. EXPANDING SANCTUARY: REIMAGINING RESISTANCE AND SAFETY IN OUR CITIES
Presented by: Judith Montenegro, Latino Commission on AIDS, New York, NY + Bolivar Nieto, Latino Commission on AIDS, New York, NY + Erik Valer a, Latino Commission on AIDS, New York, NY Location: Congress, Meeting Level 4 Pathway: Race: Latinx Level: Intermediate
The resistance movement to create sanctuary cities is the defiant response to the violent and voluntary cooperation of local law enforcement and municipalities in enforcing federal immigration laws. But the criminalization and stigmatization of identities does not only affect immigrants. It is not a coincidence that the HIV epidemic has comfortably found its home in the deep South, a region plagued with detention centers, 287 contracts, voter ID laws, outdated HIV criminalization laws, poverty, anti-blackness and some of the most draconian anti-LGBTQ legislation. This
workshop will help advocates redefine and expand the concept of ‘sanctuary’ to include PLWHA, provide examples of policies across the country that are promoting safety in our communities to combat oppressive policies and practices at the local, city and county level, and an opportunity to develop concrete steps to expand sanctuary in our respective organizations, communities, and home states. WHERE IS THE LOVE? ENDING THE EPIDEMIC
Presented by: C. Virginia Fields, National Black Leadership Commissions AIDS, Inc., New York, NY
Hepatitis B and C are serious public health concerns in the United States. These concerns are exacerbated by racial, ethnic and classdriven health disparities, leading to significant suffering and death in African American, Asian American, Latino/a, and Native American populations, as well as immigrant populations. This session will provide an overview of the epidemiology of viral hepatitis in these populations, discuss key strategies to address health disparities and close with a highlight of innovative programs that work improve the viral hepatitis outcomes in these populations.
Location: Mint, Meeting Level 4 Pathway: Race: African American and Black Level: Intermediate
Building healthy relationships in the black community can be a challenge. With a community that faces so much adversity, it can be difficult to find the time and energy to maintain healthy social relationships. However, these relationships—between lovers, friends, family, co-workers, and neighbors—can provide much needed support, respect and joy. Therefore, it is important that we make a consistent effort to combat social stigmas that have the potential to inhibit or stunt relationships in the black community. After a screening of 90 Days, a short 19-minute film that explores how a black couple overcomes challenges in their relationship, this workshop will discuss ways to invest in and sustain healthy relationships in the black community. Examining not only intimate partner relationships, but all social relationships, the workshop will address ways in which to begin conversations, maintain physical and emotional health, and have fun in lasting relationships. THE FUTURE OF MEDICAID, THE MARKETPLACES, AND RYAN WHITE
Presented by: Phil Waters, Center for Health Law and Policy Innovation, Harvard Law School, Cambridge, MA + Naomi Seiler, Milken Institute, George Washington University, Washington, DC + Mir a Levinson, JSI, Boston, MA Location: Shaw, Meeting Level 3 Pathway: HIV Health Care Access Level: Beginner
Learn about the recent threats to Medicaid, the Affordable Care Act (ACA), private health insurance Marketplaces, and the Ryan White program as well as opportunities and strategies for making these programs work for people living with HIV in your state. In this session, advocates and educators will provide up-to-date information on challenges facing these vital health care programs and their experiences and strategies for protecting and promoting them. They will also describe opportunities for community engagement in advocacy and education efforts. Learn how to make health care programs work for you and/or the people you serve! RACE AND HEALTH DISPARITIES IN HEPATITIS: A CALL TO ACTION Presented by: A. Toni Young, Community Education Group, Washington, DC + Ivonne Cameron, Independent Consultant, Lanham, MD Location: George Washington, Meeting Level 1 Pathway: Hepatitis Level: Beginner
THE INTERSECTION OF RACIAL JUSTICE, MASS INCARCERATION AND HIV IN THE SOUTH Presented by:Vanessa Johnson, JD, Ribbon Consulting Group, LLC/PWNUSA, Washington, DC + Marvell Terry, II, The Red Door Foundation, Memphis, TN + Megan McLemore, Human Rights Watch, New York, NY Moder ator: Charles Stephens, Counter Narr ative Project, Atlanta, GA Location: Treasury, Meeting Level 4 Pathway: South Level: Intermediate
As we move into the fourth decade of the AIDS epidemic, the South now has the distinction of being the center of the epidemic because it has the highest rate and prevalence of HIV and AIDS of any other region in the US. Also, the South has the highest incarceration rates in the country. There is no coincidence that African Americans, trans women of color, and gay and bisexual men and youth of color are disproportionately at risk for both incarceration and HIV. The goal of the workshop is to discuss how broader issues of racial justice and mass incarceration continue to fuel the epidemic in the South. This workshop will explore the historical underpinnings of the criminal justice system and its design to control and oppress communities of color. We will discuss ways that organizations can work more effectively at this intersection by centering their work on racial justice, criminal justice reforms, human rights and economic justice. STRONG COMMUNITIES: RACE & SOCIAL DRIVERS OF HIV
Presenter by: Moisés Agosto-Rosario, NMAC, Washington, DC + Bernadette Wright, Washington, DC Location: Tulip, 2nd Floor Track: People Living with HIV Level: Intermediate
In 2017 NMAC’s Treatment Division will develop and implement the next phase of the Strong Communities program funded by Merck and Janssen Pharmaceutical. The main goal is to promote an intentional discussion among people of color, community base organizations and clinics about HIV treatment, race and social drivers of HIV. The social drivers that influence people of color premature deaths are economics, violence, health literacy, and mental health.This is compounded when we take into account race, sexual orientation, gender identity or geography. The underlying and systems of inequality are larger than HIV and thus must be addressed simultaneously.Taking a holistic view allows us to identify the urgency of HIV while integrating the other intersectional realities of people’s lives.
6:30 pm – 7:30 pm AFFINITY SESSIONS
Location: *Check Affinity Session board located near registration booths.
7:30 pm – midnight A MAGICAL NIGHT OF THE DANCING GOWNS Location: Marquis Ballroom, Meeting Level 2
The 2nd Annual DC Trans Ball, hosted by Casa Ruby, is an event to bring HIV Awareness to the community. Come to support the local LGBTQ and Trans Community. Conference attendees must wear their USCA conference badge for entrance to the Ball.
UNITE TO END THE EPIDEMICS Our mission is to end the intersecting epidemics of HIV, viral hepatitis, and related conditions by strengthening domestic and global governmental public health through advocacy, capacity building, and social justice. Our vision is a world free of HIV and viral hepatitis Learn more at www.NASTAD.org
SCHEDULE AT A GLANCE 7:00 am – 7:45 am
MORNING WORSHIP SERVICE
9:00 am – 11:00 am
SOCIAL MEDIA LAB
9:00 am – 11:00 am
Location: Dogwood, 2nd Floor
Location: Marquis Salon 14, Meeting Level 2 Session 9 Workshops
Ask a Provider: Updates on HIV and HCV Treatment Location: Scarlet Oak, 2nd Floor
Leveraging Health Systems Data to Address Disparities and Service Gaps Location: Capitol, Meeting Level 4
Age is Not a Condom — Older Adults and HIV Prevention Location: Tulip, 2nd Floor
The Promise of Viral Hepatitis Elimination in the United States Location: George Washington, Meeting Level 1
Supporting the Leadership of Jurisdictions in Integrated HIV Prevention and Care Planning Location: Chinatown, Meeting Level 3
Advocacy: Engagement Strategies to End the Epidemic Location: Mint, Meeting Level 4
Sex Work and Safe Syringes: HIV Criminalization Advocacy — Beyond Non-Disclosure Location: Judiciary Square, Meeting Level 3
Together We Can: Bridge Building between National HIV Organizations and Regional/State/ Local HIV Organizations Location: Archives, Meeting Level 4
You Better Werk: Incorporating Drag Performance in HIV Prevention Location: LeDroit Park, Meeting Level 3 The Pedagogy of Action Module: Exploring HIV Education through Dance Location:Mount Vernon Square, Meeting Level 3 Centering Transgender Leadership in the HIV Field Location: Union Station, Meeting Level 3
Benefits of Facilitating an HIV Self-Management Intervention for HIV-Positive Peers Location: Congress, Meeting Level 4 Southern Salvation: Black Gay Men, HIV, and the Black Church Location: Treasury, Meeting Level 4
Closing Plenary Luncheon
11:30 am – THE POWER OF WOMEN AND THE FUTURE 1:30 pm
OF LEADERSHIP FOR WOMEN OF COLOR Location: Marquis Ballroom, Meeting Level 2
9:00 am – 11:00 am Session 9 Workshops
ASK A PROVIDER: UPDATES ON HIV AND HCV TREATMENT
Presented by: Erin Athey, DNP, FNP-BC, RN, George Washington University, Association of Nurses in AIDS Care, Washington, DC + Lisa Fitzpatrick, MD, MPH, HIV Medicine Association, Washington, DC + David Hardy, MD, Whitman Walker Health, HIV Medicine Association, Washington, DC + Jeffrey Kwong, DNP, MPH, ANP-BC, ACRN, Columbia University, Association of Nurses in AIDS Care, New York, NY Moder ator: Andrea Weddle, HIV Medicine Association, Washington, DC Location: Scarlet Oak, 2nd Floor Pathway: Health Care Providers Level: Intermediate
Seasoned HIV experts with Hepatitis C treatment experience will kick off the discussion with a brief overview of the latest drugs and treatment recommendations for managing HIV and Hepatitis C and then open it up to take questions from participants. This session offers the opportunity to ask those questions that you haven’t been able to ask your provider or to get tips for helping your clients make the most of their medical visits. Open dialogue between participants and panelists makes this an informative and interactive session. AGE IS NOT A CONDOM — OLDER ADULTS AND HIV PREVENTION
SUPPORTING THE LEADERSHIP OF JURISDICTIONS IN INTEGRATED HIV PREVENTION AND CARE PLANNING
Presented by: Sonya Hunt Gr ay, HRSA/HAB, Rockville, MD + Terri Richards, HRSA/HAB, Rockville, MD + Amelia Khalil, HRSA/HAB, Rockville, MD + June Mayfield and Erica Dunbar, Centers for Disease Control and Prevention, Atlanta, GA + Stewart Landers, Julie Hook and Julie Powers, John Snow Inc. Location: Chinatown, Meeting Level 3 Pathway: HRSA Level: Intermediate
Presented by the CDC/HRSA Integrated HIV PlanningWorkgroup, this workshop will provide an overview of CDC and HRSA’s ongoing efforts to promote integrated HIV prevention and care plans and planning activities to reduce new HIV infections, increase access to care for people living with HIV (PLWH), improve health outcomes for PLWH, and reduce HIV-related disparities and health inequities through a more coordinated, data- and communitydriven, jurisdictional response. SEX WORK AND SAFE SYRINGES: HIV CRIMINALIZATION ADVOCACY — BEYOND NONDISCLOSURE
Presented by: Joe Lunievicz, ACRIA, New York, NY + Lisa Frederick, ACRIA, New York, NY + Mark Brennan-Ing, PhD, ACRIA, New York, NY + Michelle Lopez, ACRIA, New York, NY + Leo Asen, AARP and Member of New York State Older Adults and HIV Coalition
Presented by: Kathryn Boulton, Center for HIV Law and Policy, New York, NY + Sabrina Reward, National LGBTQ Task Force, Washington, DC + Kiefer Paterson, Harm Reduction Coalition, Washington, DC + Sasank a Jinadasa, HIPS, Washington, DC
Location: Tulip, 2nd Floor Pathway: Aging Level: Intermediate
Location: Judiciary Square, Meeting Level 3 Track: Public Policy Level: Intermediate
Adults 50+ are an invisible population in the HIV epidemic. Older adults account for 18 to 22 % of all new HIV detections and the highest rates of concurrent HIV/AIDS diagnosis. Care providers are reluctant to talk with older adults about sexual health, HIV prevention, testing and the use of PrEP and PeP. The reality is that older adults have sex, often while using licit and illicit drugs.While post-menopausal women find themselves liberated and seek the pleasure of sex and a companion to share the joys and challenges of aging, condom use remains critically low.This interactive workshop will provide an overview of the greying of the HIV epidemic, examining key prevention and sexual health issues for older adults living with and at risk for HIV. The rallying phrase Age is Not A Condom will be explored as well as recent images developed for older adult HIV prevention campaigns.
The HIV criminalization reform movement has focused on laws criminalizing non-disclosure of a person’s positive HIV status prior to consensual sexual activities. Although people living with HIV who inject drugs or engage in sex work are particularly vulnerable to criminalization, the movement for HIV criminal law reform has been largely divorced from advocacy for decriminalization of sex work or support for safe syringe access. In the 33 states that have HIV criminal laws on the books, nearly half specifically target people who inject drugs. Sex workers charged under archaic antiprostitution laws often face enhanced criminal penalties if they are living with HIV. Advocates working on decriminalization of sex work, promotion of safe syringe access, and HIV criminal law reform are natural allies. Improving communication, collaboration, and coordination between these different advocacy communities would benefit our collective efforts.
YOU BETTER WERK: INCORPORATING DRAG PERFORMANCE IN HIV PREVENTION
Presented by:Carlos Fr agoso, Puerto Rican Cultur al Center, Chicago, IL + Matthew Gr aham, Puerto Rican Cultur al Center, Chicago, IL Location: LeDroit Park, Meeting Level 3 Track: Gay Men Level: Beginner
Despite the major strides in HIV prevention in recent years, some groups have experienced an increase in incidence rates, including young African American and Latinx men who have sex with men (YMSM). One of the attributing factors to this trend is the lack of culturally relevant engagement amongst HIV service providers with this demographic. If implemented properly, the incorporation of drag culture and performance in HIV prevention services can prove incredibly useful in conducting outreach to MSM youth. This workshop will provide insights, strategies and best practices on leveraging your available resources to incorporate drag into your work. Whether your organization has previous experience in this area or is completely new to drag, we hope to provide valuable information in exploring this pathway. THE PEDAGOGY OF ACTION MODULE: EXPLORING HIV EDUCATION THROUGH DANCE Presented by: Adrian Neil, Jr., AIDS United, Washington, DC + Rodney Brown, The Brown Dance Project, New York, NY Location: Mount Vernon Square, Meeting Level 3 Pathway: Youth Level: Beginner
Education Options in Dance Composition: The Brown Dance Project (The BDP) Translating the Pedagogy of Action (POA) Module on HIV Education involves words and Dance Composition HIV education. The imperative of this translation research seeks to develop dance material such that a viewer can distinguish some functional differences between Red and White Blood Cells, dissimilarities of HIV and AIDS, understanding of Stigma, 4 factbased ways HIV can be transmitted and ways to prevent HIV infection — mediated with the Modern or Contemporary Dance genus. Can the dance teach? Can the POA module be an effective tool as a way to teach individuals who might be unaware of HIV? We do know, that dance can communicate and information can be shared through movement and words. This session will not only focus on using the art of dance as a tool educate communities but will also empower participants to take what they’ve learned and teach it back to their communities.
This workshop will have two goals. First, it will present the consensus statement developed by a Transgender Think Tank convened by AIDS United. That statement, formed through the expertise of think tank participants and using lessons learned from two AIDS United grantmaking initiatives, can inform programs tailored to serve the transgender community, particularly related to engagement into HIV care. Second, the workshop will provide an overview of AIDS United’s new Transgender Leadership Initiative, focused on supporting and centering the leadership of people of trans experience within the HIV field. The initiative encompasses both program and policy advocacy work and aims to strengthen grantee capacity in both areas. The workshop will be presented by AIDS United staff and affiliates along with at least one grantee organization of the Transgender Leadership Initiative and will review early lessons learned from this new funding initiative.
LEVERAGING HEALTH SYSTEMS DATA TO ADDRESS DISPARITIES AND SERVICE GAPS Presented by: Alyssa Kitlas and Edwin Corbin-Gutierrez, NASTAD, Washington, DC Eduardo Alvarez, Illinois Department of Public Health, Springfield, IL + Jenny R. McFarlane, Texas Department of State Health Services, Austin, TX + Andrea Lombard, Connecticut Department of Public Health, Hartford, CT Location: Capitol, Meeting Level 4 Pathway: Health Departments Level: Intermediate
Fully understanding the HIV and Hepatitis burden in a jurisdiction is an essential starting place in any effort aiming to end the epidemics. Matching surveillance and service delivery data with data on other health conditions and social determinants of health available through electronic health records (EHRs), Medicaid claims, and all-payer claims databases can provide powerful insights for community providers and health departments. These data can help contextualize existing gaps in services across the prevention and care continuum and pinpoint new opportunities to improve health outcomes. In this workshop, participants will hear examples of how HIV prevention and care programs are using these data to engage health care providers through strategies such as academic detailing to expand HIV and hepatitis screening, PrEP, and other essential services. Participants will also learn how hepatitis programs are leveraging EHR and Medicaid claims data to build HCV cure cascades to help target services.
CENTERING TRANSGENDER LEADERSHIP IN THE HIV FIELD
Presented by: Morey Riordan, Riordan Str ategies, San Fr ancisco, CA + Shannon Wyss, AIDS United, Washington, DC Location: Union Station, Meeting Level 3 Track: Cis & Trans Women Level: Intermediate
THE PROMISE OF VIRAL HEPATITIS ELIMINATION IN THE UNITED STATES Presented by: Katie Burk, San Fr ancisco Department of Public Health, San Fr ancisco, CA + Elizabeth Paukstis, National Vial Hepatitis Roundtable, Washington, DC Location: George Washington, Meeting Level 1 Pathway: Hepatitis Level: Beginner
We can end viral hepatitis. Hepatitis C drugs cure 90-100% of people living with HCV in 12 weeks with mild side effects. While there is no cure for hepatitis B, but there are medications that one can take to reduce liver damage and long-term risks. Also unlike HCV, we DO have a vaccine to prevent HBV. This year the National Academies of Sciences, Engineering and Medicine released a report entitled “A National Strategy for the Elimination of Hepatitis B and C.” In it, they make a series of recommendations that, if followed, serve as a blueprint to prevent new infections, cure existing HCV infections and treat and manage hepatitis B until a cure is discovered. This session will review this plan, and provide hepatitis elimination examples from a city, state and national level, as well as discuss key populations we must work with if we want to be successful. ADVOCACY: ENGAGEMENT STRATEGIES TO END THE EPIDEMIC
TOGETHER WE CAN: BRIDGE BUILDING BETWEEN NATIONAL HIV ORGANIZATIONS AND REGIONAL/STATE/LOCAL HIV ORGANIZATIONS Presented by: Sable K. Nelson, Esq., NMAC, Washington, DC Location: Archives, Meeting Level 4 Track: Public Policy Level: Intermediate
The HIV Community has experienced a several unexpected challenges since November 2016. In light of the persistent threats to healthcare access that would perpetuate and exacerbate health disparities that exist across the HIV Care Continuum, it is imperative that national, regional, state, and local HIV/AIDS organizations communicate and work collaboratively to protect gains achieved under the Affordable Care Act and advocate for sufficient funding to support HIV prevention and treatment programs. Unfortunately, we haven’t always done that well. NMAC is committed to leading with race and holding space for a vibrant discussion of how national, regional, state, and local HIV/AIDS organizations can work and communicate better together towards our shared goals of providing the best outcome possible for people living with, affected by, and at-risk for HIV. Participants will leave the session with concrete actions they can take to improve interorganizational communications and collaborations.
Presented by: Lestian L. McNeal, The Black AIDS Institute, Los Angeles, CA Location: Mint, Meeting Level 4 Pathway: Race: African American and Black Level: Advanced
In today’s fight to end the epidemic it is nearly impossible to separate the work from the politics and policies surrounding HIV. HIV Criminalization Laws, Funding, Research and Mass Incarceration all play a role in how the epidemic continues to impact the Black community. History has shown us that despite the state of our current politics progress and social change are not beyond our reach.We saw it in 1955 Montgomery, in the streets of Washington, DC in 1968, and in the election of the first Black President of the United States in 2008. Advocacy has shaped nearly every aspect of our world and its effectiveness to push us all forward is not lost here at the Black AIDS Institute. Here at the Black AIDS Institute we intend to use advocacy as one of many tools at our disposal to push our needs to the forefront and make the systemic changes needed to end the epidemic.
BENEFITS OF FACILITATING AN HIV SELFMANAGEMENT INTERVENTION FOR HIVPOSITIVE PEERS
Presented by: Amanda Raker, MPH, New York City Department of Health and M ental H ygiene , L ong I sland C ity , NY + S tephen H ile , MSW, N ew Y ork City Department of Health and Mental Hygiene, Long Island City, NY + Matthew Feldman, PhD, MSW, New York City Department of Health and Mental Hygiene, Long Island City, NY Location: Congress, Meeting Level 4 Track: People living with HIV Level: Intermediate
Peer educators (“peers”) represent a valuable resource in delivering HIV treatment interventions to people living with HIV (PLWH), as individuals who are similar to participants in terms of demographic characteristics and HIV status. Specifically, HIV-positive peers can better understand the experience of living with HIV, and therefore enhance the relevance and credibility of intervention content.While there is evidence that peer-led HIV treatment interventions are effective in improving HIV health outcomes among those who are the targets of the intervention, few studies have assessed the health and psychosocial benefits of working as an HIV-positive peer. We conducted qualitative interviews to examine how the experience of being a peer for an HIV self-management intervention impacts: (a) health behaviors; (b) social support; and (c) opportunities for professional development.
SOUTHERN SALVATION: BLACK GAY MEN, HIV, AND THE BLACK CHURCH
Presented by: Shanell L. McGoy, PhD, MPH, Tennessee Department of Health, Nashville, TN + Khafre K. Abif, Southern AIDS Coalition, Atlanta, GA + Mardrequs Harris, National Association of County and City Health Officials, Washington, DC Location: Treasury, Meeting Level 4 Pathway: South Level: Intermediate
For generations, the Black Church has been a leader for change in the Black community on issues of social justice, including voting rights and employment opportunities. For many families, the Black Church is also the epicenter of faith, community, and understanding. Instead of reaching out and ministering to Black gay men, however, the Black Church has opted for rejection, ridicule, and condemnation. Where does the Black gay man turn for healing and hope? Who helps to validate him? How has this approach contributed to the HIV epidemic in Black America? We will explore these questions through an interactive session that includes an in-depth discussion about HIV in the Black Church, allowing participants to share personal experiences and discuss strategies for how to successfully enlist faith leaders as change agents in the fight against HIV in Black America.
11:30 am – 1:30 pm Closing Plenary Luncheon
THE POWER OF WOMEN AND THE FUTURE OF LEADERSHIP FOR WOMEN OF COLOR Location: Marquis Ballroom, Meeting Level 2
Join us for this powerful closing plenary as we celebrate the leadership of women of color. Invited speakers will address the importance of women’s leadership at all levels — in community organizing, on planning bodies and in health care. The panelists will also discuss the importance of developing and fostering new leaders. Presenters:
Linda Sarsour, Co-Chair, Women’s March
Naina Khanna, Positive Women’s Network-USA
Grissel Granados, Children’s Hospital Los Angeles
Tiommi Luckett, The Well Project
Gina Brown, Southern AIDS Coalition
Location: Meeting Level 3 Friday, September 8, 1:30 pm – 2:00 pm Saturday, September 9, 1:30 pm – 2:00 pm
Biomedical HIV Prevention
“PrEP in the Wild”: What is Motivating “Informal” PrEP Use?
• Ryan Cook, UCLA, Los Angeles, CA
Promoting PrEP Use Among Women of Color in Washington, DC
• Ashlee Wimberly, MPH,Washington AIDS Partnership, Washington, DC Rapid START — Quickly Lowering Community Viral Load with Expedited Linkage
San Francisco’s Biomedical HIV Prevention and Care Continuum for Youth
• Adam Leonard and Miranda Nordell, San Francisco Department of Public Health, San Francisco, CA, • Eva Kersey and Julie Frank, Larkin Street Youth Services, San Francisco, CA • Carol Dawson-Rose, Amy Schustack, and Ladan KhoddamKhorasani, University of California at San Francisco, San Francisco, CA
• Joseph Olsen MPH and Nicole Hubschman MPH, CrescentCare, New Orleans, LA Cis & Trans Women
Innovative Assessment of Childhood Trauma and HIV in Post-incarcerated Women
• Nike Blue, MPH, and MaxineYoung, AIDS Foundation Houston, Inc., Houston,TX
Implementing Targeted Interventions Using Identified Barriers to Care for Women
• Kelsey Holloman, MPH, CHES, Broward Regional Health Planning Council, Hollywood, FL
Represent Your Cupcake: A Sex-Positive Workshop Promoting HIV/AIDS Awareness
• Shawna Edgerson, MPH, CHES, Kansas City CARE Clinic, Kansas City, MO Gay Men
Gayming at Work: Creating Effective Engagement for YMSM of Color
Online Health Promotion for Gay/Bi Men: California’s Peer2Peers Project
Innovative LTC Methods for Newly Diagnosed Gay Youth
Structural Factors Impacting HIV Service Utilization for Latino GBT Youth
• Mikael Kiezer and Obed Caballero, Latinos Salud,Wilton Manors, FL
• Tony Iniguez, AltaMed Health Services, Los Angeles, CA
• Patrick Piper, CAPTC, Long Beach, CA
• Diana Lemos, AIDS Foundation of Chicago, Chicago, IL
Building Leadership and Capacity in Mid-Level Organizations Practices
• Cynthia Tucker, AIDS Foundation of Chicago, Chicago, IL Passing The Baton: From Outreach to Leadership
• Azul DelGrasso, Denver Prevention & Training Center, Denver, CO • Alex Demopoulos, Asian & Pacific Islander Wellness Center, Inc., San Francisco, CA; • Bolivar Nieto, Latino Commission on AIDS, New York, New York
Sistas Organizing to Survive: Mobilizing Black Women to Address HIV
• Krystle Mobley, Janelle Taveras and Ivy Ye, Florida Department of Health Broward County, Ft. Lauderdale, FL Who Cares? Self Cares! Wellness Strategies for HIV Positive Communities of Color
• Adrian Neil, Jr., AIDS United, Washington, DC
People Living with HIV
• Tiana Monteilh and Jeff Bailey, APLA Health, Los Angeles, CA
The HOPWA Homebuyer Project: “Homeownership: The Forgotten Option”
The Health Needs of Older HIV+ Latinos: A National Assessment
Reducing Tobacco Use Among PLWH: Saving Lives Through Systems Change
Looking Back to Move Forward: HIV & Older Adults
• Dr. David Garcia, Latino Commission on AIDS, New York, NY
• Michael G Smith, The Housing Trust, Santa Fe, NM
• Carrie Kirpatrick, Michigan Department of Health and Human Services, Lansing, MI
90/90/90/50 Plan: Framework for Ending the HIV Epidemic in DC
• Lena Lago, DC Department of Health, Washington, DC
NYS Integrated Plan: Partnerships in Ending the Epidemic
• Karen Hagos, MPH, New York State Department of Health AIDS Institute, Albany, NY
Community-Based Agencies Leading Prevention & Care Integration: Washington State Strategies
• Michael Barnes and Karen Robinson, Washington State Department of Health • Lorenzo Cervantes, Pierce County AIDS Foundation • Tony Koester, Lifelong
EN THURSDAY ESPAÑOL
Sesiones en Español Todas las sesiones traducidas al idioma tendrán lugar en el Judiciary Square, Nivel 3 de Reuniones del hotel Marriott Marquis. Jueves 7 de septiembre
Sesión 1: De 10:15 am a 12:00 p.m.
EL Liderazgo y su Importancia en la Prevención y las Intervenciones de VIH
Sesión 2: De 2:45 pm a 4:45 pm
Desmitificación de la Educación Sexual y su Rol en la Prevención del VIH Viernes 8 de septiembre
Sesión 3: De 9:00 am a 11:00 am
Reformas en la Determinación de los Precios de Medicamentos — Una Caja de Herramientas para los Activistas
Sábado 9 de septiembre
Sesión 6: De 9:00 am a 11:00 am
Construir Apoyo para la Reforma de las Leyes que Penalizan el VIH
Sesión 7: De 2:00 pm a 4:00 pm
El Panorama de la Atención Médica está Cambiando; ¿está Su Organización Considerando Cambios en el Modelo de Prestación de Servicios?
Sesión 8: De 4:15 pm a 6:15 pm
Cómo Redactar Solicitudes de Subsidios Exitosas Domingo 10 de septiembre
Sesión 4: De 2:00 pm a 4:00 pm
Movilización de las Comunidades: Facilitadores y Barreras en 9 Ciudades de los EE. UU.
Sesión 5: De 4:15 pm a 6:15 pm
El Enfoque Indirecto: Acceso para los Hombres Gay a Través del Compromiso y el Empoderamiento
Sesión 9: De 9:00 am a 11:00 am
Trabajo Sexual y Jeringas Seguras: Defensa Frente a la Penalización del VIH — Más allá del Ocultamiento
EN THURSDAY ESPAÑOL
Sesión 1: Jueves 7 de septiembre de 10:15 am a 12:00 pm
Sesión 3: Viernes 8 de septiembre de 9:00 am a 11:00 am
EL LIDERAZGO Y SU IMPORTANCIA EN LA PREVENCIÓN Y LAS INTERVENCIONES DE VIH
REFORMAS EN LA DETERMINACIÓN DE LOS PRECIOS DE MEDICAMENTOS — UNA CAJA DE HERRAMIENTAS PARA LOS ACTIVISTAS
Presentado por:Quinn M. Gentry, PhD, MBA, Messages of Empowerment Productions, Atlanta, GA Tema: Liderazgo Nivel: Intermedio
Este taller se centra en reducir la brecha entre el “´liderazgo organizativo” y la “gestión de los programas” de una manera que optimice el uso eficaz de los recursos necesarios para combatir las desigualdades en salud en VIH/SIDA. Dirección y gestión son funciones colaborativas dentro de una organización que deben funcionar sin roces para que el desempeño sea óptimo y facultar a las agencias para que desarrollen mayor capacidad de respuesta frente a los factores sociales y estructurales subyacentes determinantes delVIH/SIDA. En un sentido práctico, este taller se centrará en las funciones clave dentro de una organización que deben estar integradas para una mejor capacidad, entre ellas: (1) dirección general y operaciones; (2) presupuestos y contabilidad; (3) administración de recursos humanos; (4) participación de interesados; (5) dirección y gestión de programas; (6) sistemas de información y tecnología; (7) captación de fondos; (8) marketing y gestión de marca; (9) manejo de crisis; y (10) planificación estratégica. El taller también incluye un componente de autodesarrollo donde los directores y gerentes trabajan sobre un modelo para establecer planes de acción individuales y a nivel de la organización para institucionalizar la integración de la dirección y la gestión.
Sesión 2: Jueves 7 de septiembre de 2:45 pm a 4:45 pm
Presentado por: Britten Pund, NASTAD, Washington, DC + Tim Horn, Treatment Action Group, Nueva York, NY Tema: Política Pública Nivel: Intermedio
En Washington, DC, todo el mundo habla de cómo se fijan los precios de los medicamentos. No obstante, los detalles de esto suelen seguir siendo un misterio y no son parte del debate. Esta sesión facilitará a los proveedores de atención de VIH y a los defensores de los derechos de las personas con VIH las herramientas para entender el sistema de fijación de precios de los medicamentos y apoyar reformas que reducirán los precios para los pacientes, proveedores y seguros públicos (Medicare and Medicaid). Esta sesión ofrecerá una perspectiva general del sistema americano de fijación de los precios de medicamentos y explorará el impacto de varias propuestas de políticas en el sector del VIH, incluido el Programa de Descuentos de Medicamentos 340B
Sesión 4: Viernes 8 de septiembre de 2:00 pm a 4:00 pm MOVILIZACIÓN DE LAS COMUNIDADES: FACILITADORES Y BARRERAS EN 9 CIUDADES DE LOS EE. UU.
Presentado por: Kenyon Farrow, Treatment Action Group, Nueva York, NY + Tim Horn, Treatment Action Group, Nueva York, NY
DESMITIFICACIÓN DE LA EDUCACIÓN SEXUAL Y SU ROL EN LA PREVENCIÓN DEL VIH
Presentado por: Jesseca Boyer, Guttmacher Institute, Washington, DC + Kaitlyn Marchesano, Planned Parenthood Feder ation of America, Nueva York, NY Tema: Política Pública Nivel: Inicial
La educación sexual podría ser la herramienta de prevención del VIH más poderosa disponible. Pero no solo es a menudo dejada de lado en las conversaciones de política, sino que además es confusa y malinterpretada. Simplemente, ¿qué significa “educación sexual”? Participe de una discusión con los representantes de las organizaciones nacionales que encabezan los esfuerzos por mejorar la calidad de la educación sexual en los Estados Unidos sobre la situación actual del financiamiento, las políticas y las prácticas a lo largo del país, las oportunidades y los desafíos en el clima político actual y lo que todo ello significa para la prevención del VIH y la salud y los derechos sexuales y reproductivos de la gente joven.
Tema: Política Pública Nivel: Intermedio
Cuál es el papel de la comunidad en combatir la epidemia en los EE. UU. Desde el inicio de la epidemia de VIH, las comunidades se han movilizado para instar a las instituciones de asistencia sanitaria y a las autoridades de salud pública a dar respuesta a las necesidades de las personas que viven con VIH o que son vulnerables a la enfermedad. Las redes de activistas movilizadas también crearon las organizaciones basadas en la comunidad (CBO por sus siglas en inglés) para prestar servicios de prevención y asistencia, y se organizaron para cambiar políticas y leyes a todos los niveles de gobierno. Si bien este trabajo está detallado en historias orales y escritas de la respuesta a la epidemia, en la literatura científica hay escasas descripciones acerca de sus metodologías y resultados. Este taller revelará los resultados de un informe del Treatment Action Group, TAG (Grupo de Acción para Tratamiento) titulado “Community Mobilization: An Assessment of Mechanisms and Barriers at Community-Based and AIDS Service Organizations in Nine U.S. Metropolitan Areas” (movilización de las
THURSDAY SUNDAY EN THURSDAY ESPAÑOL
comunidades: una evaluación de los mecanismos y las barreras en las organizaciones basadas en la comunidad (las CBO) y las organizaciones de servicios contra el SIDA (las ASO) en nueve áreas metropolitanas de los EE. UU.) e invitará a los asistentes a participar en soluciones para lograr que la movilización de las comunidades sea una mayor prioridad en la respuesta de los EE. UU. al VIH.
Criminalization Clinicians Guidelines) como un mecanismo para abrir el diálogo y lograr la participación de otras personas en los esfuerzos de modernizar las leyes de penalización del VIH.
Sesión 7: Sábado 9 de septiembre de 2:00 pm a 4:00 pm
Sesión 5: Viernes 8 de septiembre de 4:15 pm a 6:15 pm EL PANORAMA DE LA ATENCIÓN MÉDICA EL ENFOQUE INDIRECTO: ACCESO PARA LOS HOMBRES GAY A TRAVÉS DEL COMPROMISO Y EL EMPODERAMIENTO
Presentado por: Yashica Ellis, Wellness Services Inc., Flint, MI + Teresa Springer, Wellness Services Inc., Flint, MI Tema: Hombres Gay Nivel: Intermedio
Los servicios de prueba deVIH y conexión con asistencia para hombres gay siempre se han enfocado en la educación sobre el VIH y luego en la prueba de detección. Ha sido una carga para los hombres gay tener la prevención o la asistencia de VIH como centro principal de atención en sus vidas sociales. Este taller se centrará en crear puntos de acceso seguro en la comunidad que no se enfoquen directamente en la educación y prueba de VIH sino en el compromiso y el empoderamiento con un enfoque de reclutamiento para los servicios de prueba y asistencia. El proceso de reclutamiento de Wellness Services incluye un centro social de acogida de jóvenes LGBTQ+, talleres de desarrollo de capacidades, un centro cibernético, noches de juegos y películas, conexión con recursos de la comunidad, despensa de alimentos, ropa gratuita, presentación del festival del Orgullo Gay de Flint. Nos centramos en lograr conexión y confianza primero mientras trabajamos en preparar a la persona para la prueba y el tratamiento. Esto ha conducido a un aumento de los servicios de prueba y asistencia para los MSM (hombres que tienen sexo con hombres) de color entre las edades de 13 a 29.
ESTÁ CAMBIANDO; ¿ESTÁ SU ORGANIZACIÓN CONSIDERANDO CAMBIOS EN EL MODELO DE PRESTACIÓN DE SERVICIOS? Presentado
Laur a Ger ard, John Snow Research & Tr aining, Inc.
Tema: Política Pública Nivel: Inicial
El panorama de la prevención del VIH ha cambiado radicalmente en los últimos años y probablemente continuará experimentando fuertes cambios en los próximos años. Con fondos limitados y mandatos que requieren apoyar la totalidad del continuo de asistencia médica de VIH, las organizaciones basadas en la comunidad tradicionales, es decir, las CBO, han tenido que reevaluar sus modelos de prestación de servicios y determinar cómo seguirán siendo viables en un entorno cambiante. La solicitud para convertirse en un centro de salud habilitado por el gobierno federal, es de decir, en un FQHC (por sus siglas en inglés) es una opción de consideración para muchas CBO. Además de conocer acerca de los 19 requisitos específicos de política federal para los FQHC, los participantes se informarán acerca de los beneficios de convertirse en un FQHC, entre ellos, subsidios para compensar los costos de la asistencia no remunerada, descuentos en los precios de los medicamentos de productos farmacéuticos bajo el programa 340B, garantías de préstamos federales para mejoras de capital y acceso a proveedores médicos, dentales y mentales del National Health Service Corps o NHSC (Cuerpo Nacional de Servicios de Salud). A lo largo de la sesión se presentará un caso práctico de una Organización de Servicios contra el SIDA —una ASO— que se transformó exitosamente para convertirse en un FQHC.
Sesión 6: Sábado 9 de septiembre de 9:00 am a 11:00 am
Sesión 8: Sábado 9 de septiembre de 4:15 pm a 6:15 pm
CONSTRUIR APOYO PARA LA REFORMA DE LAS LEYES QUE PENALIZAN EL VIH
CÓMO REDACTAR SOLICITUDES DE SUBSIDIOS EXITOSAS
Presentado por: Erin Athey ANAC + Barb Cardell PWN + Sean Strub Sero Project + Carole Treston ANAC Tema: Política Pública Nivel: Intermedio
Lo invitamos a escuchar una actualización del estado actual de la penalización del VIH en los EE. UU. Se discutirán estrategias para construir alianzas entre los defensores de derechos y los proveedores de atención. Se destacará el impacto de las leyes de penalización delVIH sobre el estigma delVIH. Esta sesión interactiva utilizará las Directrices Clínicas sobre la Penalización del VIH (HIV
Presentado por: Stephen Fallon, PhD, Skills4, Ft Lauderdale, FL + Theo Noel, II, The Guiding Right — Midwest City, + Ok an Gunay, Esq., Ok an, Latinos Salud — Wilton Manors, FL Tema: Liderazgo Nivel: Intermedio
El otorgamiento de fondos para la prevención delVIH y los servicios de VIH está cambiando. Las agencias deben adaptarse si desean completar con éxito solicitudes cada vez más complejas. Este taller altamente interactivo guiará a los participantes para evaluar sus prioridades de servicios, alinearlas con los objetivos establecidos
EN THURSDAY ESPAÑOL
por cada financiador y luego ponderar cada palabra de sus solicitudes de subsidios para lograr la adjudicación del escaso financiamiento. Los facilitadores descifrarán el código de redacción de subsidios y revelarán los gajes del oficio que hacen que algunas solicitudes tengan más probabilidades de conseguir el financiamiento. Los participantes examinarán ejemplos reales de la narrativa de subsidios y aprenderán a identificar las fortalezas presentes en cada uno, y también las oportunidades desaprovechadas. Los facilitadores también mostrarán a los participantes la manera de dividir la inmensa tarea de preparar una solicitud de subsidio estatal o federal, de manera tal de llegar a tener la propuesta completa a tiempo para satisfacer los plazos.
Sesión 9: Domingo 10 de septiembre de 9:00 am a 11:00 am TRABAJO SEXUAL Y JERINGAS SEGURAS: DEFENSA FRENTE A LA PENALIZACIÓN DEL VIH —MÁS ALLÁ DEL OCULTAMIENTO
Presentado por: Kathryn Boulton, Center for HIV Law and Policy, Nueva York, NY + Sabrina Reward, National LGBTQ Task Force, Washington, DC + Kiefer Paterson, Harm Reduction Coalition, Washington, DC + Sasank a Jinadasa, HIPS, Washington, DC Tema: Política Pública Nivel: Intermedio
El movimiento de reforma de la penalización del VIH se ha centrado en leyes que penalizan el ocultamiento del estado VIH positivo de una persona antes de tener actividades sexuales consensuadas. Si bien las personas que viven con VIH que utilizan drogas inyectables o que hacen trabajo sexual son especialmente vulnerables a la penalización, el movimiento para la reforma de las leyes penales contra el VIH ha estado en gran medida separado de la defensa en favor de la despenalización del trabajo sexual o el apoyo para el acceso a jeringas seguras. En los 33 estados que tienen leyes penales para el VIH, prácticamente la mitad apuntan específicamente a las personas que se inyectan drogas. Los trabajadores sexuales inculpados en virtud de las arcaicas leyes contra la prostitución a menudo se enfrentan con sanciones penales incrementadas si tienen VIH. Los defensores de derechos que están trabajando en la despenalización del trabajo sexual, la promoción del acceso a jeringas seguras y la reforma de las leyes penales contra el VIH son aliados naturales. Mejorar la comunicación, la colaboración y la coordinación entre estas comunidades de defensa diferentes sería beneficioso para nuestros esfuerzos colectivos.
Many thanks to our organizers, guests, and attendees
Ever yours in the struggle. 1000 Vermont Ave. NW, Suite 200 Washington, DC 20005 202-853-0021 www.nmac.org
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Copyright © 2017 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. INFC-1198984-0011 05/17
Talk with your healthcare provider for information.